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I  
Abstract 
 
 
Vibrio vulnificus is a significant human pathogen commonly isolated from temperate 
marine environments, where it is particularly abundant within filter-feeding shellfish. V. 
vulnificus is currently increasing in prevalence, theorised to be due to climate change 
facilitating V. vulnificus growth in previously inhospitable environments. Infection of 
susceptible individuals with V. vulnificus typically results in either primary septicaemia 
or necrotic wound infection, depending upon the route of entry, and frequently results 
in death if not treated rapidly. 
Two type 6 secretion systems (T6SS) have been identified in V. vulnificus, termed the 
T6SS1 and the T6SS2. The T6SS is a molecular syringe utilised to inject cytotoxic 
effector proteins into neighbouring cells. Whilst the T6SS2 is present in all sequenced 
V. vulnificus strains, only a subset possesses the T6SS1. Previous bacterial co-culture 
killing assays between T6SS1+ and T6SS1- V. vulnificus strains demonstrated 
thermoregulated T6SS1-mediated killing of T6SS1- strains. This study further 
characterised the role of both the T6SS1 and the T6SS2 in vitro. In vitro co-culture 
assays demonstrated that both the T6SS1 and the T6SS2 have antibacterial killing 
activity at the environmentally representative temperature of 21 °C. This is the first 
characterised role for the T6SS2 of V. vulnificus. No anti-eukaryotic activity was 
observed following co-culture with the phagocytic amoeba, Dictyostelium discoideum, 
suggesting that T6SS activity is purely antibacterial. 
In vitro bacterial co-culture assays were replicated in vivo using an oyster model. To 
facilitate high-level uptake of bacterial strains of interest by oysters, an artificial marine 
snow model was developed where bacteria were incorporated into easily ingested 
phytoplankton aggregates. Uptake of bacteria from artificial marine snow was 
extremely successful, resulting in bacterial loads within oysters significantly greater 
than achieved by any study to date. Using this model, this study was able to 
demonstrate that V. vulnificus utilises both the T6SS1 and the T6SS2 to target and kill 
neighbouring bacteria, in both an intra and inter-species manner. This data suggests 
that the T6SSs of V. vulnificus play a key role in V. vulnificus ecology and the dynamics 
between bacterial populations in vivo. 
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Introduction 
2  
1.1. Vibrios and Vibrio vulnificus 
 
Vibrios are ubiquitous aquatic microorganisms typically found in association with 
organisms such as molluscs, fish, phytoplankton and corals 1–4. Vibrios were first 
discovered in 1854, following the identification of Vibrio cholerae by Italian anatomist, 
Filippo Pacini 5. Vibrios have since been divided into four families, Vibrionaceae, 
Enterovibrionaceae, Salinivibrionaceae and Photobacteriaceae 6. To date, ~ 140 
Vibrionaceae family members have been identified, including established species 
such as Vibrio vulnificus, Vibrio parahaemolyticus, V. cholerae and more recently 
discovered species such as Vibrio crassostreae, Vibrio punensis and Vibrio celticus 7–
10. V. vulnificus was originally isolated in 1976 by the Centre for Disease Control and 
Prevention (CDC) upon receipt of 38 cultures of an unnamed halophilic bacterium11. V. 
vulnificus is a Gram-negative, comma shaped bacterium measuring 1.4 – 2.6 m in length and 
0.5 – 0.8 m in width 12. Described as having a lower salt tolerance than V. parahaemolyticus 
and as being a lactose positive Vibrio, their isolation primarily from blood samples 
inspired further study by clinical microbiologists 13. Initially typed as a new pathogenic 
species of genus Beneckea, this was adapted to V. vulnificus in 1979 following 
comparisons with other Vibrio species 14,15. 
 
 
1.2. Genetic diversity 
 
V. vulnificus is frequently notes as being a highly genetically diverse organism 4,16,17. 
Numerous strains have been genome sequenced and assembled in full, including 
CMCP6, FORC_017 and the reference strain YJ016, with the species having a 
common two-chromosome organisation 16,18–20. Chen et al., (2003) performed a 
chromosome-by-chromosome analysis of the sequences from V. vulnificus YJ016, V. 
3  
cholerae El Tor N16961 and V. parahaemolyticus RIMD 2210633 16. Results showed 
that overall V. vulnificus YJ016 displayed greater propensity towards conservation of 
gene organisation than V. cholerae and V. parahaemolyticus. Despite Vibrio genome 
evolution consisting of numerous intra and inter-chromosomal rearrangements, the 
overall topography of the larger chromosome was generally conserved. Further 
investigation into the functionalities contained within each chromosome revealed that 
the larger chromosome tends to contain housekeeping genes, such as those involved 
with growth whereas the smaller chromosome typically contains genes geared towards 
bacterial adaption 21,22. 
 
 
1.3. Typing 
 
Initially, V. vulnificus strains were subdivided by biotyping, the classification of a 
species based on a combination of serological, phenotypic and host range 
characteristics 12. Based on this, three V. vulnificus biotypes were proposed, named 
biotype 1 – 3. Identified in 1980, biotype 1 strains are predominantly associated with 
human infection 23. Biotype 2 strains were identified in 1982 and originally classified 
as eel pathogens 24. However, subsequent studies showed that not only were biotype 
2 strains capable of causing infection in humans, but when tested in a mouse model 
of infection they were more virulent (LD50 - 105 – 106 CFU) than biotype 1 strains (LD50 
- 108 CFU) 25–28. Biotype 3 strains were isolated following an outbreak of V. vulnificus 
 
wound infections in Israel, 1999 29. A 1996 – 1999 marketing policy enabling the sale 
of pond-raised tilapia and carp, combined with the hottest summers on record for 40 
years, resulted in outbreak of a novel V. vulnificus clonal variant 30,31. Patients suffered 
wound infections similar to those caused by biotype 1 strains, with 10 % mortality 31. 
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Interestingly, biotype 3 strains are geographically restricted, found exclusively within 
Israel and in the Sea of Galilee where they have caused ~ 200 infections between 
1996 – 2008 30. An exploratory study into the genome of the biotype 3 V. vulnificus 
strain, VVyb1, revealed 90 % sequence similarity to clinical biotype 1 strains 32. The 
authors also found that 29 of the ‘unique’ V. vulnificus VVyb1 genes had Shewanella 
homologues, a bacterium commonly co-isolated from Israeli aquaculture ponds. This 
suggests that biotype 3 strains may have evolved from a biotype 1 strain following 
acquisition of genes from Shewanella species. 
Whilst biotyping can help us subdivide V. vulnificus, there is an overlap between the 
three biotypes in terms of biochemical properties, host range, genotypes and 
phenotypes. Therefore, researchers have attempted to identify biomarkers for division 
of V. vulnificus into pathogenic and non-pathogenic strains. This would allow rapid 
identification of strains significant to human health in fields such as aquaculture and 
clinical microbiology. Currently, four genetic markers have been identified, 
polymorphisms in 16S ribosomal RNA (rRNA), the virulence correlated gene (vcg), 
pilF polymorphisms and variation in the capsular polysaccharide (CPS) operon 33–37. 
Perhaps the least well explored typing method, CPS composition has yet to be 
significantly correlated with pathogenicity 38,39. 
However, multilocus sequence typing (MLST) analysis of the genetic diversity of V. 
vulnificus enabled division of V. vulnificus populations based on variance in the pilF 
gene 34. 20 environmental and clinical strains were sequenced, and a multiplex PCR 
developed to identify V. vulnificus species dangerous to human health. Nearly all 
pathogenic strains were correctly identified, except for the type strain, CECT 529T. 
However, the relevancy of this pilF typing method is obscured by the fact that CECT 
529T, supposedly a pathogenic blood isolate, was unable to cause infection in an iron- 
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overloaded mouse model and has been identified as an environmental isolate by other 
typing methods. More recently, Baker-Austin et al., (2012) have developed a real-time 
PCR assay for more rapid and efficient identification of pathogenic V. vulnificus strains 
based on a polymorphism in the pilF gene 40. This method enabled 97.9 % detection 
of pathogenic isolates (n = 47). 
16S rRNA-based subdivision of V. vulnificus into separate genotypes has been 
reported by Aznar et al., (1994) 36. The authors hybridised oligonucleotide probes to 
the 16S rRNA of 13 V. vulnificus strains, dividing the strains into two groups, termed 
rRNA types A and B. This was based on a 17-nucleotide difference out of 1,536 bases 
in the 16S rRNA variable region. Nilsson et al., (2003) determined that rRNA type A 
strains are typically non-pathogenic (31 of 33), whereas rRNA type B strains are 
significantly correlated with disease in humans (26 of 34) 41. 
The most commonly referenced method of V. vulnificus genotyping is based on 
presence or absence of the virulence-correlated gene (vcg) 42. Randomly Amplified 
Polymorphic DNA PCR (RAPD-PCR) identified a 200 bp DNA fragment in all clinical 
V. vulnificus samples but only occasionally present in environmental isolates 42. 90 % 
of isolates from human infection cases were found to harbour the vcgC sequence and 
93 % of environmental strains the vcgE variant 43. Interestingly, vcgC has not yet been 
found to code for any protein despite its ability to differentiate the two genotypes. Four 
16S rRNA type B strains were characterised as C-type by vcg genotyping, while four 
other type A strains were classified as E-type. This serves to further support both 
methods as viable techniques for V. vulnificus genotyping to distinguish between 
clinical and environmental isolates. 
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The drawback to these typing methods is that the extensive genetic heterogeneity of 
 
V. vulnificus prevents 100 % prediction of pathogenicity. Even the development of 
multiplex PCR assays which combine biotype, CPS, vcg and 16S rRNA data are 
unable to provide a definitive classification 38,44. The examination of multiplex PCR 
assays in comparison to MLST data has resulted in the division of V. vulnificus into 
two distinct lineages, LI and LII 44. While LII was primarily comprised of clinical isolates, 
there were still environmental isolates found within this lineage. Therefore, the results 
are not a guarantee or indicator of virulence, but instead appear to suggest a strain’s 
potential to cause disease. 
 
 
 
1.4. Epidemiology 
 
1.4.1. Environmental habitat 
 
V. vulnificus is a halophilic bacterium, primarily isolated from brackish, temperate 
waters in tropical or sub-tropical climates. V. vulnificus is frequently found around the 
United States and the Gulf of Mexico where water commonly exceeds 18 °C and 
ranges between 15 - 25 ppt salinity. Due to its requirement for sodium ions to retain 
cell membrane integrity, V. vulnificus is unable to grow in freshwater 39. Other Vibrio 
species such as V. cholerae, V. anguillarum and V. mimicus do not share this 
constraint, only utilising sodium ions for starvation survival, not growth 45. Whilst most 
cases reported come from coastal waters surrounding Gulf Coast states, V. vulnificus 
has also been isolated from Japan, Malaysia, the Netherlands, Israel, Sweden, Brazil, 
Denmark, India, Thailand, Australia, Belgium, Italy, Korea, Germany, Turkey, Spain 
and Taiwan 46–55. Isolation of V. vulnificus from water bodies has been shown to be 
temperature-dependent, with seasonal fluctuations 56,57.  Abundance is greatest in the 
summer when oceanic temperatures exceed 20 °C, viable cell counts fall to 
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undetectable levels when temperatures drop below 10 °C 57,58. This is likely due to 
adaption into a viable but non-culturable (VBNC) state in which the cells retain 
enzymatic and respiratory activity but lack the ability to grow under standard laboratory 
conditions 59. In this state cellular metabolism is restricted, enabling survival, but not 
proliferation, of the bacterium 60. As ambient temperatures increase leading into spring, 
VBNC V. vulnificus gradually resuscitate, resulting in resumed detection in coastal 
waters and in association with other aquatic organisms 59. 
V. vulnificus populations are commonly found concentrated in the digestive glands of 
filter feeding shellfish such as oysters, mussels and clams 11. In oysters V. vulnificus 
concentrations can reach up to 106 CFU/g tissue 11,61. This is due to the frequent 
association of V. vulnificus with marine biological flora such as diatoms, zooplankton, 
phytoplankton and algae upon which filter-feeding shellfish feed 62,63. Greenfield et al., 
(2017) demonstrated a link between harmful algal blooms and an increase in 
pathogenic V. vulnificus population when temperatures > 10 °C 63. Thickman et al., 
(2017) also presented similar findings for V. parahaemolyticus 64. V. vulnificus’ 
association with these aquatic organisms results in uptake and retention by shellfish. 
Consequently, consumption of raw or undercooked shellfish is the leading route of V. 
vulnificus infection 65. There are other major V. vulnificus reservoirs that have been 
identified, such as the intestines of fish which can hold bacteria at levels 10,000-fold 
greater than in water samples 66. However, as these food sources are typically cooked 
prior to consumption they are less likely to facilitate the infection of a human host 
through ingestion. 
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1.4.2. Consequences of climate change on V. vulnificus distribution and clinical 
incidence 
In the past decade, the focus on V. vulnificus ecology has expanded in response to 
the impact of climate change on the prevalence of pathogenic bacteria 56,67–70. Climate 
change has been linked to increased occurrences of V. parahaemolyticus, V. cholerae, 
V. alginolyticus and V. mimicus 68,71–73. Increases in oceanic temperature and salinity 
gradients caused by global warming is expanding the available geographic range for 
V. vulnificus proliferation 69. New regions are exposed to these bacteria, causing 
increasing V. vulnificus infections in zones where the pathogen had been previously 
undetectable. Baker-Austin et al., (2012) investigated the emergence of Vibrios at high 
latitudes in response to warming of the Baltic Sea 67. Analysis of sea-surface 
temperatures (SST) showed a shift in temperature of up to 1 °C per decade, exceeding 
seven times the global rate. SST increases in conjunction with the low salinity (< 25 
ppt NaCl) has also been shown to promote V. vulnificus growth and proliferation in the 
Baltic sea. Herrfurth et al., (2013) were able to isolate V. vulnificus from Baltic Sea blue 
mussels at concentrations of up to 2.2 × 107 CFU/g tissue 74. Not only does the increase 
in SST result in greater proliferation of Vibrios, but it also has the effect of more people 
coming into contact with V. vulnificus, either through swimming in contaminated water 
or handling of contaminated seafood. 
Climate change has other impacts aside from increases in SST. One of which is the 
increased variance in precipitation and extreme weather patterns, resulting in already 
wet areas experiencing increased rainfall, and dry areas becoming more arid 75. 
Excessive rainfall can reduce the salinity of select marine ecosystems, indirectly 
creating the ideal environment for Vibrio growth. Esteves et al., (2015) monitored V. 
vulnificus, V. parahaemolyticus and V. cholerae populations in French Mediterranean 
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coastal lagoons following periods of heavy rainfall and freshwater flooding. The 
freshwater influx resulted in salinity reduction from 314 – 361 ppt to 22 – 164 ppt over 
15 days 76. V. vulnificus concentrations measured 0.7 – 2.1 × 103 most probable 
number (MPN)/L before salinity decrease. Once salinity dropped to ~150 ppt, this 
increased to 4.6 × 104 MPN/L. Extreme storms also have the potential to cause storm 
surges, where regions are flooded with seawater as a result of high wind speeds and 
changes in atmospheric pressure causing tsunami-like rising water 77. This has the 
effect of bringing in V. vulnificus-containing seawater inland where it encounters other 
water bodies, floodwater and human populations. The environmental disturbance 
caused by Hurricane Katrina in 2005 resulted in widespread exposure of people to 
Vibrio contaminated water 78. Over the following weeks, 22 Vibrio infections were 
reported, 82 % of which were V. vulnificus. Of these, all were wound infections, with 
only V. cholerae causing non-wound associated illness 79. 
 
 
1.5. V. vulnificus infection 
 
1.5.1. Clinical presentation 
 
V. vulnificus infection can be contracted either via ingestion or wound exposure. 
 
Ingestion of raw or undercooked seafood, such as oysters, contaminated with virulent 
 
V. vulnificus is a major route for V. vulnificus transmission to humans 80. It is believed 
that 106 bacilli are required to initiate V. vulnificus infection via ingestion of 
contaminated food, however this number may drop to as low as one bacterium in hosts 
suffering liver disease 81,82. Following consumption gastroenteritis symptoms typically 
appear within 7 days, however it is not unknown for 14 days to pass before the infection 
presents itself 83,84. Patients initially present with diarrhoea, nausea, vomiting, 
10  
abdominal cramps, headaches, chills and fever 85. Although unpleasant, death is rare, 
with studies postulating that deaths from gastroenteritis were actually a consequence 
of undiagnosed septicaemia 86–88. Progression of the infection to primary septicaemia 
results in development of more medically significant symptoms, including secondary 
lesions on the extremities and severe hypotension. In this case ~ 50 % of patients die 
within 48 hours of hospital admission 85. 
The secondary route of infection is through exposure of an open wound. This can be 
as a result of either submersion in contaminated waters or following contact with 
infected seafood. Cases of V. vulnificus wound infection have been reported following 
seafood handling, submersion of a fresh tattoo in seawater and even acupuncture on 
a fish hatchery worker 89–91. Within four hours to four days patients will present with 
erythema, haemorrhagic bullae, cellulitis and intense pain 92. Failing immediate 
treatment, the infected lesions frequently turn necrotic. Whilst being visually more 
aggressive than primary septicaemia, wound infections carry a much lower mortality 
rate of ~ 25 % 85. Interestingly, despite the relatively recent identification and 
classification of V. vulnificus, medical historians have identified several historical 
clinical cases which appear highly indicative of V. vulnificus wound infection. The 
oldest dates to the fifth century B.C. where Hippocrates observed the infection and 
rapid death of a patient whose foot became swollen, erythematous and developed black 
blisters following a wound in his toe 93. Although other potential causative pathogens 
have been suggested, such as virulent Streptococcus, the rapid nature with which the 
disease killed the patient and the development of black blisters reminiscent of 
haemorrhagic bullae suggest a V. vulnificus infection. 
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1.5.2. Risk factors 
 
Like many human pathogens, V. vulnificus infection severity is largely determined by 
the pre-existing health of the host. This includes patients with HIV/AIDS, liver disease, 
kidney disease, haematological disorders, cancers and the immunosuppressed 83,89,94. 
Menon et al., (2015) analysed all Cholera and Other Vibrio Illness Surveillance System 
(COVIS)-reported cases of V. vulnificus infection from 1988 – 2006 to determine the 
importance of pre-existing medical conditions in establishment of V. vulnificus infection 
(n = 1,212) 94. The authors reported that 80 % of patients already had at least one pre-
existing medical condition, either liver disease (40 %), heart disease (23 %), diabetes 
(20 %), renal complications (10 %) or other conditions (< 10 %). This is likely due to 
the importance of iron in V. vulnificus establishment and proliferation in a human host. 
Most patients presenting with V. vulnificus infection have elevated serum- iron levels, 
either as a result of a haematological disorder or chronic liver disease causing high 
serum saturation of transferrin and ferritin 84,85,95–98. Therefore, it is 80 times more likely 
that the immunosuppressed, or sufferers of chronic liver disease, will develop primary 
septicaemia compared to healthy individuals 83. The importance of iron for sustaining 
V. vulnificus infection is so vital that researchers have been assessing the potential of 
a novel iron-chelator, deferiprone, to hinder in vivo growth 99,100. Interestingly, studies 
have demonstrated that certain pre-existing conditions rendered patients more 
susceptible to either V. vulnificus septicaemia or wound infection. Patients with liver 
disease were more likely to develop primary septicaemia following ingestion of the 
pathogen, whereas those with renal complications or malignancy were more 
susceptible to infection through wound exposure 94. 
Males are at a greater risk of infection from V. vulnificus than females. Of the 1,212 
cases reported between 1988 and 2006 by COVIS, 86 % were male 101. The only 
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current potential explanation for this disparity is the inhibitive effects of oestrogen on 
the impact of LPS-mediated endotoxic shock. Using a rat model, Merkel et al., (2001) 
were able to increase mortality in female rats following gonadectomy and decrease 
mortality in male rats via oestrogen supplementation 102. However, to date no further 
studies have examined further the impact of oestrogen on inhibiting endotoxic shock 
and the benefits it may provide. 
 
 
 
1.5.3. Diagnosis and treatment 
 
Due to the fulminating nature of V. vulnificus infection it is critical that infection is 
diagnosed and treated as quickly as possible. Initial examination of patients will 
indicate a severe bacterial infection, with a marked shift in white blood cell count 89. 
Patients fitting this description along with the previously discussed symptoms of fever, 
erythema, swelling, diarrhoea, nausea, vomiting and a change in mental status should 
be questioned to determine whether they have had any contact with seafood within 
the past week. This is especially relevant if they have a history of liver disease, 
immunodeficiency or renal complications. Radiography studies can be employed on 
affected tissues to identify changes in soft tissue and locate pockets of fluid, which can 
be used to exclude other possible conditions and advise attempts of surgery. In 
previous case studies where the species of pathogen was not already known, V. 
vulnificus was identified as an ‘encapsulated, aerobic, Gram-negative bacillus’ 97. If V. 
vulnificus is suspected, it can be confirmed via culture on Vibrio selective thiosulfate- 
citrate-bile-salts-sucrose (TCBS) agar. TCBS utilises an alkaline pH, bile salts and a 
sucrose carbon source to inhibit growth of non-Vibrio species. 
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There is no defined cure for V. vulnificus infection, with the consensus being surgical 
debridement in combination with a variety of antibiotics 89,103. Due to the speed with 
which the infection progresses it is crucial that surgery and administration of drugs is 
performed immediately. Patients who undergo surgical debridement are likely to 
require amputation of the infected limb to prevent further disease dissemination. A 
delay in treatment of greater than 24 hours prompts a rise in mortality rates, from 33 
% to 53 %. If left untreated for 72 hours, mortality increases from 50 % to 100 % 103. 
The CDC recommends 2 g ceftazidime intravenously/intramuscularly every 8 hours in 
combination with 100 mg doxycycline intravenously/peroral twice daily for up to two 
weeks. Some recent studies state that monotherapy with glycylcyclines, namely 
tigecycline, may present a better therapeutic option 104. Nevertheless, case studies 
demonstrate the effectiveness of an extensive range of effective treatments, including 
the use of cefotaxime, gentamicin, minocycline and ciprofloxacin 83,89,104. 
Worryingly, a study of Japanese emergency physicians by Osaka et al., (2004) 
reported that only 15.7 % (n = 235) had a basic understanding of V. vulnificus infection 
and the required treatment 46. Due to the temperate climate, seafood intake, 
consumption of raw seafood and prevalence of chronic liver disease, Japan presents 
ideal conditions for V. vulnificus outbreak. For this reason, individuals at risk and the 
medical community should be familiar with the disease and how to treat it effectively 
and rapidly. Patients with liver disease, haematological conditions or cancer should be 
advised against the exposure of wounds to seawater. All patients should be seriously 
advised against the consumption of raw seafood. 
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1.5.4. Low global V. vulnificus clinical incidence 
 
The CDC has reported a 115 % increase in V. vulnificus infections between 1996 and 
2010 105. The ubiquity of the organism, in conjunction with increased prevalence due 
to climate change suggests that a greater number of infections would be reported 
annually, particularly in areas that are extremely conducive for V. vulnificus growth and 
proliferation such as the Gulf of Mexico, Japan and the USA. However, the number of 
reported cases is surprisingly low. The CDC estimates that V. vulnificus infects ~ 100 
– 200 people annually in the USA, despite reporting ~ 80,000 infections caused by 
Vibrio species. Despite the severity of V. vulnificus infections, they are significantly 
rarer than less virulent but more prevalent Vibrios, such as V. parahaemolyticus, 
estimated to be responsible for ~ 45,000 infections annually in the USA 106,107. 
One cause may be the underreporting of V. vulnificus cases due to infection 
misdiagnosis. V. vulnificus infections in the Gulf Coast have been monitored by the 
CDC since 1988, with the pathogen becoming a nationally notifiable disease in 2007. 
Disease caused by Vibrio species is reported through COVIS 108. Healthy individuals 
typically only experience gastroenteritis, resulting in common food-borne illnesses 
such as Salmonella, Campylobacter or Listeria infections being implicated. Diagnosis 
is further hindered by clinical laboratories in Gulf Coast states not routinely testing for 
V. vulnificus. A survey of 201 clinical laboratories determined that of the 82 % that 
checked stool samples, only 20 % tested specifically for V. vulnificus 109. To further 
complicate the diagnosis, when these tests are run, they may be affected by previous 
patient treatment regimens due to V. vulnificus’ sensitivity to a range of antibiotics. 
Therefore, clinicians need to be aware of the unintended impact that recent antibiotic 
administration may have on diagnostic reliability. Lee et al., (2017) performed blood 
culture analysis on eight patients confirmed to have V. vulnificus infection but who had 
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been previously been administered antibiotics that had unintentional activity against 
 
V. vulnificus 104. The study found no positive indication of V. vulnificus infection 
suggesting that V. vulnificus may not necessarily be ruled out even if not detected 
through culture. Other studies have demonstrated the efficacy of real-time PCR for 
detecting V. vulnificus from blood sample analysis, even if culturable V. vulnificus have 
been eliminated by antibiotic treatment. DNA copies in host tissues are far less 
affected by antibiotics than viable bacterial cells, as a result, molecular methods for 
identification of V. vulnificus present a far more reliable, rapid and accurate method of 
V. vulnificus diagnosis 110. 
 
 
 
1.6. Virulence mechanisms of V. vulnificus 
 
1.6.1. Adaption to low pH 
 
As one of the two routes of infection for V. vulnificus is through ingestion it is vital that 
the bacterium can neutralise the acids of the digestive system. Exposure to gastric 
fluids and oxidative stress in the upper gastrointestinal tract following ingestion is partly 
counteracted via production of lysine decarboxylase, CadA 111. Located within the 
cadBA operon, cadA expression is regulated by CadC, whose own expression is 
upregulated under low pH conditions 112. CadA catalyses the decarboxylation of lysine 
into cadaverine and CO2, which are exported out of the cell via CadB to counteract 
external acidification 113. A cadA V. vulnificus mutant demonstrated significantly 
reduced tolerance to acidic stress relative to the wild-type strain 114. CadA has also 
been shown to play a role in the acid responses of a number of other human 
pathogens, including Salmonella enterica and Escherichia coli 115. 
16  
Kim et al., (2005) also demonstrated that induction of manganese-containing 
superoxide dismutase (MnSOD) is essential for V. vulnificus acid tolerance 116. 
MnSOD is involved in both acid neutralisation and superoxide reduction in a number 
of bacteria and has the beneficial effect of being a superoxide radical scavenger 116–
119. Repression of MnSOD resulted in significantly reduced tolerance to low pH, 
whereas a mutant de-repressing MnSOD demonstrated greater tolerance than the 
wild-type 116. As would be expected from enzymes that neutralise low pH and reduce 
superoxide, both proteins are upregulated at low pH. However, this has been linked to 
the accumulation of intracellular superoxide as opposed to low pH itself. 
 
 
 
1.6.2. Motility and adhesion 
 
V. vulnificus employs several virulence factors involved in motility and adhesion to 
facilitate permeation of the intestinal wall and entrance to the bloodstream. Like many 
pathogens, V. vulnificus is highly motile, possessing a single polar flagellum which has 
been implied to have a role in adhesion, cytotoxicity, biofilm formation and lethality to 
mice 120. Kim et al., (2014) performed mutagenesis studies on V. vulnificus to elucidate 
the role of the flagellin genes, flaA-F 121. The authors found that motility was only fully 
suppressed when all six fla genes were deleted, whereas single mutants demonstrated 
varied levels of motility reduction and cytotoxicity. Interestingly, the flaB/flaD mutant 
demonstrated a 23 and 91-fold increase in LD50s, highlighting the importance of the 
flagella and motility in V. vulnificus infection. Deletion of V. vulnificus structural pili 
genes, pilA and pilD, has been shown to have similar detrimental effects on adherence 
to host cells 122. Paranjpye et al., (2005) showed that pilA deletion reduced the ability of 
V. vulnificus to form biofilms, to adhere to HEp-2 cells and significantly 
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reduced virulence in iron-dextran treated mice 122. Inactivation of pilD resulted in 
reduced adherence to HEp-2 cells, decreased virulence and inhibition of Type 2 
Secretion System (T2SS) exoenzymes. Inactivation of V. vulnificus pili results in 
reduced virulence, this is likely due the requirement for cell-cell contact for V. vulnificus 
cytotoxicity 123. 
 
 
1.6.3. Surface proteins 
 
Once V. vulnificus penetrates the epithelial lining and enters the bloodstream it is 
exposed to the host immune system, including the effects of opsonisation by 
complement and phagocytosis by host macrophages. A primary defence presented by 
the bacterium against opsonisation is the generation of a capsular layer, referred to as 
capsular polysaccharide (CPS), comprised of long-chain polysaccharides with repeat-
unit structures 124. CPS has been identified in a wide range of both Gram- negative 
and Gram-positive bacteria, including Escherichia coli, Klebsiella pneumoniae, 
Staphylococcus aureus and Streptococcus pneumoniae 124–128. CPS is one of the few 
essential V. vulnificus virulence factors due to its role in evading opsonisation, masking 
immunogenic structures and resisting bactericidal serum 3,83,129. Not all strains express 
CPS, however capsulated strains show significantly greater virulence compared to 
acapsular strains 129. Expression of CPS on the cell surface facilitates slower systemic 
clearance and increased invasive activity towards subcutaneous tissues 3. Wright et 
al., (1990) also demonstrated that when injected into an iron-overloaded mouse model, 
capsulated strains resulted in significantly greater mortality than acapsular strains 130. 
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V. vulnificus also produces lipopolysaccharide (LPS) which it incorporates into its outer 
membrane, responsible for causing endotoxic shock characteristic of severe V. 
vulnificus infection 39. LPS is a known pyrogen and has been linked to 
neurodegeneration, neuronal injury through disruption of the blood-brain barrier, 
release of inflammatory mediators and release of reactive oxygen species 131. 
Intraperitoneal injection of V. vulnificus LPS into mice resulted in significant drops in 
arterial pressure within 10 minutes resulting in death in as short as 30 minutes 132. 
Interestingly, both oestrogen and low-density lipoprotein (LDL) cholesterol have been 
shown to have protective activity against the effects of LPS 102,133. This serves to help 
explain the sexually dimorphic patient demographic for V. vulnificus infection. 
However, no further studies have managed to elucidate the mechanisms behind this 
protection. 
 
 
 
1.6.4. Iron acquisition 
 
Vibrios, amongst a multitude of other bacterial species, require iron for growth and 
proliferation as iron is essential for enzyme activity 134. It is for this reason that V. 
vulnificus is commonly isolated from coastal and estuarine waters, where dissolved 
iron levels are far higher than in the open ocean due to terrestrial runoff 135. Virulence 
assays in iron-overloaded mice demonstrate a direct correlation between V. vulnificus 
infectious dose and iron concentration showing that iron availability and the ability of 
V. vulnificus to acquire iron is a major virulence factor 82. Studies show that C-type V. 
vulnificus, associated with causing infections in humans are far more capable of 
surviving in human serum than E-type strains 136. In humans, 99 % of iron is 
sequestered in haemoglobin, myoglobin or ferritin-hemosiderin, whereas extracellular 
iron is associated with iron-binding molecules such as transferrin 99,137. This results in 
19  
extremely low iron availability. However, patients suffering severe V. vulnificus 
infection frequently present with pre-existing medical conditions such as 
haemochromatosis or liver disease which result in increased serum iron levels 98,134. 
The sequestration of iron for uptake by V. vulnificus in vivo is mediated by high affinity 
siderophores which bind iron for uptake by the bacterial cell 85. These mechanisms are 
regulated by the ferric uptake regulator, Fur, and are expressed under low-iron 
conditions 138,139. V. vulnificus has been shown to produce both catechol and 
hydroxymate siderophores which form ferrisiderophore complexes when associated 
with iron 134,140. Uptake of siderophores is mediated by the TonB transport system and 
associated proteins, ExbB and ExbD 141,142. Interestingly, V. vulnificus encodes three 
TonB systems, TonB1 – 3, as opposed to the two systems more commonly found in 
other pathogenic Vibrios 143. All TonB systems within V. vulnificus mediate the uptake 
of iron-associated siderophore complexes, however these three membrane 
transporters recognise different receptors and vary in the conditions under which they 
are active 134 TonB systems have even been shown to have the ability to take up 
siderophores produced by foreign bacteria, enhancing their ability to compete with 
other bacteria for iron 144. 
 
 
1.6.5. Effectors 
 
V. vulnificus has been shown to secrete several fulminating and destructive cytotoxic 
effectors. The three most significant being; cytolytic haemolysin (VvhA), elastolytic 
protease (VvpE) and repeats in toxin exoprotein (RtxA1) 145–147. VvhA and VvpE have 
a range of virulence attributes, including causing partial paralysis, fluid accumulation, 
vascular permeability, neutrophil recruitment, epithelial cell apoptosis, nitric oxide 
production, 
20  
tissue necrosis, cutaneous lesions, type IV collagen degradation and induction of 
inducible nitric oxide synthase activity 146,148–155. Interestingly, despite these extensive 
induced conditions, inactivation of vvhA and vvpE both individually and together did 
not result in impaired virulence in a mouse model of infection 101,156. Further exploration 
of the V. vulnificus genome led to the discovery of a gene encoding a repeats-in-toxin 
(RTX) exoprotein essential for virulence in mice and tissue cultures, termed RtxA1 157. 
RTX toxins have been identified in a wide range of Gram-negative bacteria, including 
V. cholerae 158,159. Translocated in a contact-dependent manner via the type 1 
secretion system (T1SS), these proteins consist of N- and C-terminal repeats believed 
to form pores in target cell plasma membranes, enabling translocation of the effector- 
containing central portion of the toxin 160. Eukaryotic cells exposed to the wild-type 
protein demonstrated cytoskeletal rearrangements, blebbing and necrotic cell death 
161. Inactivation of RtxA1 resulted in significantly decreased cytotoxicity and reduced 
cell lysis, demonstrating that this is one of the key virulence factors in causing V. 
vulnificus infection. 
 
 
 
1.7. The Type 6 Secretion System (T6SS) 
 
Bacterial secretion systems demonstrate highly diverse structure, function and 
regulation. To date, nine secretion systems have been identified, termed T1SS – T9SS 
(Fig. 1.1) 162. Whilst well characterised systems such as the T3SS have been identified 
and studied in a range of different microorganisms since their discovery, novel 
secretion systems are still being discovered and characterised 163–165. The latest of 
which being the T9SS, identified in 2010 and labelled the Por secretion system 
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(PorSS), before being renamed to fit current secretion system naming nomenclature 
in diderm bacteria 166,167. 
 
 
 
 
Figure 1.1: Bacterial secretion systems schematic. Secretion in monoderm bacteria 
(left) is largely mediated by the Sec and Tat transport pathways, or the T7SS. In diderm 
bacteria (middle and right), proteins are either secreted in a one-step process directly into 
the surrounding environment/target cell (T1SS, T3SS, T4SS, and T6SS), or they are first 
secreted into the periplasm by the Sec system (T2SS, T5SS, and T9SS) or the Tat system 
(T2SS). Figure taken from Maffei et al., (2017) 168. 
 
 
 
 
The T6SS was identified by Pukatzki et al., (2006) following the observation that V. 
cholerae was able to target and kill the phagocytic amoeba, Dictyostelium discoideum 
169. This was linked to extracellular translocation of virulence-associated secretion 
(VAS) proteins. Further exploration demonstrated that VAS proteins were translocated 
in a contact-dependent manner. The study was also able to demonstrate similar 
cytotoxicity against mammalian J774 macrophages, suggesting an anti-eukaryotic role 
for the T6SS. Since its initial identification in V. cholerae, the T6SS has been 
discovered in > 25 % of proteobacterial genomes, and in 30 % of these genomes there 
are multiple copies of almost complete loci, encoding different T6SS variants 170. 
Further genetic analysis confirms that these are not simply the result of duplication 
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events but have been conserved through evolution. This implies that these T6SS 
variations play a defined role, whether this be in competition, nutrient acquisition, 
quorum sensing, or other activities 170. Burkholderia pseudomallei, for example, 
contains six T6SSs (T6SS1 – T6SS6), which have a range of roles including the 
formation of giant, multi-nucleated cells for bacterial propagation by the T6SS5 and 
the acquisition of metal ions by the T6SS4 in the surrogate organism, Burkholderia 
thailandensis 171. Church et al., (2016) was the first study to identify the T6SS in V. 
vulnificus and to identify two T6SSs, named the T6SS1 and the T6SS2 (Fig. 1.2) 172. 
Despite all sequenced V. vulnificus strains possessed the T6SS2, only a subset 
possessed the T6SS1. Furthermore, whilst the T6SS1 was demonstrated to have anti-
bacterial activity at 30 °C in vitro, the T6SS2 demonstrated no anti-prokaryotic or anti-
eukaryotic activity. 
 
 
 
 
 
 
Figure 1.2: V. vulnificus T6SS1 and T6SS2 operons. This schematic shows the genetic 
organisation of the T6SS1 and T6SS2 operons from V. vulnificus. Genes have been colour 
matched to highlight matching genes. Figure taken from Church et al., (2016) 172. 
 
 
 
 
The anti-bacterial activity of the T6SS plays an important role in the interactions 
between microorganisms within a niche. Contrary to the environments in which in vitro 
studies are performed, in vivo conditions are far less nutrient rich, resulting in the need 
for a means to compete with other present microorganisms. Speare et al., (2018) 
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utilised a Euprymna scolopes squid model to demonstrate that attacker strains of 
Vibrio fischeri were able to target and kill prey strains in vivo in a T6SS-dependent 
manner 173. The ability for the T6SS to target and kill neighbouring microorganisms 
can also be important in the context of causing disease. Recent studies have shown 
that V. cholerae kills host commensal microbiota in vivo in a T6SS-dependent manner, 
enhancing gut colonisation by the pathogen 174. Furthermore, clearance of host 
microbiota was shown to increase Cholera-associated diarrhoea, suggesting that 
T6SS-antagonism of host commensals by V. cholerae can increase potential for 
transmission. These are just a selection of T6SS activities which have subsequently 
been identified in a range of human pathogens, such as Serratia marcescens, P. 
aeruginosa and Acinetobacter baumannii 175–177. 
 
 
1.7.1. T6SS regulation 
 
The T6SS is activated in response to a range of conditions, including temperature, 
salinity, iron-starvation, biofilms, stress response, and osmolarity 178–186. The regulation 
of T6SS activity at both a transcriptional and translational level is theorised to be due 
to the high energetic requirements of assembly, firing and disassembly. There are a 
diverse range of transcriptional regulators involved in T6SS transcriptional regulation. 
These include proteins such as VasH, a bacterial enhancer binding protein that serves 
to activate 54, an alternative sigma factor 186. Interestingly, in V. cholerae, vasH is 
encoded within the primary T6SS operon but has only been shown to activate 
transcription of two auxiliary clusters in the genome encoding hcp and vgrG variants. 
As V. vulnificus does not contain these auxiliary clusters it is yet unknown as to the 
target of VasH in T6SS transcription activation. Furthermore, vasH 
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is only found within the T6SS1 operon of V. vulnificus, T6SS1- strains possess no vasH 
gene that has yet been identified, perhaps suggesting that VasH in V. vulnificus is only 
required for T6SS1 regulation. 
Bacteria also demonstrate post-translational control of T6SS activity. An example of this 
that has been identified in P. aeruginosa is the threonine phosphorylation pathway 
(TPP) 187,188. Upon detecting a T6SS-mediated attack by neighbouring cells, a serine-
threonine kinase (PpkA) phosphorylates a forkhead- associated protein (Fha), 
promoting assembly of a T6SS at the site of attack. A serine- threonine phosphatase 
(PppA) inhibits this interaction. The TPP has been shown to compete with the negative 
regulation of TagF to delay T6SS re-assembly post-firing to allow for spatial 
reorganisation and re-targeting of prey strains 188. Interestingly, the T6SS2 of V. 
vulnificus encodes pppA and ppkA , but the T6SS1 encodes neither of these, 
suggesting that the T6SS2 of V. vulnificus may be similarly regulated to the T6SSs of 
P. aeruginosa 172. 
 
 
1.7.2. T6SS structure 
 
The T6SS is a molecular syringe through which cytotoxic effectors are injected into 
target cells. The T6SS is typically composed of 13 core genes (listed in Table 1.1) 
required for secretion system assembly and mobilisation. The T6SS can be divided 
into the tail, trans-membrane and baseplate complexes. A schematic of the T6SS can 
be seen in Fig. 1.3. The tail complex is named after its remarkable similarity to the 
contractile tail of T4 bacteriophage 189. When T4 bacteriophage make contact with 
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Protein Function Source 
 
TssA 
Involved in T6SS biogenesis through baseplate 
complex recruitment and TssB/C/D polymerisation. 
 
Zoued et al., (2016) 190 
 
TssB (VipA) 
Forms a contractile sheath surrounding the Hcp needle 
in conjunction with TssC. 
 
Brackmann et al., (2018) 191 
 
TssC (VipB) 
Forms a contractile sheath surrounding the Hcp needle 
in conjunction with TssB. 
 
Brackmann et al., (2018) 191 
 
TssD (Hcp) 
Hcp subunits form a hollow tube for effector 
translocation. Involved in TssB/C recruitment. 
 
Brunet et al., (2014) 192 
 
TssE 
Baseplate complex protein also required for proper 
assemble of the Hcp tube. 
 
Brunet et al., (2015) 193 
 
TssF 
Baseplate complex protein, TssF and TssG stabilise 
one another for proper assembly of the Hcp tube. 
 
Brunet et al., (2015) 193 
 
TssG 
Baseplate complex protein, TssF and TssG stabilise 
one another for proper assembly of the Hcp tube. 
 
Brunet et al., (2015) 193 
 
TssH (ClpV) 
AAA+ ATPase, controls disassembly and recycling of 
the T6SS. 
 
Basler et al., (2012) 189 
 
TssI (VgrG) 
Forms a trimeric spike complex at the tip of the Hcp 
needle in association with PAAR proteins. 
 
Hachani et al., (2014) 194 
 
TssJ (VasD) 
Trans-membrane complex lipoprotein that anchors to 
the outer membrane in association with TssL/M. 
 
Durand et al., (2015) 195 
 
TssK 
Hypothesised to interact with TssD/L/C to link the 
TssB/C/D complex to the trans-membrane complex. 
 
Zoued et al., (2014) 87 
 
TssL (DotU) 
Trans-membrane complex lipoprotein, interacts with 
TssM/J to anchor the T6SS to the cell membrane. 
 
Durand et al., (2012) 196 
 
TssM (IcmF) 
Trans-membrane complex lipoprotein that anchors to 
the outer membrane in association with TssL/J. 
 
Durand et al., (2015) 195 
 
Table 1.1: A list of the 13 proteins essential for T6SS assembly and function. All 
proteins have been labelled according to the type six secretion (Tss) nomenclature. More 
commonly utilised names for particular proteins have been identified in brackets. 
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target bacterial cells they inject genetic material through a contractile tail to which the 
T6SS bears remarkable similarity with the exception that the T6SS is translocating 
cytotoxic effectors as opposed to genetic material 197. The needle of the bacterial T6SS 
is composed of stacked haemolysin co-regulated protein (Hcp) hexamers which share 
homology with the gp19 tube protein of T4 phage 198. Protein crystallisation studies 
showed that Hcp forms a hollow tube with a 40 Å internal diameter, similar to that of 
T4 phage 199,200. To facilitate penetration of target cell membranes, the Hcp needle is 
 
 
Figure 1.3: The structure of the T6SS. The host cell assembles the T6SS in the extended 
state. Here the Hcp needle is contained within a contractile TssB/C sheath anchored to a 
membrane complex consisting of TssM, TssJ and TssL and a baseplate complex consisting 
of TssE, TssF, TssG, and TssK. TssA serves to aid in baseplate recruitment and priming, 
coordination of tail/sheath extension, and maintenance of the sheath in its extended 
position. Contraction of TssB/C drives the Hcp/VgrG/PAAR complex into the neighbouring 
cell.  Effector delivery into the target cell is followed by disassembly of the T6SS by the 
AAA+ ATPase, ClpV. A bacteriophage tail schematic has been included to highlight the 
similarities between the T6SS and the contractile phage tail. Figure taken from Navarro-
Garcia et al., (2019) 201. 
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topped with a trimeric valine-glycine repeat G (VgrG) complex in association with 
proteins from the proline-alanine-alanine-arginine (PAAR) repeat superfamily 202. This 
complex serves to ‘sharpen’ the tip of the needle and aid T6SS penetration of the 
target cell. Finally, the needle and tip complex are encased in a tubular cog-like sheath 
of VipA and VipB proteins, comparable to the gp15/gp18 contractile sheath of T4 
phage 197. Named after their interactions with the AAA+ ATPase, ClpV, VipA/VipB 
(ClpV–interacting proteins) are essential for T6SS functionality through their 
contraction to drive needle propulsion 203,204. Once contracted, the VipA/VipB sheath 
is recognised and disassembled by ClpV. 
The tail complex of Hcp, VgrG-PAAR and contractile VipA/B is bound to the host 
membrane through interactions with a baseplate complex consisting of interactions 
between six proteins, TssA, TssE, TssF, TssG, TssK, and VgrG 205. In T4 phage the 
nucleus for tail assembly is the baseplate, this is comparably observed in bacterial 
T6SSs, with VgrG acting as the nucleus for tail formation 206,207. Baseplate proteins 
are recruited to the inner-membrane where they interact with the trans-membrane 
complex consisting of two inner-membrane components, TssL and TssM, a lipoprotein 
associated with the outer membrane, TssJ, and an accessory protein, TagL (only 
present in a few bacterial T6SS baseplate complexes) 167. Assembly of these two 
complexes is mediated by the baseplate proteins, TssL/K and TssL/M binding due to 
cytoplasmic loop interactions 190. Once established, the baseplate and trans-
membrane complexes are maintained through interactions between TssK/L, TssK/M, 
TssL/E, and TssM/G 190,193,208. The trans-membrane complex allows for passage of 
the tail-complex and serves to maintain cell integrity during secretion. 
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1.7.3. T6SS effector and immunity proteins 
 
Since the discovery of the T6SS, new effector and immunity proteins have been 
routinely discovered and characterised. Antibacterial effectors can be broadly divided 
into three separate classes: cell wall targeting effectors, membrane targeting effectors 
and nucleic acid targeting effectors 209. Recently, T6SS effectors whose activity is not 
covered by these three categories have been identified in P. aeruginosa and Yersinia 
pseudotuberculosis suggesting that there is a potentially diverse array of T6SS 
associated effectors which have yet to be characterised 210,211. Whilst more effectors 
have been identified than can be reasonably discussed in this work, the primary groups 
have been identified and discussed below.  
 
 
1.7.3.1. Cell wall targeting effectors 
 
T6SS effector-mediated degradation of peptidoglycan was first identified in P. 
aeruginosa in which two effector proteins, Tse1 and Tse3, were shown to hydrolyse 
peptidoglycan following delivery to the periplasm 212. P. aeruginosa was shown to 
protect itself from the hydrolytic activity of Tse1/Tse3 through the possession of 
cognate immunity proteins, Tsi1 and Tsi3, which bind the cognate effectors. 
Characterisation of Tse1/Tse3 showed that these proteins have amidase and 
glycoside hydrolase activity respectively, interaction with peptidoglycan results in the 
cleaving of peptide cross-links between glycan strands by Tse1 and cleaving of the 
glycan backbone by Tse3, resulting in cell wall degradation and loss of integrity. Since 
their discovery in P. aeruginosa, further research has demonstrated that there is a 
versatile superfamily of T6SS peptidoglycan-degrading effectors which can be 
organised into four groups of different amidase specificities termed T6SS amidase 
effector 1 – 4 (Tae1 – 4) 212. Similar effectors have been identified in V. cholerae. 
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Specifically, VgrG3, which is part of the VgrG trimeric complex forming the tip of the 
needle has been shown to have peptidoglycan degrading activity and TseH, which 
carries a hydrolase domain and results in E. coli death when expressed in the 
periplasm 213,214. 
 
 
 
1.7.3.2. Membrane targeting effectors 
 
The plasma membrane is vital for maintaining cell integrity in both prokaryotic and 
eukaryotic cells. As such, there are a range of T6SS effectors that have evolved to 
target this component as a means of inducing cell death. Russell et al., (2013) reported 
the discovery of a superfamily of bacterial  phospholipase enzymes who were 
demonstrated to have roles as T6SS effector proteins 215. These effectors were 
labelled type VI lipase effectors (Tle). Tle cognate immunity proteins are labelled type 
VI secretion lipase immunity (Tli) proteins and are believed to localise to the periplasm 
where they protect the host cell from the membrane targeting activity of Tle effectors. 
Tle phospholipase effectors have been identified in a range of bacteria, including P. 
aeruginosa PldB (Tle5b), V. cholerae TseL (Tle2) and Burkholderia thailandensis Tle1 
216–218
. Another type of membrane targeting effectors are pore-forming toxins. T6SS 
pore-forming toxins integrate into the membrane, where the pore in the inner 
membrane facilitates loss of membrane potential through a voltage-dependent ion 
channel, halting cellular respiration 219. T6SS pore-forming toxins have been identified 
in a range of organisms, including P. aeruginosa, S. marcescens, and B. thailandensis 
219.  
Whilst more widely characterised, membrane-targeting effectors are not solely geared 
towards antibacterial activity. S. marcescens, was recently shown to possess 
antifungal activity mediated by T6SS-dependent secretion of two effectors, Tfe1 and 
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Tfe2 218. This is the first example of antifungal activity mediated by a T6SS. 
Characterisation of Tfe1 and Tfe2 identified Tfe1 as a membrane targeting effector, 
which stimulates depolarisation of the fungal cell membrane 220. Furthermore, not all 
T6SS membrane-targeting effectors have membrane degradation functionality. VgrG- 
5, secreted in association with the T6SS5 of B. thailandensis, plays a role in the fusion 
of mammalian host membranes which results in the formation of multinucleated giant 
cell formation 221. 
 
 
1.7.3.3. Nucleic acid targeting effectors 
 
A subset of T6SS effector proteins have been demonstrated to target nucleic acids in 
prey cells for degradation resulting in cell death. Rearrangement hot spot (Rhs) 
proteins are large toxins with highly variable C-terminal domains. Rhs proteins in 
Dickeya dadantii were shown to inhibit cell growth in E. coli through contact-dependent 
degradation of host DNA 222. Similarly to plasma membrane and cell wall targeting 
effectors, nucleic acid targeting effectors are expressed in association with their 
respective cognate immunity proteins (RhsI) 222. In S. marcescens Db10, two of the 
primary determinants of antibacterial killing were shown to be Rhs effectors, termed 
Rhs1 and Rhs2 223. Of these effector proteins, Rhs2 was demonstrated to inhibit prey 
cell growth through DNase activity and degradation of target cell DNA. 
Recently, Jana et al., (2019) identified a novel DNase toxin domain named PoNe 
(polymorphic nuclease effector) associated with the T5SS, T6SS and T7SS 224. The 
PoNe toxin family was identified as a member of the PD-(D/E)xK superfamily of 
phosphodiesterases and was identified across a diverse range of bacterial species. 
As previously described, the respective PoNe immunity proteins were labelled PoNi 
and were typically identified downstream of cognate PoNe proteins. Whilst this study 
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has yet to characterise the precise method of activity of the PoNe family, they were 
able to confirm DNase activity by observing induction of a fluorescent SOS response 
in E. coli responding to DNA damage 224. 
 
 
1.7.3.4. Micronutrient acquisition 
 
All the previously discussed effector proteins function from within target cells following 
injection by the T6SS, however there have also been identified a range of T6SS 
effectors which demonstrate extracellular functionality. Lin et al., (2017) observed that 
a P. aeruginosa strain deficient in iron acquisition possessed the ability to grow in 
sequestered-iron media 225. Further investigation showed that the T6SS H3 (H3-T6SS) 
secreted TseF for incorporation into outer membrane vesicles (OMVs). TseF acts as 
an activator of the Fe(III)-pyochelin receptor, FptA and OprF porin. TseF interaction 
with FptA and OprF facilitated the uptake of OMV-associated iron which is essential 
for growth and virulence of P. aeruginosa 143. Similar micronutrient scavenging activity 
associated with the T6SS has been demonstrated in B. thailandensis. Manganese is 
vital for B. thailandensis response to oxidative stress as well as cellular processes 
such as transcriptional regulation 226,227. The T6SS has been recently demonstrated to 
secrete a manganese-binding effector termed TseM which mediates the transfer of 
bound manganese across the cell membrane through interaction with MnoT, an outer 
membrane transport protein 228. B. thailandensis has also demonstrated T6SS 
secretion of the zinc-binding protein, TseZ 210,229. Similarly to TseM, TseZ binds to an 
outer membrane transporter, HmuR, to stimulate uptake of extracellular zinc following 
exposure to oxidative stress. TseZ secretion, zinc-binding and interaction with HmuR 
facilitates a sensitive response to perceived oxidative stresses. 
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1.7.3.5. T6SS effector delivery 
T6SS effectors are classified into one of two categories according to their mode of 
delivery, these being either specialised or cargo effectors 230. Cargo effectors are the 
more well characterised of two, consisting of an effector that non-covalently interacts 
with a structural component, such as VgrG or Hcp, for ‘á la carte’ delivery 194. These 
effectors often require the assistance or one or more chaperone proteins to aid in their 
loading onto the lumen of the Hcp tube or VgrG spike 231. Recently however, research 
has identified an alternative method of effector delivery, termed ‘specialised’ or 
‘evolved’ effectors 231. Specialised effectors contain C-terminal extension domains 
which facilitate fusion to the C-terminus of T6SS structure proteins, such as VgrG 
230,231. Interestingly, specialised effectors commonly possess enzymatic abilities, 
which in themselves facilitate host cell subversion, enabling bacterial uptake, as 
demonstrated by the VgrG-3 protein from V. cholerae 232. The details of this covalent 
transport system have yet to be properly understood. It has been demonstrated that 
the C-terminal effector extension is not required for VgrG delivery 232, however there 
has been little research yet to characterise whether any extension domain can be 
delivered or if there is a limit to size and type of cargo. One study has demonstrated 
that various passenger domains, such as -lactamase and Hcp-dependent T6SS toxin 
Tse2, could be fused to the C-terminus of a canonical VgrG (no C-terminus extension) 
and be successfully secreted into the extracellular milieu 230. Whilst they identified no 
current limit to passenger type, they noted that efficacy varied greatly between 
passenger proteins. 
 
 
 
 
 
 
 
33  
1.8. Models and methodologies investigating bacterial interactions in oysters 
 
1.8.1. Oyster microflora 
 
Aquaculture of oysters typically involves growth in marine environments where the 
shellfish feed on phytoplankton present in the surrounding water column. However, as 
a side-effect of this practice, oysters also ingest local microorganisms, some of which 
may be pathogenic towards humans. Therefore, before consumption, oysters are 
required to meet ‘category A’ quality as determined by the Food Standards Agency’s 
guidance on live bivalve molluscs in England, Wales, and Northern Ireland (2016) 233. 
Category A oysters contain < 230 E. coli/100 g shellfish tissue and are suitable for 
immediate sale and raw consumption. Category B shellfish (230 – 4,600 E. coli/100 g 
tissue) require depuration or relaying to reduce bacterial loads. Category C (> 4,600 
E. coli/100 g tissue) require relaying for a minimum two-month period. Oyster relaying 
involves transferring oysters to clean environments where contaminating 
microorganisms are purged by the oyster. Depuration involves immersing oysters in 
tanks through which UV-treated saltwater is circulated to stimulate further expulsion of 
contaminating microorganisms and pollutants 234. It should be noted that whilst 
depuration can result in substantial bacterial clearance, studies have shown that total 
depuration of bacteria from oysters is difficult to achieve 235. 
Consumption of contaminated oysters is widely recognised as the leading source of 
V. vulnificus infection 35,58,236. A study on oysters taken from two individual estuaries in 
India identified V. vulnificus in 85 % of samples following enrichment 237. A separate 
study isolated V. vulnificus from 67 % of raw oysters in Louisiana, USA, and more 
worryingly, from 25 % of cooked oysters sampled 238l. Oysters commonly inhabit 
environments such as estuaries due to salinity, temperature, sediment content and pH 
conditions, where they perform a pivotal role in nutrient cycling and particle mediation 
of the water column 239–242. As filter-feeders, oysters are exposed to a diverse range 
34  
of marine microorganisms which they ingest and retain within their digestive glands. 
Not all microorganisms are capable of surviving within oysters, due to resource 
availability and bacterial competition. This results in establishment of drastically 
different oyster microflora relative to the water column. Analysis of the bacterial flora 
of the Pacific oyster, Crassostrea gigas, collected from Hong Kong , showed that these 
shellfish were predominantly colonised by heterotrophic bacteria, including anaerobes 
and spore-forming bacteria, included in which were Pseudomonas, Vibrio, 
Acinetobacter, and Aeromonas species 243. Conversely, the surrounding seawater 
consisted primarily of coliform and cornyeform bacteria. Interestingly, over 90 % of 
isolated heterotrophic microorganisms isolated from bivalve shellfish were associated 
with the digestive tract and stomach, indicating that ingested microorganisms primarily 
impacted the microflora of the digestive system. These findings were similar to studies 
performed using C. gigas collected from commercial oyster farms in Oregon (USA) in 
which the most frequently encountered microorganisms were Vibrio, Pseudomonas, 
Acinetobacter, Flavobacterium and Gram-positive Bacillus species 244. 
 
1.8.2. Currently employed oyster models 
 
Whilst there have been studies exploring V. vulnificus growth in homogenised oyster 
tissues, the majority of V. vulnificus studies in oysters have utilised a live oyster in vivo 
model 245,246. However, these typically suffer from low-level uptake due to the size- 
based filter-feeding mechanism of oysters. Particles within a specific size range are 
preferentially retained and ingested whereas particles that fall outside the optimum 
range see drastically reduced uptake efficiencies. Riisgård, (1988) explored the 
efficiency of particle retention and filtration in six bivalve species, including the Eastern 
oyster, Crassostrea virginica and the blue mussel, Mytilus edulis 247. Microscopic 
particles and phytoplankton were used to gauge the retention efficiency of particles of 
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varying sizes. Riisgård determined that larger particles were more effectively retained 
with only certain species being able to effectively filter and ingest smaller (< 7 m) 
particles. C. virginica, has an optimum range of 5 – 7 m, resulting in 90 % retention 
efficiency 248. When particle size approximates to ~ 1.8 m this drops to 50 % 249. Other 
species of oyster display similar uptake efficiencies, with C. gigas having an optimal 
range of 4 - 6 m and only retaining 17 % of particles ≤ 2 m in size 250,251. V. vulnificus 
measures 1.4 – 2.6 m in length and 0.5 – 0.8 m in width, falling below the ideal size 
for retention in filter-feeding bivalves. In C. virginica, V. vulnificus retention has been 
shown to be as low as 16 % 249. 
Current methods for facilitating uptake of bacteria by oysters consist of inoculating 
oyster tanks with bacteria for filtration. Srivastava et al., (2009) added 106 CFU/mL V. 
vulnificus to oyster tanks (4.5 × 109 CFU total). After 24 hours, V. vulnificus was 
isolated from oysters at 104 CFU/g tissue 252. Froelich et al., (2013) inoculated oyster 
tanks with 7.5 × 105 CFU/mL V. vulnificus (3.75 × 108 CFU total) and recovered V. 
vulnificus from oysters at 104 CFU/g tissue 253. Similar results were obtained by Pu et 
al., (2018) and Froelich et al., (2010) 254,255. In every case, despite the total inoculating 
culture being > 108 CFU total, isolated V. vulnificus concentrations never rose above 
105 CFU/g tissue. Similar studies performed with Salmonella enterica serovar Newport 
also managed to demonstrate ingestion to levels of 102 – 104 CFU/g tissue 256,257. This 
shows that ingestion and retention of planktonic bacteria by oysters is highly inefficient 
when cultures are simply added to oyster tanks. 
 
 
 
1.8.3. Marine snow as a vehicle for bacterial uptake by oysters 
 
Marine microorganisms such as V. vulnificus are often naturally incorporated into 
aggregates in the environment commonly referred to as ‘marine snow’ 258. These are 
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microcosms composed of diatoms, faecal matter, microorganisms, protists, inorganic 
dust, debris and other miscellaneous elements 259–261. Free-floating microscopic 
particles are brought together at random by Brownian motion, where collision and 
adhesion results in formation of larger aggregates (Fig. 1.4). The rate at which 
aggregates form is dependent upon reaching a critical particle concentration and the 
‘stickiness’ of these components 259. Release of exopolymeric substances (EPS) by 
incorporated microorganisms promotes aggregation with neighbouring particles. EPS 
can vary in structure from a loose mucus layer to compact capsules and play many 
roles across the biological spectrum 262. Notable examples include formation of 
protective capsules in human pathogens, attachment of nitrogen-fixing bacteria to 
plant roots and establishment of biofilms 263–266. During aggregation, EPS coalesce 
into transparent extracellular polysaccharides (TEPs) which form a mucus web that 
functions to maintain the structure of the aggregate and aid in attachment of other 
particulate matter 260. 
Marine snow plays a vital role in the transport of organic materials in the ocean, 
particularly vertically 267. This has the side-effect of presenting a unique environment 
for bacterial colonisation and survival 261,268. Aggregation offers a multitude of 
advantages to V. vulnificus and other organisms. Perhaps most key is the formation 
of the detritosphere, a microenvironment of enriched nutrients which incorporated 
organisms can exploit for growth and survival 269,270. Aside from the concentrated 
presence of key nutrients, integration enables production and exchange of acylated 
homoserine lactones (AHLs) involved in quorum sensing, enhanced exchange of 
genetic material and increased nutrient uptake as a result of the increased availability 
of organic material at surfaces of transfer 271–273. However, importantly for this study, 
incorporation of bacteria into marine snow facilitates more effective uptake by oysters 
as the larger microcosm is more effectively filtered and ingested. 
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Figure 1.4: Micrograph of marine snow generated by this study. Seawater collected 
from Dawlish was utilised as a substrate to generate marine snow. Seawater (1 L) was 
supplemented with hyaluronic acid and incubated at 21 °C, 12 rpm for 24 hours to promote 
aggregation of particulate matter. The aggregate therefore consists of all the particulate 
matter present in the seawater substrate, such as sand, dust, algae, microorganisms and 
other miscellaneous components. Magnification × 400. 
 
 
 
 
1.8.4. Incorporation of V. vulnificus into marine snow 
 
The generation of marine snow for V. vulnificus incorporation and uptake by oysters 
has been explored by Froelich et al., (2013) 249. In their study the authors generated 
marine snow using seawater, into which they incorporated both E-type and C-type V. 
vulnificus. Enumeration of V. vulnificus from marine snow demonstrated successful 
integration, with the E-type strain recovered at 105 CFU/mL and the C-type strain 
recovered at < 105 CFU/mL (note that whilst the unit should be CFU/g marine snow, 
the authors in this study utilised CFU/mL marine snow as they would enumerate 
bacterial incorporation by extracting 1 mL of seawater containing marine snow for 
processing, not by establishing the weight of the aggregates). Whilst both strains 
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showed successful incorporation, E-type V. vulnificus strains showed significantly 
greater incorporation into marine snow than C- type 249. These findings help explain 
the results put forwards by Warner and Oliver, (2008) who highlighted the elevated 
presence of E-type V. vulnificus in oysters relative to C-type 33. Despite being present 
at similar concentrations in the surrounding water (E-type – 46.9 %, C-type – 53.1 %), 
E-type V. vulnificus outnumbered their counterparts 84.4 % to 15.6 % in oyster tissues. 
This inherent advantage presented by E-type strains not only offers an explanation for 
the disparity between E- and C- type presence in oysters, but also a potential 
explanation for the low clinical occurrence observed despite the organism’s ubiquity. 
If C-type V. vulnificus strains capable of causing significant disease in humans 
demonstrate less efficient incorporation into marine snow and uptake by oysters this will 
reduce human exposure to pathogenic strains. 
A possible reason for the disparity in marine snow incorporation is the difference in 
chitin-binding ability between E- and C-type V. vulnificus. Chitin is the second most 
abundant polysaccharide on earth behind cellulose and is composed of -(1→4)- 
linked N-acetylglucosamine (GlcNAc) polymers 274,275. Chitin is recognised as a major 
constituent of marine snow and studies have linked the ability of bacteria to bind chitin 
as a direct influence on cell counts recovered from aggregates 276,277. E-type V. 
vulnificus were significantly more efficient at binding chitin than C-type strains. 
Williams et al., (2013) explored the role of surface proteins in chitin attachment, notably 
the type 4 pilus of V. vulnificus 276. Two V. vulnificus type 4 pilus mutants, pilA and 
pilD, displayed significantly reduced attachment to chitin coated beads versus wild-
type strains. To determine whether this was a genotype-specific occurrence, E- and 
C-type strains were incubated with chitin and relative gene expression monitored. 
Results demonstrated that E-type strains express 23-fold more PilA and 9-fold more 
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PilD than C-type strains. This supports the hypothesis that greater E-type aggregation 
is a result of heightened chitin binding. 
However, expression levels of type 4 pilus genes are not the sole contributing factor. 
Parallel attachment assays at 30 °C and 37 °C showed an increase in C-type binding 
at 37 °C in conjunction with a decrease in E-type binding under the same conditions 
278. This suggests that the chitin binding potential of C-type strains may be 
predominantly geared towards human infection as opposed to ecological proliferation 
and survival. This hypothesis is further supported by the elevated expression of gpbA 
in C-type strains 276. GbpA is an N-acetylglucosamine binding protein that is expressed 
at levels 46-fold greater in C-type strains. Initially this suggests a mechanism for 
enhanced binding of C-type strains to chitin-containing aggregates. However, Wong et 
al., (2012) drew a link between V. cholerae GbpA and host colonisation. The GbpA of 
V. cholerae has been shown to play a role in binding both chitin and mucins that 
contain GlcNAc 279. Consequently, V. cholerae is capable of binding both marine chitin 
and mammalian intestinal mucins, suggesting that increased expression of gbpA in C-
type V. vulnificus may be primarily utilised in host colonisation. 
 
 
 
1.8.5. Marine snow uptake and bacterial retention by oysters 
 
Oysters feed using a selective mucociliary clearance mechanism. Surrounding water 
is pumped through a set of filamentous gills (Fig. 1.5). Cilia covering these gills trap 
passing particles and encase them in mucus for transport to the labial palps, mouth 
and stomach where they are digested 280. Filtration of suspended particles by bivalves 
is an active process and as a result there is some degree of selection as to what 
material is ingested. The primary factor is particle size. Preferential uptake and 
digestion of a microphytobenthos assemblage by the Pacific oyster, C. gigas, was 
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performed in which two diatom species out of sixteen showed greater propensity for 
uptake and digestion due to variations in size and mass 281. Experiments geared 
towards quantifying bacterial uptake and depuration in bivalves, notably in oysters and 
mussels, involved the seeding of oyster holding tanks with pre-determined 
concentrations of bacterial culture 253,255,282. However, this produced inherently 
unreliable results due to the size-based selection of particles by bivalves. While the 
morphology of the filter-feeding apparatus has been shown to have an impact on 
particle-retention, the principle factor is the size of the particle 252,254,264. 
 
 
 
 
 
 
Figure 1.5: Anatomy of the Pacific oyster, Crassostrea gigas. Seawater is moved over 
the gills by the beating of cilia. Suspended particle matter, such as plankton and algae, are 
trapped in mucus for transport to the mouth and oesophagus where they are eaten and 
moved to the stomach for digestion. All indigestible material is released as faeces. Figure 
taken from Laurence et al., (2009) 283. 
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Froelich et al., (2013) exposed oysters to marine snow inoculated with V. vulnificus at 
concentrations of 105  CFU/mL 249. The authors were able to demonstrate recovery of 
V. vulnificus from oyster tissues at concentrations of 102 – 103 CFU/g tissue. This is 
not particularly high, especially as marine snow demonstrated incorporation of V. 
vulnificus at 105 CFU/ml. The aim of using marine snow as a model for uptake is that 
it would facilitate greater uptake of V. vulnificus than previous tank-spiking practices. 
However, there are numerous studies that have achieved 103 – 105 CFU/g tissue 
without the use of marine snow as previously discussed in section 1.8.2. It is therefore 
apparent that this method would likely require substantial optimisation to develop a 
substantial model for promoting relevant uptake of V. vulnificus by oysters. 
 
 
 
1.9. Research aims 
 
V. vulnificus is a significant human pathogen, commonly found in high concentrations 
within filter-feeding shellfish such as oysters. Previous studies have shown that V. 
vulnificus possess two T6SSs, termed the T6SS1 and T6SS2. Of these two systems, 
the T6SS1 has been demonstrated to possess antibacterial at 30 °C in vitro. Therefore, 
this study seeks to elucidate T6SS activity in vitro at more environmentally 
representative conditions and the impact this may have on V. vulnificus ecology. To 
confirm that these results are representative of genuine in vivo interactions this study 
will also aim to develop an oyster model for in vivo bacterial co-culture killing assays. 
This will involve the development and optimisation of a marine snow model for 
facilitating high-level uptake of bacteria by oysters for in vivo competition. 
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Chapter Two 
 
 
Materials and Methods 
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2.1. Culture conditions 
 
All bacteria, phytoplankton and amoeba species and strains used in this study can be 
seen in Table 2.1. 
 
 
 
2.1.1. Bacterial culture conditions 
 
Bacterial strains were cultured in Luria-Bertani (LB) broth and on LB agar plates at 
either 30 °C or 37 °C. Vibrio species were cultured on Thiosulfate-Citrate-Bile Salts- 
Sucrose (TCBS) agar (Oxoid). Salmonella species were cultured on Salmonella 
ChromoSelect agar (Sigma) at 37 °C. Antibiotics were added to media where 
necessary at the following concentrations: ampicillin (100 g/mL; ), kanamycin (50 
g/mL), trimethoprim (50 g/mL) and chloramphenicol (35 g/mL for Escherichia coli, 10 
 
g/mL for Vibrio). 
 
 
 
2.1.2. Diatom culture conditions 
 
Thalassiosira pseudonana CCMP 1335 and Phaeodactylum tricornutum UTEX 646 
were cultured in 20 ppt salinity water supplemented with 20 mL/L Guillard’s F/2 media 
+ Si (Sigma). Cultures were inoculated at 104 cells/mL in 50 mL of media and maintained 
at 20 °C, 70 rpm, on an orbital shaker under cool fluorescent light set to a 12:12 
light:dark cycle. Total cell counts were performed daily using a haemocytometer. 
Cultures were regularly checked for bacterial contamination by plating on LB agar and 
incubating plates at 37 °C. Once diatom growth reached stationary phase, cultures 
were split for scaling up growth and maintaining reserve stocks. Once cultures reached 
105 – 106 cells/mL in 2 L Erlenmeyer flasks cultures were removed from incubation for 
experimental use. 
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2.1.3. Dictyostelium discoideum culture conditions 
 
D. discoideum AX3 (DictyBase accession number: DBS0235542) was ordered via 
DictyBase and received growing on a lawn of E. coli B/r 284. An inoculating loop of D. 
discoideum fruiting bodies was resuspended in 250 L of E. coli MG1655 culture and 
spread onto pre-dried LPB agar (0.1 % lactose, 0.1 % bacteriological peptone, 19 mM 
Na2HPO4 ∙7H2O, 30 mM KH2PO4). Plates were incubated at 21 °C for 2 – 3 days to 
facilitate D. discoideum growth. D. discoideum cultures were routinely sub-cultured 
once D. discoideum had cleared the lawn of E. coli but before formation of fruiting 
bodies. 
Axenic D. discoideum AX3 cultures were generated by inoculating 30 mL of HL5 media 
(Formedium™) supplemented with ampicillin (100 g/mL) and streptomycin (300 
g/mL) with an inoculating loop of D. discoideum fruiting bodies. Cultures were 
incubated at 21 °C, 180 rpm for 2 – 3 days. Before cultures exceeded 106 cells/mL, 1 
mL of culture was used to inoculate 30 mL of antibiotic-free HL5. Cultures were 
incubated at 21 °C, 180 rpm for 2 – 3 days and routinely checked for bacterial 
contamination. 
 
2.2. Antibiotic stock solutions 
Antibiotic stock solutions were made up as follows: ampicillin, 50 mg/mL in ddH2O; 
streptomycin, 100 mg/mL in ddH2O; chloramphenicol, 35 mg/mL in 70 % ethanol; 
trimethoprim, 10 mg/mL in DMSO; kanamycin, 50 mg/mL in ddH2O. All antibiotic 
stocks were stored at -20 °C. 
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Table 2.1: List of strains and species used in this study. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Strain Description Source 
 
 
 
V. vulnificus 
  
106-2A Environmental isolate, T6SS1+ T6SS2+, C-genotype Lab stock 
T6SS1 106-2A with a hcp1 in-frame deletion, T6SS1- T6SS2+, C-genotype This study 
T6SS2 106-2A with a hcp2 in-frame deletion, T6SS1+ T6SS2-, C-genotype This study 
T6SS1/2 106-2A with in-frame deletions of hcp1 and hcp2, T6SS1- T6SS2-, C-genotype This study 
99-743 Environmental isolate, T6SS1- T6SS2+, E-genotype Lab stock 
106-2A pVv3-kan 106-2A containing pVv3-kan, (Kanr) This study 
T6SS1 pVv3-kan 106-2A T6SS1 containing pVv3-kan, (Kanr) This study 
T6SS2 pVv3-kan 106-2A T6SS1 containing pVv3-kan, (Kanr) This study 
T6SS1/2 pVv3-kan 106-2A T6SS1/2 containing pVv3-kan, (Kanr) This study 
99-743 pVv3-tmp 99-743 containing pVv3-tmp, (Tmpr) This study 
 
S. Enteritidis 
  
CC012 Wild-type Salmonella enterica serovar Enteritidis CC012 Lab stock 
 
V. cholerae 
  
V52 O37 serogroup strain, (Smr) Lab stock 
 
E. coli 
  
S17-1  pir Routine cloning strain and donor for triparental conjugation Lab stock 
HB101 pRK2013 Helper strain for triparental conjugation containing pRK2013, Kan Lab stock 
Dh5 Routine cloning strain Lab stock 
JM109 Routine cloning strain Lab stock 
 
T. pseudonana 
  
CCMP 1335 Cosmopolitan centric diatom, 3 - 5 m diameter Samuel Barton 
 
P. tricornutum 
  
UTEX 646 Pennate diatom, 10 - 20 m in length Dr Mike Allen 
 
D. discoideum 
  
AX3 Peter Devreotes lab strain, axenic, Dictybase strain ID - DBS0235542 Dictybase 
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2.3.  Molecular genetics 
 
2.3.1. Genomic DNA extraction 
 
gDNA was extracted from overnight bacterial cultures using the Wizard® genomic 
DNA purification kit (Promega) according to the manufacturers’ instructions. Quality of 
purified gDNA was checked using 1 % agarose gel electrophoresis and quantified 
using a NanoDrop™ 1000 (ThermoFisher). gDNA was diluted 1 in 20 for use in 
downstream PCR reactions. gDNA samples were stored at -20 °C. 
 
2.3.2. Polymerase chain reaction (PCR) 
Oligonucleotides for PCR were designed and analysed using the Clone Manager 
software and synthesised by Eurofins MWG Operon. A list of the primers used in this 
study can be seen in Table 2.2. PCR products amplified with Phusion® High-Fidelity 
DNA polymerase were mixed with 4 L 5× Phusion HF buffer, 0.4 L dNTPs (10 mM), 
1 L forward primer (10 M), 1 L reverse primer (10 M), 0.2 L Phusion DNA 
polymerase, ~ 100 ng template DNA and ddH2O up to 20 L (all reagents NEB). Once 
mixed, reactions were placed in a PCR thermocycler and run at the following 
conditions. Initial denaturation – 98 °C for 30 seconds. 35 cycles of denaturation at 98 
°C for 10 seconds, annealing at 50 °C for 20 seconds and extension at 72 °C for 20 
seconds/kb. A final extension was ran at 72 °C for 10 minutes before holding at 4 °C. 
PCR products amplified with HotStarTaq® DNA polymerase were mixed with 2.5 L 
10× PCR buffer, 0.5 L dNTPs (10 mM), 0.5 L forward primer (10 M), 0.5 L reverse 
primer (10 M), ~ 100 ng template DNA, 0.2 L DNA polymerase and 2 ddH2O up to 
25 L (all reagents Qiagen). Once mixed, reactions were placed in a PCR thermocycler 
(Biometra TRIO 48, Analytik Jena) and run at the following conditions.  
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Table 2.2: List of primers used in this study. 
 
 
 
Primers Description Sequence (5' - 3') 
 
106-2A hcp1 LFF SmaI 
 
106-2A hcp1 region left flank forward 
 
TACCCGGGCAGACTCTTTCGACAGCTTATAG 
106-2A hcp1 LFR NdeI 106-2A hcp1 region left flank reverse TCCATATGTGGAGTTGGCATAGCTATTTC 
106-2A hcp1 RFF NdeI 106-2A hcp1 region right flank forward GCCATATGATCGAGGCTTAATCCTCGTC 
106-2A hcp1 RFR ApaI 106-2A hcp1 region right flank reverse TAGGGCCCGCCCATCTCTTGCAATATCTG 
106-2A hcp2 LFF SmaI 106-2A hcp2 region left flank forward TTCCCGGGCTTTGCACCGTGATGTATTG 
106-2A hcp2 LFR NdeI 106-2A hcp2 region left flank reverse TGCATATGATTTGACTGCATGCTAGTCTC 
106-2A hcp2 RFF NdeI 106-2A hcp2 region right flank forward GGACATATGGGTGTTAAAGGTCAACAAATG 
106-2A hcp2 RFR ApaI 106-2A hcp2 region right flank reverse GTTGGGCCCTGAAAGATTCGGCTGTTG 
hcp1 MutScreen FWD hcp1 crossover forward primer ACATGGTGACAAGGTTGATAG 
hcp1 MutScreen REV hcp1 crossover reverse primer CAGAATTCACGCTGAGAAAG 
hcp2 MutScreen FWD hcp2 crossover forward primer TACGAGACGATTTGTTACAG 
hcp2 MutScreen REV hcp2 crossover reverse primer TTGGCATAGCTTTTGGTCAG 
CmR FWD First crossover forward primer ATGGAGAAAAAAATCACTGGATATACCACC 
CmR REV First crossover reverse primer TTACGCCCCGCCCTGCCACTCATCGCAGTA 
vgrG1 qPCR FWD Forward primer for vgrG1 qPCR GAAATTGGTGCGAACCAACG 
vgrG1 qPCR REV Reverse primer for vgrG1 qPCR CCCACCTGGTCCCTTAATTG 
vcgE qPCR FWD Forward primer for vcgE qPCR AATGATCTCATCACTGCTATCC 
vcgE qPCR REV Reverse primer for vcgE qPCR AATCAAACCCAGGCATAAGC 
vvhA qPCR FWD Forward primer for vvhA qPCR GAGCGTGAGTTTGGTGAG 
vvhA qPCR REV Reverse primer for vvhA qPCR AGGGTTGAACTTCGTCTTATC 
sefA qPCR FWD Forward primer for sefA qPCR TGCAGCTCAGAATACAACATC 
sefA qPCR REV Reverse primer for sefA qPCR GGCTACACCACCAGATAC 
vgrG1 RT-PCR FWD Forward primer for vgrG1 RT-PCR ATGGCAAAGTTAACATTCAC 
vgrG1 RT-PCR REV Reverse primer for vgrG1 RT-PCR TCTCATCCGGACCATCAG 
clpV RT-PCR FWD Forward primer for clpV RT-PCR ATGTCGAATCTATCACTATCTAC 
clpV RT-PCR REV Reverse primer for clpV RT-PCR TTAGACGATTGAGATAGACAAG 
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vvhA FWD vvhA forward primer ATGAAAAAAATGACTCTGTTTACCC 
vvhA REV vvhA reverse primer CTAGAGTTTGACTTGTTGTAATGTG 
M13 FWD pGEM-T Easy forward primer CCCAGTCACGACGTTGTAAAACG 
M13 REV pGEM-T Easy reverse primer CAGGAAACAGCTATGAC 
pVv3-tmp OE FWD Forward primer for generating pVv3-tmp CTCGAATTCACTAGTAACACCCCTTGTATTACTG 
pVv3-tmp OE REV Reverse primer for generating pVv3-tmp AATACAAGGGGTGTTACTAGTGAATTCGAGCCA 
 
 
 
 
Initial denaturation/polymerase activation – 95 °C for 15 minutes. 35 cycles of 
denaturation at 94 °C for 30 seconds, annealing at 50 °C for 30 seconds and extension 
at 72 °C for 1 minute/kb. A final extension was ran at 72 °C for 10 minutes before 
holding at 4 °C. 
All PCR amplified DNA was stored at -20 °C for downstream reactions. 
 
2.3.3. PCR fragment A-tailing 
 
5 – 10 L of blunt-ended, purified PCR product was mixed with 2 L 10× ThermoPol® 
Buffer, 1 L dATP (10 mM), 0.2 L Taq DNA polymerase and ddH2O up to 20 L (all 
reagents NEB). The reaction was incubated at 72 °C for 20 minutes. A-tailed DNA was 
column purified using the Wizard® SV Gel and PCR Clean-Up System kit (Promega) 
and stored at -20 °C. 
 
 
 
2.3.4. Total cellular RNA extraction 
 
Total cellular RNA was extracted from overnight bacterial cultures using the 
RiboPure™-Bacteria kit (ThermoFisher) according to the manufacturers’ instructions. 
To eliminate traces of gDNA, purified RNA was treated with DNase I (Ambion) 
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according to the manufacturers’ instructions. Purified RNA was stored in RNase-free 
collection tubes at -80 °C. 
 
2.3.5. Reverse-transcription PCR (RT-PCR) 
 
SuperScript™ III Reverse Transcriptase (Invitrogen) was used to synthesise 
complementary DNA (cDNA) for RT-PCR. For primer annealing, 50 ng random 
hexamers (Invitrogen) were mixed with 1 g total RNA, 1 L 10 mM dNTPs and ddH2O 
to 13 L. This solution was incubated at 65 °C for 5 minutes and incubated on ice for a 
further 5 minutes. Following incubation, the following reagents were added to the 
microcentrifuge tube: 4 L 5× First-Strand Buffer, 1 L 0.1 M DTT, 1 L RNaseOUT™, 
1 L SuperScript™ III RT (all reagents Invitrogen). The solution was incubated at 25 
°C for 5 minutes before being incubated for a further 60 minutes at 50 °C to allow 
primer extension and cDNA generation. 
 
 
 
2.3.6. Agarose gel electrophoresis 
 
1 % agarose gels were generated by combining 70 mL 1× TAE (Tris-acetate 40 mM, 
EDTA 1 mM in ddH2O to a 1× solution) with 0.7 g of agarose (Sigma) and supplementing 
with Midori Green nucleic acid gel stain (Nippon Genetics). 100 V was passed across 
the gel for 45 minutes to separate the negatively charged DNA in a size-selective 
manner. Separated DNA was visualised using a BioRad ChemiDoc™ UV 
transilluminator with the Quantity One gel imaging software. 
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2.3.7. DNA gel purification 
 
DNA bands of interest were excised from 1 % agarose gels using a scalpel and purified 
using the GeneJET Gel Extraction Kit (ThermoFisher) according to the manufacturer’s 
instructions. Purified DNA was eluted in 30 mL ddH2O. 
 
2.3.8. Plasmid extraction and ethanol precipitation of plasmid DNA 
 
A list of plasmids used in this study can be seen in Table 2.3. Typical plasmid 
extractions were performed utilising the Thermo Scientific GeneJET Plasmid Miniprep 
Kit using 1 mL of overnight bacterial culture. Purified plasmid DNA was eluted in 30 L 
ddH2O and 5 L visualised by agarose gel electrophoresis. For low copy-number 
plasmids, 50 mL of overnight bacterial culture was processed using the Promega 
PureYield™ Plasmid Midiprep System. Purified plasmid DNA was eluted in 500 L 
ddH2O. Midiprepped plasmid DNA was then concentrated via ethanol precipitation. 
Briefly, 2 L glycogen (NEB) was added to 350 L plasmid DNA along with 1/10 volume 
3 M sodium acetate (pH 5.2) and 2× volume 100 % ethanol. Solutions were thoroughly 
mixed and incubated at -80 °C for 1 hour. Samples were centrifuged at 14,000 rpm, 4 
°C, for 30 minutes to pellet plasmid DNA. Supernatant was aspirated and the pellet 
washed with 700 l 70 % ethanol. Samples were centrifuged for 15 minutes to wash 
the pellet and the supernatant aspirated again. Pellets were left to air dry for 15 
minutes until no ethanol remained. 30 L ddH2O was added and the sample incubated 
at 65 °C for 1 hour to resuspend plasmid DNA. Concentrated plasmid DNA was 
visualised using agarose gel electrophoresis and the concentration determined using 
a NanoDrop™ 1000 (ThermoFisher). 
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Table 2.3: List of plasmids used in this study. 
 
 
 
 
 
Plasmid Description Source 
 
 
pGEM-T Easy 
 
 
Routine cloning plasmid, Ampr 
 
 
Promega 
pGEM-T Easy-hcp1LF pGEM-T Easy containing 106-2A hcp1 left flanking region This study 
pGEM-T Easy-hcp1RF pGEM-T Easy containing 106-2A hcp1 right flanking region This study 
pGEM-T Easy-hcp2LF pGEM-T Easy containing 106-2A hcp2 left flanking region This study 
pGEM-T Easy-hcp2RF pGEM-T Easy containing 106-2A hcp2 right flanking region This study 
pGEM-T Easy-vgrG1 pGEM-T Easy containing the vgrG1 fragment amplified by qPCR This study 
pGEM-T Easy-vcgE pGEM-T Easy containing the vcgE fragment amplified by qPCR This study 
pGEM-T Easy-vvhA pGEM-T Easy containing the vvhA fragment amplified by qPCR This study 
pGEM-T Easy-sefA pGEM-T Easy containing the sefA fragment amplified by qPCR This study 
pDM4 Suicide vector, R6K origin, sacBR, Cmr Lab stock 
pDM4-hcp1 pDM4 containing ligated 106-2A hcp1 left and right flanks This study 
pDM4-hcp2 pDM4 containing ligated 106-2A hcp2 left and right flanks This study 
pVv3-kan Vibrio shuttle vector from cryptic V. vulnificus plasmid pVN-0126, Kanr Dr. S. Hertwig 
pVv3-kan-tmp Vibrio shuttle vector from cryptic V. vulnificus plasmid pVN-0126, Kanr, Tmpr Dr. S. Hertwig 
pVv3-tmp Vibrio shuttle vector from cryptic V. vulnificus plasmid pVN-0126, Tmpr This study 
pRK2013 Helper plasmid for conjugation, Kanr Lab stock 
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2.3.9. Ligations 
 
Appropriate volumes of insert to vector were calculated and combined at a 3:1 
insert:vector ratio. 1 L T4 DNA ligase was added to the solution along with 1 L 10× 
T4 DNA ligase buffer (all reagents NEB). Ligation reactions were made up to a final 
volume of 10 L with ddH2O before being incubated overnight at 16 °C. 
 
 
2.3.10. Calcium chloride chemically competent E. coli 
 
1 mL of overnight E. coli culture was used to inoculate 50 mL LB broth for growth at 37 
 
°C until an OD590nm of 0.4. The culture was then incubated on ice for 30 minutes before 
being centrifuged at 3,000 rpm for 10 minutes at 4 °C. Pelleted cells were re- 
suspended in 25 mL ice cold 0.1 M CaCl2 and incubated on ice for a further hour. 
Following further centrifugation as previously described, the supernatant was 
discarded, and pelleted cells re-suspended in 2 mL ice cold 0.1 M CaCl2 with 15 % 
glycerol (v/v). 100 l aliquots were frozen and stored at -80 °C. 
 
 
2.3.11. Chemically competent cell transformation 
 
Chemically competent E. coli were thawed on ice and 2 – 4 L of plasmid DNA or 
ligation product added. Following 40 minutes incubation on ice, cultures were heat 
shocked at 42 °C for 45 seconds and incubated on ice for a further 5 minutes. 700 L 
pre-warmed LB broth was added, and cultures incubated at 37 °C, 200 rpm, to facilitate 
expression of antibiotic resistance genes. Cultures were centrifuged, 500 L of the 
supernatant removed, and pelleted cells re-suspended in the remaining 400 L. 
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200 L was then spread onto LB agar plates containing the necessary antibiotics and 
plates incubated overnight at 37 °C. 
 
 
 
2.3.12. Electrocompetent cells 
 
Electrocompetent cells were generated and electroporated according to the protocol 
published by Klevanskaa et al., (2014) 279. 1 mL of overnight bacterial culture was used 
to inoculate 30 mL LB broth for growth at 37 °C until the OD590nm reached 0.8. Cells 
were sedimented at 4,000 rpm, 4 °C, for 15 minutes. The supernatant was aspirated, 
and the pelleted cells resuspended in ice-cold electroporation buffer (1 mM Tris-HCl, 
pH 6, supplemented with 200 mM sucrose). This wash step was repeated twice, after 
which pelleted cells were resuspended in 150 L electroporation buffer. 50 L aliquots 
were frozen at -80 °C for future electroporation. 
 
 
 
2.3.13. Electrocompetent cell electroporation 
 
Electrocompetent cells (50 L) were thawed on ice and 400 ng plasmid DNA mixed 
with the cells. Following 10 minutes incubation on ice, the suspension was added to a 
pre-chilled electroporation cuvette and electroporation performed at 7.5 kV cm-1, 25 
F and 200 Ω. Immediately after, 950 L LB broth pre-warmed to 37 °C was added to 
the cells and the suspension incubated with at 37 °C, 200 rpm, for 1 hour to allow 
recovery of electroporated cells. Recovered cells were then plated on LB agar plates 
containing the required antibiotic and incubated at 37 °C overnight to select for 
successful electroporation. 
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2.3.14. Tri-parental conjugation 
 
Three bacterial strains were cultured overnight in LB in preparation for tri-parental 
conjugation. The donor E. coli strain, S17-1  pir, containing the plasmid to be 
transferred, the helper E. coli strain, HB101, containing the kanamycin resistant helper 
plasmid pRK2013, and the recipient V. vulnificus strain. 1 mL of each overnight 
bacterial culture was pelleted at 14,500 rpm and the supernatant aspirated. To remove 
antibiotic traces, cells were washed in fresh LB broth. Pelleted cells were resuspended 
in 200 L LB broth and combined in a 5:1:1 ratio with the recipient being the higher 
density. 200 l of the suspension was spotted on LB agar and incubated overnight at 
37 °C. Bacterial growths were scraped off the plate and resuspended in 1 mL phosphate 
buffered saline (PBS), a water-based salt solution utilised to maintain a consistent pH. 
100 L was spread on a TCBS plate supplemented with the necessary antibiotics and 
incubated at 37 °C for 2 – 3 days, until colonies were observed. Plasmid DNA was 
miniprepped from potential transformants to confirm presence of the plasmid and 
colonies PCR-screened with V. vulnificus specific vvhA primers. 
 
 
 
2.3.15. V. vulnificus mutant generation 
 
In-frame deletions of hcp1 and hcp2 were constructed using suicide vector pDM4 285. 
Primers were designed to amplify the flanking regions of the genes of interest and to 
incorporate specific restriction sites to allow downstream ligation (Table 2.2). Flanking 
regions were cloned into pGEM-T Easy for sequencing. Flanks were excised from 
pGEM-T Easy using SmaI/NdeI (left flank) and NdeI/ApaI (right flank), column purified, 
and utilised for a three-way ligation into pDM4 linearised using SmaI/ApaI. 
Generated constructs were transformed into E. coli S17-1  pir for conjugation into V. 
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vulnificus as described in section 2.2.11. Successful first cross-over integrants were 
identified via PCR and respective colonies were subcultured on LB agar plates 
supplemented with 10 % sucrose to promote second crossover and plasmid excision. 
PCR using primers flanking the deletion were then used to confirm whether colonies 
were successful mutants or WT revertants. 
 
 
 
2.3.16. Generation of pVv3-tmp by overlap extension PCR (OE-PCR) 
 
pVv3-tmp was constructed from pVv3-kan-tmp according to the protocol published by 
Hansson et al., (2008) 286. Primers were designed against the 20 bp region 
immediately up and downstream of the start and stop codons of the kanamycin 
resistance gene of pVv3-kan-tmp (Appendix 1). Each primer had a 5’ tail 
complementary to the other primer. Overlap-extension PCR (OE-PCR) was set up 
using 200 ng pVv3-kan-tmp as template, 10 L 5× Phusion HF buffer, 1 L dNTPs, 2.5 
L forward and reverse primer (each 10 M), 0.2 L Phusion DNA polymerase and 
ddH2O up to 50 L (all reagents NEB). PCR reactions were run at the following 
conditions. Initial denaturation – 98 °C for 30 seconds. 35 cycles of denaturation at 98 
°C for 10 seconds, annealing at 50 °C for 30 seconds and extension at 72 °C for 2 
minutes. A final extension was run at 72 °C for 10 minutes before holding at 4 °C. 
To digest the methylated template plasmid DNA (pVv3-kan-tmp) and reduce 
background transformation, PCR reactions were treated with 1 L DpnI (Agilent) for 1 
hour at 37 °C. DpnI was inactivated at 80 °C for 20 minutes and 3 L of reaction 
transformed into chemically competent E. coli JM109. Transformations were plated on 
LB agar supplemented with trimethoprim and incubated overnight at 37 °C. Potential 
transformants were used to inoculate individual wells on a 96-well plate containing 
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LB/trimethoprim. 96-well plates were incubated at 37 °C, 125 rpm, for 2 hours, to allow 
outgrowth of potential transformants. Using a colony replicator, cultures were spotted 
in parallel on LB agar supplemented with either kanamycin or trimethoprim and 
incubated overnight at 37 °C. Colonies that were able to grow on LB/trimethoprim 
plates but not LB/kanamycin plates were indicative of kanamycin deletion and taken 
forward for miniprep and plasmid confirmation by restriction endonuclease digestion. 
 
 
 
2.4. Marine snow 
 
2.4.1. Generating natural and artificial marine snow 
 
Natural marine snow was generated according to the technique outlined by Froelich 
et al., (2013) 249. 10 g/L-1 hyaluronic acid (Merck; MW ≥ 1 MDa) was added to 1 L 
Nalgene bottles containing 1 L seawater adjusted to 20 ppt salinity. The resulting 
suspensions were rolled at 12 rpm for 24 hours at 21 °C to facilitate particle collision 
and aggregate formation. 
For artificial marine snow, live phytoplankton cultures were added to 1 L 20 ppt artificial 
seawater at a final concentration of 106 CFU/mL and supplemented with 10 g/L-1 
hyaluronic acid. For marine snow generated using commercially cultured diatoms two 
different solutions were utilised. Reef Phytoplankton (ReefPhyto LTD) and TP1800™ 
(Reed Mariculture). These solutions were added to AMS suspensions in place of 
laboratory-cultured diatoms to a final concentration of 106 cells/mL. Suspensions were 
incubated at 12 rpm for 24 hours at 21 °C. 
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2.4.2. Determining the weight of natural marine snow 
 
Natural marine snow was vacuum filtered through Whatman™ qualitative filter paper, 
Grade 6 (GE Healthcare Life Sciences), to isolate aggregates (Fig. 2.1). Once filtration 
had isolated the aggregates, filter paper was removed and weighed. The weight was 
compared to a negative control in which 1 L of artificial seawater was also filtered 
through the same filter paper. The difference was calculated, and this value constituted 
the wet mass of the natural marine snow. 
 
 
 
 
 
 
 
Figure 2.1: Schematic depicting vacuum filtration of marine snow. A vacuum flask was 
topped with a Buchner funnel loaded with 3 m pore filter paper. Marine snow was added 
to the Buchner funnel and vacuum filtered to isolate all aggregates > 3 m in size. Once 
completely filtered, filter paper was weight for comparison to a negative control and wet 
mass of marine snow calculated. 
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2.4.3. Determining the weight of artificial marine snow 
 
To determine the weight of artificial marine snow, diatom cultures were adjusted to the 
required concentration and pelleted. The supernatant was aspirated, and the wet mass 
of the pellet determined. This value was then utilised in conjunction with CFU counts 
to enumerate bacterial incorporation into aggregates in CFU/g artificial marine snow. 
 
 
2.4.4. Enumeration bacterial incorporation into marine snow 
 
Aggregates isolated by vacuum filtration were resuspended in 50 mL PBS and vortexed 
vigorously for 30 seconds to disrupt aggregates and release incorporated Vibrios. 
Samples were centrifuged at 4,000 rpm for 30 minutes and the pellets resuspended in 
1 mL PBS. 500 L of the resuspended solution was diluted serially 10-fold and 100 L 
of each dilution spread in triplicate on LB agar. Plates were incubated at 37 °C 
overnight. The following day colonies were replica plated onto TCBS and incubated 
overnight at 37 °C for CFU/g marine snow calculations. 
 
 
 
2.5. In vitro molecular assays 
 
2.5.1. Bacterial growth curves 
 
Overnight bacterial cultures were set up in 5 mL LB broth and grown at 37 °C, 200 rpm. 
30 mL fresh LB broth was inoculated to an OD590nm of 0.03 using the overnight bacterial 
cultures and grown at the required temperature, 200 rpm. Every two hours OD590nm 
was read and Miles and Misra 10-fold serial dilutions performed in triplicate 287. Plates 
were incubated at 37 °C overnight and CFU/mL calculated the following day. 
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2.5.2. Co-culture killing assays 
 
1 mL of overnight bacterial culture, supplemented with antibiotics where necessary, 
was used to inoculate 30 mL fresh LB broth to an OD590nm of 0.03. Cultures were 
incubated at 30 °C, 200 rpm, until they reached an OD590nm of 1.0 where they were 
then adjusted to an OD590nm of 0.8 and centrifuged for 3 minutes at 14,500 rpm. 
Pelleted cells were washed twice with 1 mL PBS and resuspended in 1 mL LB to remove 
any traces of antibiotics. Attacker and prey cultures were combined in a 3:1 ratio, 
vortexed to mix, and 25 L of each spotted onto LB agar. LB plates were incubated at 
either 23 °C, 30 °C or 37 °C for 5 hours to allow contact-dependent killing to take place. 
Miles and Misra 10-fold serial dilutions of the suspensions were performed and 10 l 
spotted in triplicate onto selective agar. Dilution plates were incubated overnight at 37 
°C for CFU/mL calculation the following day. After 5 hours, co-culture spots were 
excised using a flame-sterilised scalpel and resuspended in 1 mL PBS. Miles and Misra 
10-fold serial dilutions of the resuspended growths were performed and 10 L spotted 
in triplicate onto selective agar. Plates were incubated at 37 °C overnight and CFU/mL 
calculated the following day. 
 
 
 
2.5.3. Plasmid stability assay 
 
V. vulnificus containing either pVv3-kan or pVv3-tmp was cultured in LB supplemented 
with either kanamycin or trimethoprim at the required temperature overnight. Overnight 
cultures were used to inoculate 30 mL LB supplemented with antibiotics to an OD590nm 
of 0.03. Once cultures reached an OD590nm of 1.0 they were adjusted to OD590nm 0.8 
and washed twice to remove any traces of antibiotic. 100 L of each strain was mixed 
with 300 L LB and 25 L of each sample spotted onto LB agar and incubated at the 
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required temperature for the required length of time. Bacterial growths were excised 
from LB agar using a flame-sterilised scalpel and resuspended in 1 mL PBS. Miles and 
Misra 10-fold serial dilutions were performed and 10 L of the resulting dilutions spotted 
in triplicate on both LB agar and LB agar supplemented with either kanamycin or 
trimethoprim. Plates were incubated overnight at 37 °C and CFU/mL calculated the 
following day. 
 
 
 
2.5.4. D. discoideum plaque-forming assays 
 
D. discoideum was cultured axenically in HL5 media as described in section 2.1.3. 
 
Overnight bacterial cultures were pelleted by centrifugation at 14,500 rpm for 3 
minutes and resuspended to an OD590nm of 5.5 in KK2 buffer (0.16 mM KH2PO4, 4 mM 
K2HPO4). 1 mL D. discoideum culture was pelleted by centrifugation at 2,500 rpm for 5 
minutes. Pelleted cells were washed once with KK2, centrifuged for a further 5 minutes 
and resuspended in 1 mL KK2. Resuspended D. discoideum AX3 were added to 1 mL 
of bacterial culture to a final concentration of 102 cells/mL. 200 L of the resulting 
suspension was spread on SM agar (Formedium) 288 and incubated at 21 °C for 2 – 3 
days to facilitate plaque formation. 
 
 
 
2.6. Oyster husbandry 
 
Pacific oysters (Crassostrea gigas) were purchased from Lindisfarne oyster farm 
(Lindisfarne Oysters, Northumberland). Shellfish were thoroughly scrubbed to remove 
external contaminants and attached organisms. Dead oysters were identified and 
removed. Oysters were maintained in individual aerated 5 L tanks filled with 20 ppt 
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salinity artificial seawater. Water was changed daily to prevent build-up of toxic 
elements. Oysters were fed a concentrated microalgae solution (TP1800, Reed 
Mariculture) every other day. Oysters were maintained at 21 °C for 5 days to allow 
them to acclimatise. 
 
 
 
2.7. In vivo co-culture assays 
 
2.7.1. Uptake of marine snow by oysters 
 
Artificial marine snow was gently added to the individual oyster aquaria, taking care to 
prevent as much disruption of the aggregates as possible. AMS was generated 
individually for each bacterial strain prior to addition to oyster tanks. No strains were 
combined into one batch of AMS. Oysters were left to filter and ingest the marine snow 
for the required length of time. A circulatory current was generated by the presence of 
an air stone which maintained the movement of particles around the beaker and 
prevented settling of the aggregates. In conjunction with this, tank water was manually 
stirred every hour to maintain particle suspension. 
 
 
2.7.2. Processing oysters for Vibrio plate enumeration 
 
Following exposure to synthetic marine snow, oysters were removed from their tanks 
using flame sterilised tongs. Shellfish were cleaned with 70 % ethanol and blotted dry. 
Using a flame-sterilised shucking knife, oysters were shucked, and the tissue 
separated from the shell by severing the adductor muscle. The stomachs were then 
isolated by carefully removing the surrounding tissue using flame-sterilised scissors. 
Stomachs were weighed and placed in plastic bags with 10 mL PBS for 
homogenisation in a stomacher (Seward 400) on medium speed for 3 minutes. 
62  
Homogenate was filtered through a 40 m cell strainer (Merck) into a clean 50 mL 
falcon tube to remove tissue debris. The resulting filtrate was utilised for Miles and 
Misra 10-fold serial dilutions in PBS. 100 L of each dilution was spread on LB agar 
and incubated overnight at 37 °C. The following day all colonies were replica plated 
onto Vibrio selective TCBS and incubated overnight at 37 °C. Colonies were then 
enumerated based off colour and recorded for CFU/g oyster tissue calculations. 
 
 
 
2.7.3. DNA extraction from oyster digestive gland homogenates 
 
1 mL of oyster stomach homogenate from section 2.6.2 was placed into a clean 
microcentrifuge tube and centrifuged at 14,500 rpm for 5 minutes to pellet bacterial 
cells. Total DNA was extracted using the Wizard DNA extraction kit (Promega) 
according to the manufacturers’ instructions. Extracted DNA was stored at -20 °C for 
future qPCR quantification. 
 
 
 
2.8. qPCR 
 
2.8.1. qPCR probe and primer design 
 
Primer and probe sets were designed against vgrG1, vcgE, vvhA and sefA of V. 
vulnificus and S. Enteritidis. Primers were designed according to the following criteria: 
a Tm of between 58 – 60 °C, a GC content of between 20 – 80 %, between 9 – 40 
base pairs long, < 2 °C difference between the forward and reverse primers and a 
maximum of two G/Cs in the last five base pairs of the 3’ end. Primers were designed 
to result in an amplicon of ~ 100 bp. 
Probes were designed according to the following criteria: a Tm 10 °C higher than the 
Tm of the primer pair, a GC content of between 20 – 80 %, between 9 – 40 base pairs 
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long, no G on the 5’ end, < 4 contiguous Gs, less Gs than Cs and the as close to the 
3’ end of the forward primer as is possible without overlap. Probes were designed with 
a 5’ (6)FAM fluorophore and a 3’ TAMRA quencher (Eurofins). Probe sequences are 
recorded in Table 2.4. 
 
 
 
 
 
Table 2.4: List of TaqMan qPCR probes used in this study. 
 
 
Probes Description Sequence (5' - 3') 
 
 
vgrG1 
 
V. vulnificus 106-2A vgrG1 probe, 5' FAM reporter, 3' 
TAMRA quencher 
 
 
[FAM] TGAGCGTTGCTAACGAAAGCTACTT [TAM] 
 
vcgE 
V. vulnificus 99-743 vcgE probe, 5' FAM reporter, 3' 
TAMRA quencher 
 
[FAM] CTCATTGAGCAGTAACGAAAGCACC [TAM] 
 
vvhA 
V. vulnificus vvhA probe, 5' FAM reporter, 3' TAMRA 
quencher 
 
[FAM] ATGAACTGCGCCGCCAAGA [TAM] 
 
sefA 
S. Enteritidis CC012 sefA probe, 5' FAM reporter, 3' 
TAMRA quencher 
 
[FAM] ACAACATCAGCCAACTGGAGTCAG [TAM] 
 
 
 
 
 
 
 
 
 
2.8.2. Generation of qPCR positive control material 
 
Positive control material was constructed to allow generation of standard curves for 
enumeration of V. vulnificus. vvhA, vgrG1 and vcgE were PCR amplified using 
Phusion® High-Fidelity DNA polymerase (NEB) according to the protocol outlined in 
section 2.2.2. PCR amplicons were column purified and cloned in pGEM®-T Easy 
(Promega). Constructs were transformed into chemically competent E. coli DH5 and 
successful transformants identified through miniprep of the contrast and excision of 
the insert with EcoRI. Once extracted, plasmid concentration was determined using a 
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NanoDrop™ 1000 (ThermoFisher) and the constructs serially diluted from 108 – 101 
copies/L. Purified plasmid DNA was converted to copies/L using Equation 2.1. 
 
 
 
Equation 2.1: Equation for converting plasmid DNA to copies/l for qPCR standards. 
 
 
𝒊) 𝑆𝑖𝑛𝑔𝑙𝑒 𝑝𝑙𝑎𝑠𝑚𝑖𝑑 𝑚𝑎𝑠𝑠 (𝑔) = (𝐷𝑁𝐴 𝑠𝑖𝑧𝑒 (𝑏𝑝)) 𝑥 (1.096𝑥10−21) 
 
 
 
 
𝒊𝒊) 𝑀𝑎𝑠𝑠 𝑜𝑓 𝑝𝑙𝑎𝑠𝑚𝑖𝑑 𝐷𝑁𝐴 𝑛𝑒𝑒𝑑𝑒𝑑 (𝑔) 
 
= 𝐶𝑜𝑝𝑦 𝑛𝑢𝑚𝑏𝑒𝑟 𝑜𝑓 𝑖𝑛𝑡𝑒𝑟𝑒𝑠𝑡 𝑥 𝑀𝑎𝑠𝑠 𝑜𝑓 𝑎 𝑠𝑖𝑛𝑔𝑙𝑒 𝑝𝑙𝑎𝑠𝑚𝑖𝑑 (𝑔) 
 
 
 
 
𝒊𝒊𝒊) 𝐹𝑖𝑛𝑎𝑙 𝑐𝑜𝑛𝑐𝑒𝑛𝑡𝑟𝑎𝑡𝑖𝑜𝑛 𝑜𝑓 𝑝𝑙𝑎𝑠𝑚𝑖𝑑 𝐷𝑁𝐴 (𝑔⁄𝜇L) = 
 
𝑀𝑎𝑠𝑠 𝑜𝑓 𝑝𝑙𝑎𝑠𝑚𝑖𝑑 𝐷𝑁𝐴 𝑛𝑒𝑒𝑑𝑒𝑑 (𝑔) 
𝑉𝑜𝑙𝑢𝑚𝑒 𝑜𝑓 𝑝𝑙𝑎𝑠𝑚𝑖𝑑 𝐷𝑁𝐴 𝑎𝑑𝑑𝑒𝑑 𝑡𝑜 𝑟𝑒𝑎𝑐𝑡𝑖𝑜𝑛 (𝜇L) 
 
 
 
 
 
 
2.8.3. qPCR protocol 
 
All qPCR reactions were set up in 0.2 mL non-skirted 96-well PCR plates 
(ThermoFisher) and analysed in a Stratagene Mx3005P qPCR system using the 
MxPro software (Agilent). Reactions were set up in triplicate according to the following 
protocol (optimised primer and probe concentrations are listed in section 2.7.4): 10 L 
Luna® Universal Probe qPCR Master Mix (NEB), × nM forward primer, × nM reverse 
primer, × nM TaqMan probe, 5 L template DNA, and ddH2O to 20 L. No-template 
controls were established using ddH2O in place of DNA. Samples were run according 
to the following thermocycler conditions: 95 °C for 10 minutes, then 40 cycles of 95 °C 
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for 15 seconds, 55 °C for 1 minute and 72 °C for 1 minute. Fluorescence was recorded 
using the FAM channel. 
 
 
 
2.8.4. qPCR optimisation 
 
To optimise qPCR reactions, TaqMan primer and probes combinations were tested at 
a range of concentrations. Primer concentrations were optimised by generating a 
primer concentration matrix in a 96-well plate in which forward and reverse primers 
were combined at combinations of 50, 100, 200, 400, 600, and 800 nM in duplicate. 
PCRs were set up as described above in section 2.7.3. The optimum combination was 
determined by whichever combination resulted in a sigmoidal curve at the earliest 
reaction cycle. Once confirmed, this primer combination was optimised for probe 
concentration at 50, 100, 200, 400, 600, and 800 nM TaqMan probe. Again, the most 
suitable concentration was determined by the earliest and most typical sigmoidal 
curve. The final optimised concentrations for primer and probe sets have been listed 
in Table 2.5. 
 
 
 
 
 
Table 2.5: Optimised qPCR primer and probe concentrations. 
 
 
 vvhA vcgE vgrG1 sefA 
Forward primer (nM) 200 600 200 100 
Reverse primer (nM) 800 600 800 600 
TaqMan probe (nM) 800 100 600 800 
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2.9. Graphing and statistical analysis 
 
All graphing and statistical analysis was performed using GraphPad Prism 8 v8.1.2. 
 
 
 
 
2.10. Scanning Electron Microscopy of marine snow 
 
1 mL samples of artificial marine snow were extracted for processing. Samples were 
fixed in 2 % glutaraldehyde and 2 % paraformaldehyde in 0.1 M piperazine-N,N′-bis(2-
ethanesulfonic acid) (PIPES) buffer (Merck) pH 7.2 and kept at 4 °C until further 
processing. Using a mild vacuum, fixed samples were transferred onto a 0.1 m 
polycarbonate filter. The filter was washed for 5 minutes in Pipes buffer a total of 3 
times. The aggregates attached to the filter were then dehydrated using an ethanol 
gradient. This consisted of washing the filter for 5 minutes in 30, 50, 70, 80, 90 and 95 
% ethanol for 5 minutes followed by two final 10- minute washes using 100 % ethanol. 
Keeping the filter in 100 % ethanol, the filter was incubated for 3 minutes in 
hexamethyldisilazane before air-drying the filter. Dried filters were mounted onto an 
aluminium sample pin using carbon conductive tabs. Samples were then sputter-
coated with 10 nm gold/palladium (80/20) and imaged using a JEOL JSM 6390 LV 
scanning electron microscope operated at 5 kV. 
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Chapter Three 
 
 
V. vulnificus T6SSs exhibit antibacterial activity at 
environmental temperature conditions in vitro 
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Introduction and aims 
 
Analysis of a number of V. vulnificus genomes led to the identification of two T6SSs, 
termed the T6SS1 and the T6SS2 172. Whilst all strains in the study possessed the 
T6SS2, only three sequenced strains had the T6SS1 (106-2A, S3-16 and 99-796). The 
authors established that V. vulnificus 106-2A can target and kill both V. vulnificus 99-
743 and V. fluvialis NCTC 11327 in a T6SS1-dependent manner. 
This chapter describes the construction of V. vulnificus T6SS mutants to enable further 
characterisation of V. vulnificus intra and inter-species killing activity. Following on 
from previous finding that T6SS1+ V. vulnificus strains can target and kill T6SS1- strains 
in vitro, T6SS1+ strains were labelled ‘attackers’, and T6SS1- strains were labelled 
‘prey’. This study focused primarily on in vitro co-culture of relevant attacker and prey 
strains at environmentally representative temperatures. For ease of comprehension, 
T6SS genes are referred to by their name most commonly used in the literature e.g. 
hcp instead of tssD. 
 
 
 
Results 
 
3.1. Generation of V. vulnificus 106-2A T6SS1 and T6SS2 mutants 
 
To characterise the role of the T6SSs of V. vulnificus, mutants were generated from 
wild-type (WT) V. vulnificus 106-2A through markerless, in-frame deletion of hcp1 and 
hcp2. In-frame deletion of hcp1 and hcp2 prevents T6SS needle assembly, preventing 
the activity of the T6SS1 and T6SS2. From here on 106-2Ahcp1 and 106-2Ahcp2 
will be referred to as T6SS1 and T6SS2. 
To generate these strains, up and downstream flanking regions of hcp1 and hcp2 were 
PCR amplified with the primers detailed in Fig. 3.1 and listed in Table 2.2, before being 
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pGEM-T Easy-hcp1LF 
ligated into commercial holding vector, pGEM-T Easy. Following confirmatory 
sequencing, flanking regions were excised from pGEM-T Easy using SmaI and NdeI 
(left flank) or NdeI and ApaI (right flank). In parallel, the counterselectable suicide 
vector, pDM4, was digested with SmaI and ApaI 285. The inclusion of these restriction 
sites ensured that three-way ligation of pDM4, the left flank and the right flank would 
result in the construction of an in-frame hcp1 or hcp2 deletion cassette within pDM4 
(Fig. 3.1). Once assembled, pDM4–hcp1 and pDM4–hcp2 were sequenced to 
confirm in-frame assembly and that no mutations or errors had been introduced. Both 
pDM4–hcp1 and pDM4–hcp2 constructs were separately triparentally conjugated 
into V. vulnificus 106-2A and plated on TCBS/Cm to select for first crossover 
 
A. 
 
 
 
 
 
 
 
B. C. 
 
 
 
 
 
 
pGEM-T Easy-hcp1RF 
 
 
 
 
 
 
Figure 3.1: Construction of pDM4-based suicide vectors for markerless in-frame 
deletion of hcp1 and hcp2. This schematic depicts construction of pDM4-hcp1 but is 
representative of pDM4-hcp2 also. (A) Left and right flanking regions of hcp1 and hcp2 
were PCR amplified with primers incorporating restriction endonuclease sites for 
downstream cloning. (B) Amplified flanks were individually cloned into holding vector 
pGEM-T Easy and sequenced to confirm sequence identity. (C) Flanks excised using 
SmaI, NdeI and ApaI were cloned into pDM4 in a three-way ligation, facilitating ligation of 
the two flanks into digested pDM4. 
LFF SmaI RFF NdeI 
LFR NdeI RFR ApaI 
pDM4-hcp1 
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integrants. Potential first-crossover integrants were checked using both the MutScreen 
FWD/CmR REV and MutScreen REV/CmR FWD primers. MutScreen FWD and REV 
were both designed to bind distally to hcp1 or hcp2, and CmR FWD and REV were 
designed to the Cm resistance gene in pDM4. Therefore, amplification of a PCR 
product using both MutScreen and CmR primers would confirm plasmid integration 
into the genome (Fig. 3.2). 
pDM4 is a sacB-based suicide vector, expressing Bacillus subtilis levansucrase at 10 
 
% sucrose conditions 289. SacB is lethal to a wide range of Gram-negative bacteria, 
including Vibrio species, allowing for easy pDM4 counter-selection following 
integration into the genome as described in the methods (section 2.2.16). First- 
crossover integrants were checked by PCR using the MutScreen primers listed in 
Table 2.2 and plated onto chloramphenicol plates to confirm resistance. pDM4 
excision was promoted by plating successful first crossovers onto LB supplemented 
with 10 % sucrose. Colonies were plated on chloramphenicol plates and any able to 
grow on sucrose but susceptible to chloramphenicol were PCR checked to confirm 
second crossover and hcp deletion (Fig. 3.3A). Amplification of hcp1 and hcp2 from 
WT V. vulnificus 106-2A resulted in a 1,639 bp and a 1,569 bp band, respectively. 
Successful deletion of hcp1 and hcp2 resulted in reduced band sizes of 1,131 bp and 
1,150 bp. DNA bands observable at 500 bp were V. vulnificus-specific vvhA PCRs to 
confirm colonies were the correct species. PCRs were performed separately; however, 
they have been loaded on the gel together for ease of viewing. Successful in-frame 
deletion mutants were plated on LB/Cm agar to confirm plasmid absence and samples 
submitted for confirmatory sequencing (Fig. 3.3B/C). 
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A. 
 
 
 
 
 
 
 
 
 
MutScreen FWD CmR REV 
 
 
B. 
 
 
 
 
C. 
 
 
 
 
 
 
 
 
 
D. E. 
 
MutScreen FWD MutScreen REV MutScreen FWD MutScreen REV 
  
WT revertant Mutant 
 
Figure 3.2: pDM4 allelic exchange schematic. (A) Homologous recombination of 
constructed suicide vectors into the chromosome. The dotted line represents the plasmid 
backbone. SacB is the B. subtilis levansucrase protein, CmR denotes chloramphenicol 
resistance. The bacterial chromosome is represented by the bold line. (B) Merodiploid first 
crossover strain following recombination of the suicide vector into the genome. Screening 
primers to identify successfully crossover integrants are labelled, if the construct has not 
integrated then no amplification is possible. (C) The cytotoxic effect of sacB expression in 
the presence of sucrose allows for counter-selection and excision of pDM4 from the 
chromosome resulting in either a WT revertant (D) or a successful mutant (E). MutScreen 
FWD and REV are designed to bind upstream of the left and right flanks to determine 
whether mutation has occurred successfully or whether the bacterium has reverted to the 
WT genotype. 
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Figure 3.3: Confirmation of T6SS1 and T6SS2 in-frame deletion. (A) PCR 
confirmation of V. vulnificus 106-2A T6SS1 and T6SS2 mutants. Comparison of hcp1 
and hcp2 regions from WT 106-2A versus successful hcp deletions. M – Molecular marker 
(bp). 1 – Negative control using nuclease free water in place of gDNA. 2 – Positive WT 
control band for hcp1 at 1,639 bp. The 500 bp band is the V. vulnificus specific vvhA control. 
3 – Successful hcp1 mutant band at 1,131 bp and positive vvhA band. 4 – Positive WT 
control band for hcp2 at 1,569 bp with corresponding vvhA control band. 5 – Successful 
hcp2 mutant demonstrated by a band at 1,150 bp and confirmatory vvhA band. 
 
Hcp regions were PCR amplified and sequenced to confirm no mutations had been 
introduced during allelic exchange. (B) Truncated hcp1 is marked with both start and stop 
codons boxed in red. Ligation of the left and right flanks has reduced the gene from 519 bp 
to 30 bp. The sequence data for the region is displayed above. (C) Truncated hcp2 is 
marked with both start and stop codons boxed in red. Ligation of the left and right flanks 
has reduced the gene from 466 bp to 42 bp. The sequence data is displayed above. 
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3.2. Reverse-transcriptase PCR confirmation of T6SS1 and T6SS2 
 
To confirm that hcp1 and hcp2 deletion had not negatively affected expression of 
downstream genes RNA was extracted from T6SS1 and T6SS2 for reverse- 
transcriptase PCR (RT-PCR). Primers were designed against vgrG1 and clpV2 as the 
downstream genes for hcp1 and hcp2, respectively. Template complementary DNA 
(cDNA) was generated from total extracted cellular mRNA according to the methods 
(section 2.2.5). Fig. 3.4 shows RT-PCR of vgrG1 and clpV2 from WT V. vulnificus 106- 
2A and both T6SS1 and T6SS2 mutants. Lane 1 comprises a no template control 
and lane 2 a no reverse transcriptase control to ensure there was no gDNA 
contamination. 
No bands were observed in either negative control, confirming that there was no 
reagent contamination or gDNA carry-over. Lanes 3 and 4 show DNA amplified from 
WT V. vulnificus 106-2A using vgrG1 (2,064 bp) and clpV2 (2,565) primers 
respectively. Lane 4 demonstrates successful amplification of vgrG1 from T6SS1 
cDNA as noted by the presence of a band at 2,064 bp. Similarly, in lane 6, clpV2 has 
been successfully amplified from T6SS2 cDNA as noted by the presence of a 2,565 
bp band. This data confirms that in-frame deletion of hcp1 and hcp2 has not affected 
transcription of downstream T6SS genes. 
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Figure 3.4: RT-PCR of V. vulnificus 106-2A T6SS1 and T6SS2. (A) Primer binding 
sites for vgrG1 and clpV2 RT-PCR primers. Gene stop and start codons are highlighted in 
red boxes. (B) Expression of genes downstream of hcp1 and hcp2 (vgrG1 and clpV 
respectively) confirmed using RT-PCR. M – molecular marker (bp), 1 – no template control, 
2 – no reverse-transcriptase genomic DNA (gDNA) control, 3 – 106-2A WT positive vgrG1 
control (2,056 bp), 4 – 106-2A WT positive clpV2 control (2,565 bp), 5 – T6SS1 vgrG1 
(2,056 bp), 6 – T6SS2 clpV2 (2,565 bp). The presence of a 2,056 bp band in lane 5 
confirms vgrG1 transcription in T6SS1. The presence of a 2,565 bp band in lane 6 
confirms clpV2 transcription in T6SS2. 
 
 
 
3.3. Growth comparison of WT V. vulnificus 106-2A to T6SS mutants 
 
To ascertain whether the introduction of the hcp mutations had a phenotypic effect, 
the growth of all attacker and prey strains was characterised at 21 °C, 30 °C and 37 
°C temperatures. 30 °C and 37 °C were selected to confirm that T6SS mutants 
resulted in similar results to previous studies temperatures. 21 °C was selected as an 
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environmentally representative temperature ideal for V. vulnificus growth in marine 
environments 290. Attacker strains tested were V. vulnificus 106-2A, T6SS1 and 
T6SS2, and prey strains were V. vulnificus 99-743 and Salmonella enterica serovar 
Enteritidis CC012. These prey strains were selected as they are representative of 
species with which V. vulnificus would come into contact with in vivo 2,291. 
Strains were cultured in LB broth at 21 °C, 30 °C and 37 °C. Bacterial cultures were 
incubated for 24 hours and OD590nm absorbance readings taken at T0, T2, T4, T6, T8 
and T24 at each temperature. Samples from each timepoint were serially diluted and 
plated on LB agar for CFU/mL enumeration (Fig. 3.5). Statistical comparison of WT V. 
vulnificus 106-2A, T6SS1 and T6SS2 at each temperature concluded that there was 
no significant difference in growth rate. This demonstrates that deletion of hcp1 and 
hcp2 has no negative impact on growth. Equally, prey strain V. vulnificus 99-743 
showed no significant difference in growth rate relative to 106-2A, T6SS1 or T6SS2. 
S. Enteritidis CC012 did demonstrate some significant differences in growth compared 
 
V. vulnificus at 30 °C and 37 °C. CFU/mL at T8 and T24 were significantly greater than 
all V. vulnificus strains (p < 0.05). However, this was not considered as a major 
obstacle, primarily because the in vitro killing assays to be performed at 30 °C and 37 
°C would only be incubated for five hours, at which point growth between bacterial 
species showed no statistical difference. Whilst 21 °C co-culture assays were to be 
incubated for 24 hours, at these temperature conditions S. Enteritidis showed no 
significant difference in growth compared to V. vulnificus. 
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Figure 3.5: Growth curves of V. vulnificus and S. Enteritidis at 21 °C, 30 °C and 37 °C.  Growth 
curves were performed according to the methods for V. vulnificus 106-2A, T6SS1, T6SS2, 99-743 and 
S. Enteritidis CC012. OD590nm readings were taken at T0, T2, T4, T6, T8 and T24. Samples from each 
time point were serially diluted 10-fold and enumerated on LB agar. Growth curves were performed in 
triplicate under three individual temperature conditions. (A & B) 21 °C. (C & D) 30 °C. (E & F) 37 °C. 
Statistics were performed using a two-way ANOVA with Tukey’s multiple comparisons corrections, * p < 
0.05. 
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3.4. V. vulnificus intra-species T6SS activity 
 
3.4.1. Construction of antibiotic resistant V. vulnificus using pVv3-kan and 
pVv3-tmp 
Previously, studies performing competition assays using Vibrio species have utilised 
TCBS agar to distinguish between different strains 172. TCBS contains sucrose, which 
only particular V. vulnificus strains are capable of fermenting. Vibrio strains able to 
degrade sucrose generate a localised acidic environment, resulting in colonies 
appearing yellow. Therefore, using a sucrose-fermenting prey strain results in yellow 
prey colonies, whilst non-fermenting attacker strains remain green, allowing for colour- 
based enumeration of attacker and prey colonies. 
However, this was highly unreliable. Fig. 3.6 shows that bacterial cultures plated on 
TCBS demonstrated a 10,000-fold growth difference relative to the same cultures 
plated on LB agar. This is not the first study to identify this problem as Tagliava et al., 
(2019) recently noted that TCBS as a selective medium may be hampering Vibrio 
isolation due to substantial underestimations and even total isolation failures 292. It was 
therefore decided to generate antibiotic resistant V. vulnificus to enable plate selection 
following co-culture. No antibiotic resistance was introduced to S. Enteritidis CC012 as 
selection could be performed using Salmonella specific chromogenic media which 
inhibited the growth of Vibrio species but had no deleterious effect on S. Enteritidis 
growth (Appendix 2). 
To date, the only published shuttle vector for V. vulnificus is pVv3, first identified as 
pVN-0126, a 1,301 bp cryptic plasmid from V. vulnificus VN-0126 293. Introduction of a 
kanamycin resistance gene cassette, lacZ gene, polylinker and T7 promoter resulted 
in construction of pVv3-kan. pVv3-kan can be easily introduced into a number 
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of Vibrio species via electroporation, including V. parahaemolyticus and V. cholerae. 
To introduce antibiotic resistance to V. vulnificus, pVv3-kan was electroporated into 
106-2A, T6SS1 and T6SS2. Plasmid DNA extracted from transformants was 
confirmed as pVv3-kan by digestion of purified plasmid DNA with ApaI, KpnI and NdeI. 
 
 
 
 
Unfortunately, pVv3-kan contains only a kanamycin resistance cassette. Effective 
selection of attacker and prey cells required pVv3-kan containing a different antibiotic 
resistance cassette. The plasmid pVv3-kan-tmp, with a trimethoprim resistance gene 
inserted outside of the kanamycin resistance gene was modified by in vitro 
mutagenesis to generate a version of pVv3 solely conferring trimethoprim resistance. 
The kanamycin resistance gene was removed by overlap-extension PCR (OE-PCR), 
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Figure 3.6: V. vulnificus growth comparison on LB and TCBS agar. V. vulnificus 106- 
2A, T6SS1, T6SS2 and 99-743 cultures were adjusted to an OD590nm of 0.8 and 
serially diluted 10-fold for Miles and Misra spot-plate enumeration on LB and TCBS agar. 
Colonies were enumerated and statistics performed using a t-test with Holm-Sidak’s 
correction for multiple comparisons, * p < 0.05. ** p < 0.01. 
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where OE primers were designed to bind to the DNA directly up and downstream of 
the kanamycin resistance gene, facilitating PCR amplification of pVv3-kan-tmp but 
omitting the kanamycin resistance gene). A schematic for this process can be seen in 
Fig. 3.7. 
PCR-amplified plasmid product was incubated with DpnI to digest template DNA 
before transformation into E. coli DH5. DpnI is a restriction enzyme that recognises 
and cleaves methylated DNA. As such, DpnI treatment of the PCR product resulted in 
the degradation of the methylated template plasmid DNA extracted from E. coli DH5 
294,295. As the newly constructed plasmid, pVv3-tmp, had not come into contact with 
any methyltransferases it was not targeted for degradation by DpnI. This process 
therefore resulted in the degradation of all template plasmid DNA still containing the 
kanamycin resistance gene whilst preserving the newly generated construct containing 
only trimethoprim resistance. pVv3-tmp was transformed into chemically competent E. 
coli and selected for on LB/Tmp. Resistant colonies were subcultured on LB/Kan to 
confirm kanamycin susceptibility. Transformants that grew on LB/Tmp but not LB/Kan 
were digested to confirm plasmid integrity. 
Before newly generated antibiotic-resistant V. vulnificus strains could be used for in 
vitro co-culture assays the impact of pVv3-kan and pVv3-tmp on V. vulnificus growth 
was assessed. No difference in growth rate was observed for any of the resistant V. 
vulnificus strains when compared to the same strain lacking the resistance plasmid 
(Appendix 3). Plasmid retention assays also demonstrated no significant plasmid loss 
over 24 hours (Appendix 4). 
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Figure 3.7: Schematic depicting PCR deletion of the kanamycin resistance gene from 
pVv3-kan-tmp to generate pVv3-tmp. The region of plasmid DNA to be excised is shown 
in black with the flanking regions indicated by dashed and shaded regions. Plasmid DNA 
was amplified using primers with complementary 5’ tails to facilitate the joining of the two 
plasmid ends following gene excision. Once amplified, the PCR product was treated with 
DpnI to digest the template plasmid DNA, leaving only the newly synthesised product 
lacking the kanamycin resistance gene. The product was transformed into chemically 
competent E. coli DH5 and plasmid DNA extracted from successful transformants. Figure 
was taken from Hansson et al., (2008) 286. 
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3.4.2. The T6SS1 is active at 30 °C, but not 37 °C 
 
To characterise V. vulnificus intra-species killing activity in vitro, prey strain 99-743 
pVv3-tmp was individually co-cultured on LB agar with 106-2A pVv3-kan, T6SS1 
pVv3-kan and T6SS2 pVv3-kan. Bacterial cultures adjusted to an OD590nm of 0.8 were 
combined at an attacker to prey ratio of 3:1 and incubated for 5 hours at 30 °C and 37 
°C on LB agar as described previously for V. vulnificus in Church et al., (2016) 172. 
Growth spots were resuspended and serially diluted for Miles and Misra plate 
enumeration on either LB/Kan or LB/Tmp to select for attacker and prey strains 
respectively. 
Fig. 3.8 shows viable cell counts of prey 99-743 following co-culture with just LB 
(negative), 106-2A, T6SS1 or T6SS2 at 30 °C and 37 °C, respectively. Co-culture 
with LB at 30 °C resulted in recovery of 1010 CFU/mL 99-743, demonstrating 100-fold 
growth from the T0. Interestingly, when co-cultured with 106-2A and T6SS2, recovery 
of prey 99-743 was 107 CFU/mL, 1,000-fold less than the negative control (p < 0.01). 
This data suggested that prey killing is T6SS1-dependent, as co-culture of 99-743 with 
T6SS1 resulted in recovery of ~ 1010 CFU/mL 99-743, equal to the negative control 
exposed to no attacker strain. 
When incubated at 37 °C, > 1011 CFU/mL were recovered from the negative control. 
99-743 co-cultured with 106-2A, T6SS1 or T6SS2 showed no significant reduction, 
with all samples recovered at 1011 CFU/mL. This data shows that T6SS1 activity is 
thermoregulated, demonstrating intra-species killing activity at 30 °C, but not 37 °C. 
The T6SS2 demonstrated no observable killing activity under any temperature 
condition tested as has been previously demonstrated. 
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Analysing recovered cell counts for attacker strains showed no statistically significant 
difference, suggesting that there is no reciprocal killing taking place by 99-743 
(Appendix 5). 106-2A, T6SS1 and T6SS2 all demonstrate uninhibited growth with 
no statistical significance observed between the T5 time points of any strain at either 
30 °C or 37 °C relative to their increase from T0. This result is largely expected as 99- 
743 only contains the T6SS2, which has been shown to be inactive under these 
conditions. In conclusion, this data showed that 106-2A is capable of T6SS1-mediated 
targeting and killing of 99-743 at 30 °C. Under these same conditions no T6SS2 activity 
was observed, suggesting that intra-species competition at 30 °C is purely T6SS1-
dependent. It is therefore likely that T6SS1+ strains possess a competitive 
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Figure 3.8: Recovery of prey V. vulnificus following co-culture with attacker V. 
vulnificus at 30 °C and 37 °C. Prey V. vulnificus 99-743 was co-cultured with attacker V. 
vulnificus 106-2A, T6SS1 and T6SS2, for 5 hours at 30 or 37 °C. Bacterial spots were 
resuspended and serially diluted to facilitate 99-743 enumeration. The horizontal lines 
represent the mean and the error bars represent the standard deviation (n = 3). Statistics 
were performed using an ordinary one-way ANOVA with Dunnett’s corrections for multiple 
comparisons, ** p < 0.01. 
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advantage over T6SS1- strains in vivo, impacting V. vulnificus populations in habitats 
such as filter-feeding shellfish. 
 
 
 
3.5. The T6SS1 is involved in inter-species competition 
 
It was hypothesised that if V. vulnificus can target other Vibrios using the T6SS1 then 
it is possible that it could also target other bacterial species. S. Enteritidis CC012 is a 
rod-shaped, Gram-negative bacterium frequently associated with causing disease in 
humans, manifesting as diarrhoea, gastroenteritis and feverish symptoms 296. Whilst not 
as ubiquitously present in oysters as Vibrio species, Salmonella species have been 
identified in oysters previously 256,257,297,298. CC012 was therefore utilised as the prey 
strain to investigate inter-species bacterial killing by V. vulnificus. 
 
 
 
3.5.1. The T6SS1 can target S. Enteritidis CC012 at 30 °C 
 
Co-culture assays were conducted using S. Enteritidis as prey to explore the inter- 
species killing activity of the T6SS1. Fig. 3.9A shows co-culture of S. Enteritidis CC012 
with either V. vulnificus 106-2A, T6SS1 or T6SS2 for 5 hours at 30 °C. Co-culture 
with LB demonstrates that CC012 growth over 5 hours results in 1010 CFU/mL from an 
initial plated concentration of 108 CFU/mL. Interestingly, as previously observed, co-
culture with 106-2A and T6SS2 resulted in a significant reduction in recovered CC012 
CFU/mL, with a 1,000-fold reduction compared to the negative control (p < 0.01). 
Again, co-culture with T6SS1 showed no significant difference compared to the 
negative control, confirming that V. vulnificus inter-species killing of S. Enteritidis is 
T6SS1-dependent. 
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Fig. 3.9B supports findings from the previous section showing that the T6SS1 is 
temperature regulated, as co-culture of attacker and prey bacterial strains at 37 °C 
resulted in no significant reduction in recovery of the prey strain relative to the negative 
control. Also, no retaliatory killing of attacking V. vulnificus strains by S. Enteritidis was 
observed (Appendix 6). 
 
In conclusion, this study has demonstrated that the T6SS1 of V. vulnificus has both 
intra and inter-species killing activity at 30 °C in vitro. The lack of antibacterial activity 
at 37 °C suggested that the activity of the T6SS1 is temperature regulated. No 
observable killing at 37 °C implies that the T6SS1 may not be involved in human 
infection, but rather utilised to provide a competitive edge in environmental conditions. 
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Figure 3.9: Recovery of prey S. Enteritidis following co-culture with attacker V. 
vulnificus at 30 °C and 37 °C. (A) Prey S. Enteritidis CC012 was co-cultured with attacker 
V. vulnificus 106-2A, T6SS1 and T6SS2, on LB agar for 5 hours at 30 and (B) at 37 °C. 
Bacterial spots were resuspended and serially diluted to facilitate CC012 enumeration. The 
horizontal lines represent the mean and the error bars represent the standard deviation (n 
= 3). Statistics individually comparing each strain to the negative control were performed 
using an ordinary one-way ANOVA with Dunnett’s corrections for multiple comparisons, ** 
p < 0.01. 
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3.6. V. vulnificus T6SS1 demonstrates prey growth inhibition at 21 °C in vitro 
 
This study aims to demonstrate that the observed in vitro T6SS1 killing is 
representative of in vivo activity in an oyster host. However, currently all co-culture 
assays have only been performed at 30 °C and 37 °C. Future in vivo studies will be 
performed at 21 °C as it has been shown that this temperature is ideal for V. vulnificus 
growth in seawater 290. Thus, before embarking on oyster in vivo studies, in vitro 
competition assays were performed as previously described at 21 °C for 24 hours. It 
was decided to incubate co-culture for the longer time period of 24 hours due to the 
slower growth of the strains under these conditions (Appendix 3). 
The recovery of viable prey V. vulnificus 99-743 and S. Enteritidis CC012 following co- 
culture at 21 °C with attacker V. vulnificus strains 106-2A, T6SS1 or T6SS2 can be 
seen in Fig. 3.10. Prey recovery when co-cultured with just LB was recorded at 1011 
CFU/mL for both 99-743 and CC012. However, both prey strains showed a significant, 
> 10-fold reduction when co-cultured with either 106-2A, T6SS1 or T6SS2 (p < 
0.05). The inhibition of prey growth when co-cultured with T6SS2 suggested that the 
T6SS1 is active at 21 °C as it is as 30 °C. No reciprocal growth inhibition of attacker 
V. vulnificus strains by either prey V. vulnificus 99-743 or S. Enteritidis CC012 was 
observed at 21 °C (Appendix 7).  Interestingly, the reduction in prey growth when co-
cultured with T6SS1 suggested that growth inhibition is also T6SS2-mediated at 21 
°C. Fascinatingly, this implies that at environmentally representative temperatures of 
21 °C both T6SSs are active and demonstrate antibacterial activity. 
However, it is possible that 106-2A possesses uncharacterised antibacterial 
mechanisms active at 21 °C, resulting in the observed inhibition phenotype rather than 
this being attributable to the T6SS2. Therefore, a 106-2A double mutant in which both 
hcp1 and hcp2 were deleted, inhibiting T6SS activity from both secretion systems, was 
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generated. If co-culture with the double mutant still demonstrated a reduction in prey 
strain growth, this implies that growth inhibition is T6SS-independent. 
 
 
 
3.7. Generation of a double T6SS mutant in V. vulnificus 106-2A (T6SS1/2) 
 
Previously constructed allelic exchange vector, pDM4–hcp2, was triparentally 
conjugated into T6SS1 and an in-frame deletion generated as previously described. 
Deletion of hcp1 and hcp2 was PCR-confirmed and total RNA extracted for RT-PCR 
of downstream genes. In-frame deletion of hcp2 was confirmed via sequencing 
(Appendix 8). From here on the double mutant will be referred to as T6SS1/2. As 
previously described, pVv3-kan was electroporated into T6SS1/2, conferring 
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Figure 3.10: Recovery of prey V. vulnificus and S. Enteritidis following co-culture 
with attacker V. vulnificus at 21 °C. Prey V. vulnificus 99-743 (A) and S. Enteritidis 
CC012 (B) were co-cultured with attacker V. vulnificus 106-2A, T6SS1 and T6SS2, for 
5 hours at 21 °C. Bacterial spots were resuspended and serially diluted to facilitate 
enumeration of 99-743 and CC012. The horizontal lines represent the mean and the error 
bars represent the standard deviation (n = 3). Statistics individually comparing each strain 
to the negative control were performed using an ordinary one-way ANOVA with Dunnett’s 
corrections for multiple comparisons, * p < 0.05. 
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kanamycin resistance. T6SS1/2 growth curves were generated with and without 
pVv3 to ensure that deletion of both T6SSs had no deleterious impact on growth 
(Appendix 9). As expected, no significant difference was observed between T6SS1/2 
growth and growth of the other V. vulnificus strains utilised in this study. 
 
 
 
3.8. T6SS1/2 demonstrates that killing at 21 °C is mediated by both T6SS1 
and T6SS2 
In vitro competition assays were performed at 21 °C with the inclusion of T6SS1/2 to 
determine whether there was a reduction in prey killing. The results can be seen in 
Fig. 3.11. The 10-fold reduction in recovery of V. vulnificus 99-743 and S. Enteritidis 
CC012 observed following co-culture with attacker V. vulnificus strains was not 
observed following co-culture with the double mutant, T6SS1/2. Instead, recovery of 
both strains was 1011 CFU/mL, consistent with the negative control. This data indicates 
that the killing demonstrated by 106-2A, T6SS1 and T6SS2 was a result of the 
activity of the T6SS1 and T6SS2, and not an uncharacterised antibacterial 
mechanism. 
This is the first study to identify a role for the T6SS2 of V. vulnificus and these findings 
suggest that V. vulnificus employs both the T6SS1 and the T6SS2 in vivo for intra and 
inter-species killing. This may potentially have a significant impact on the composition 
of in vivo habitats, such as within shellfish. 
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3.9. V. vulnificus demonstrates no anti-eukaryotic killing activity against 
 
Dictyostelium discoideum 
 
T6SSs have been shown to have a distinctly wide range of potential target organisms, 
depending on the activity of the host cell and the environments it commonly encounters 
169,173,220,299. Whilst the data presented so far in this chapter have confirmed the intra 
and inter-species killing activity of the T6SSs of V. vulnificus 106- 2A, it has yet to be 
investigated whether these secretion systems have anti-eukaryotic killing ability. 
Exploration into the anti-eukaryotic potential of the T6SSs of V. vulnificus had been 
previously carried out by Church et al., (2016) using the larvae of the greater wax moth, 
Galleria mellonella, as an infection model 172. In this study, the more commonly utilised 
Dictyostelium discoideum model has been employed. D. discoideum is a free-living, 
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V. vulnificus 99-743 S. Enteritidis CC012 
Figure 3.11: V. vulnificus and S. Enteritidis growth following co-culture with V. 
vulnificus attacker strains at 21 °C. In vitro co-culture assays with V. vulnificus 99-743 
and S. Enteritidis CC012 (B) as prey were repeated with the inclusion of T6SS1/2 as an 
attacking strain. Error bars represent the standard deviation, horizontal bars represent the 
mean (n = 3). Statistics individually comparing each strain to the negative control were 
performed using a one-way ANOVA with Dunnett’s multiple corrections test, * p < 0.05. 
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eukaryotic amoeba which primarily feeds on bacteria found within soil and decaying 
matter, such as E. coli 300. D. discoideum predation of bacterial lawns results in the 
formation of phagocytic plaques where the lawn has been cleared by the amoeba, 
indicating killing. However, T6SS+ anti-eukaryotic bacteria have been shown to target 
and kill D. discoideum before they can be predated, preventing the formation of 
plaques 169. 
D. discoideum AX3 was ordered via DictyBase and upon arrival fruiting bodies were 
subcultured in HL5 media to generate axenic cultures 284. Cultures were checked daily 
using a haemocytometer and subcultured into fresh media before concentrations 
reached higher than 106 cells/mL. Once D. discoideum cultures reached mid-log phase, 
they were resuspended in KK2 buffer and added to bacterial overnight cultures at a 
final concentration of 102 cells/mL. This concentration enables easy distinction of 
singular amoeba by the formation of a plaque in the bacterial lawn where D. 
discoideum had predated the plated bacteria. Suspensions were plated on SM agar 
and incubated at 21 °C for 3 days until visible plaque formation was observed. 
Fig. 3.12 presents the results of D. discoideum plaque forming assays with V. vulnificus 
106-2A, T6SS1 and T6SS2. D. discoideum was plated on V. cholerae V52 as a 
positive control as this bacteria has been previously shown to kill D. discoideum in a 
T6SS-dependent manner, resulting in no plaque formation 169. Culture of D. discoideum 
on V. vulnificus 106-2A, T6SS1 and T6SS2 resulted in the formation of visible 
plaques, indicative of bacterial predation by the amoeba. To quantify this data, plaque 
diameters were measured to determine whether there were any empirical differences 
between strain predation by D. discoideum (Fig. 3.12B). This data confirmed that there 
was no significant difference between average plaque sizes formed through growth on 
either 106-2A, T6SS1 or T6SS2. 
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In conclusion, this data demonstrates that neither the T6SS1 nor the T6SS2 of V. 
vulnificus 106-2A can kill D. discoideum. This finding serves to further support the lack 
of anti-eukaryotic activity of V. vulnificus T6SS observed when previously put through 
a G. mellonella infection model. From here on, the project will focus purely on 
elucidating the antibacterial activity of the T6SS and its utilisation both in vitro and in 
vivo. 
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Figure 3.12: D. discoideum plaque-forming assays with V. vulnificus and V. cholerae. 
(A) Cultures of V. vulnificus 106-2A, T6SS1, T6SS2 and V. cholerae V52 were combined 
with D. discoideum and plated on SM agar at 21 °C until visible plaque formation occurred. 
No plaques can be seen on the V52 control; however, plaques can be observed on all 
plates containing V. vulnificus strains. Example plaques are marked with white arrows. (B) 
D. discoideum plaque diameters were measured following growth on V. cholerae V52, V. 
vulnificus 106-2A, T6SS1 and T6SS2 to quantify differences between strains. Statistics 
were performed using a one-way ANOVA with Tukey’s corrections for multiple 
comparisons, ns – not significant. 
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Discussion 
 
The T6SS is used by a diverse range of bacteria to target and kill susceptible 
prokaryotic and eukaryotic cells. To date, two T6SSs have been identified in V. 
vulnificus, namely the T6SS1 and the T6SS2. Previously, the T6SS1 was shown to 
have antibacterial activity at 30 °C in vitro 172. This chapter aimed to further 
characterise the in vitro activity of the T6SS1 at an environmentally representative 
temperature to explore the role of the T6SS1 in V. vulnificus ecology. Initial co-culture 
assays at 30 °C demonstrated that V. vulnificus 106-2A could target and kill both V. 
vulnificus 99-743 and S. Enteritidis CC012 in a T6SS1-dependent manner. However, 
in an attempt to closer mimic relevant environmental conditions, co-culture assays 
were performed at 21 °C. This surprisingly led to the finding that both T6SS1 and 
T6SS2 had antibacterial activity at these temperature conditions. Generation of a V. 
vulnificus double T6SS mutant, T6SS1/2, and co-culture with prey 99-743 and 
CC012 resulted in no significant reduction in recovered viable prey. This confirmed 
that the killing observed with 106-2A, T6SS1 and T6SS2 was T6SS-dependent and 
that both T6SSs were expressed and active. 
T6SS expression is regulated at a transcriptional, post-transcriptional, and post- 
translational level to ensure tight control over T6SS activity 198. Recognised methods 
of regulation include temperature, salinity, osmolarity, quorum sensing, nutrient 
limitation, and biofilm formation 178,180,301–306. This study focused on the impact of 
temperature on T6SS activity in vitro. It is not yet entirely clear why the T6SS2 is active 
at 21 °C but remains inactive at 30 °C, whilst the T6SS1 is active at both temperature 
conditions. Previous investigations of T6SS expression in the closely related V. 
cholerae species, identified the cold-shock protein, CspV, as playing a role in T6SS 
thermoregulation 307. Quantification of hcp expression at 25 °C showed a 14-fold 
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decrease in hcp transcripts in a cspV V. cholerae strain compared to WT V. cholerae. 
Co-culture of cspV V. cholerae with prey E. coli demonstrated a significant decrease 
in T6SS-mediated killing at 25 °C and 37 °C. Interestingly, V. cholerae T6SS genes 
were downregulated at 15 °C whereas CspV expression increased 60.9-fold. These 
results highlight a role for CspV in V. cholerae T6SS regulation. Whilst V. vulnificus 
has been shown to contain a CspV homologue, Csp5, no studies have yet explored 
the regulatory action of Csp5 on the T6SS. It is therefore possible that V. vulnificus 
Csp5 is similarly involved in T6SS regulation as CspV is in V. cholerae. 
The data presented in this chapter demonstrates thermoregulation of V. vulnificus 
T6SS1 and T6SS2 under different temperature conditions. Differential T6SS regulation 
is common in microorganisms expressing multiple T6SSs. For example, V. 
alginolyticus expresses two T6SS, named VaT6SS1 and VaT6SS2 308. Competition 
assays between V. alginolyticus and E. coli at 30 °C showed a reduction of prey E. coli 
as a result of VaT6SS1 activity. An increase in salinity from 1 % to 3 % subsequently 
resulted in VaT6SS2-mediated killing. Closer investigation into the T6SS1 and T6SS2 
operons of V. vulnificus may present some clues as to the differential regulation of 
these two systems. Whilst both operons encode all 13 essential genes as expected, 
the T6SS2 operon contains a number of accessory genes, ppkA, pppA and fha. In 
other T6SS+ microorganisms such as P. aeruginosa and S. marcescens these genes 
have been shown to be components of a threonine phosphorylation pathway (TPP) 
187,188. Investigation of P. aeruginosa T6SS competition suggested that the TPP 
pathway plays a role in the ‘tit-for-tat’ T6SS response 299. This occurs when a cell 
attacked by a neighbouring cell in a T6SS-dependent manner launches a 
counterattack in response. The presence of these genes within the T6SS2 cluster 
suggests that the T6SS2 may play a role in targeted counterattack against other T6SS+ 
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species. However, it should be noted that the counterattacking phenotype of P. 
aeruginosa is dependent upon the TaqQRST signal sensing complex, which is 
exclusive to Pseudomonas. More in-depth analysis of T6SS regulation and dynamics 
under a range of variable conditions, such as salinity, would be required to fully 
understand how these conditions impact T6SS activity. 
Surprisingly, these results demonstrate that V. vulnificus 106-2A strain can target and 
kill strain 99-743 in a T6SS2-dependent manner. Typically, T6SS-expressing cells are 
protected from self-intoxication by T6SS effectors through expression of cognate 
immunity proteins 209. This also serves to protect from sister-cells with identical T6SS 
effector profiles. Since both 106-2A and 99-743 are T6SS2+ it was assumed that 106- 
2A would be unable to target 99-743 using the T6SS2, as 99-743 would be expressing 
the necessary immunity proteins. However, co-culture between 106-2A and 99-743 
showed T6SS2-mediated killing of 99-743 by 106-2A. A possible explanation for this 
is that 106-2A expresses T6SS2 effector proteins to which 99-743 does not possess 
the cognate immunity protein. This has been previously shown in V. cholerae, where 
competing strains possessing dissimilar effector modules were deemed ‘incompatible’ 
309
. 
There is evidence demonstrating that exchange of effector/immunity modules between 
T6SS+ bacteria is not only common, but also offers a distinct competitive advantage. 
Adaption and evolution of bacterial T6SS warfare is largely driven by horizontal gene 
transfer (HGT), both vertically and horizontally 310. Recombination analysis of all public 
V. cholerae strains showed that there were a subgroup of strains possessing runs of 
orphan immunity genes, to which the cognate effector was not present in the genome. 
Instead the strain encoded just one primary effector 311. These authors suggested that 
this is due to homology-facilitated illegitimate recombination, where conserved regions 
within effectors enable illegitimate insertion of the sequence, including the associated 
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cognate immunity protein. Interestingly, it appears that addition of novel effectors is 
minimal, with established effectors being replaced by newly acquired effector genes. 
This results in a limited effector protein profile coupled with an extensive array of 
immunity proteins. Also, clearly observed in V. alginolyticus, orphan effector/immunity 
cassettes have been found neighbouring mobile genetic elements, promoting HGT 
with other bacteria 308. Therefore, when competing with one another, strain 
compatibility is determined by the effector/immunity profile of the strains in question. 
Given these findings, it is interesting that not all published data supports that T6SS 
toxin genotypes are sufficient for predicting strain compatibility. Speare et al., (2018) 
explored the co-culture of compatible and incompatible V. fischeri strains isolated from 
squid light-organ crypts 173. Based on observed toxin alleles, 10 V. fischeri strains were 
separated into six predicted compatibility groups. However, the authors observed intra-
group killing in groups 1 and 3, suggesting that toxin genotypes are not guaranteed 
indicators of strain compatibility. 
These studies support the idea that 106-2A can target and kill 99-743 in a T6SS2- 
dependent manner due to expression of effector proteins to which 99-743 is 
susceptible. As all V. vulnificus are T6SS2+, this suggested that all V. vulnificus strains 
possess a means of T6SS-mediated competition. Therefore, the distribution of 
effector/immunity modules is a primary factor in colonisation and population dynamics. 
Future work to explore this will involve the sequencing of a panel of V. vulnificus 
strains, both T6SS1+/T6SS1-, for comparative genomics and elucidation of effector 
distribution and interactions. 
Having established the intra-species killing activity of the T6SS1 and the T6SS2, V. 
vulnificus was co-cultured with prey S. Enteritidis CC012 to explore the roles of the 
T6SSs in inter-species competition. Co-culture assays showed reductions in S. 
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Enteritidis prey following co-culture with attacker V. vulnificus at both 21 °C and 30 °C. 
This killing was confirmed as T6SS-dependent using a T6SS1/2 double mutant. 
Interestingly, no reciprocal killing of V. vulnificus by S. Enteritidis was observed during 
competition, despite S. enterica serovars containing T6SSs 312. This may be due to a 
24 kb deletion in the Salmonella pathogenicity island, SPI-19. SPI-19 encodes a T6SS 
locus and has been identified in S. enterica serovars Dublin, Gallinarum, Agona, 
Weltervreden and Enteritidis 313. Activity of SPI-19 T6SS has been demonstrated in S. 
Gallinarum, the causative agent of fowl typhoid, where the T6SS mediates survival 
within macrophages 314. Conversely, the same S. Gallinarum strain demonstrated no 
antibacterial activity in co-culture assays. The deletion of a 24 kb region in this 
pathogenicity island suggests that the activity of this T6SS may be impaired if not 
entirely deleted. An alternative explanation is that the SPI-19 T6SS has no 
antibacterial activity. S. enterica serovars such as serovars Typhi and Typhimurium 
encode their T6SS on an alternative pathogenicity island, SPI-6, and have 
demonstrated both antibacterial and anti-eukaryotic T6SS activity 315,316. It is therefore 
possible that SPI-19 is geared towards anti-eukaryotic activity, facilitating 
establishment and disease in a eukaryotic host, and consequently may be non- 
antibacterial. 
Based on the data showing V. vulnificus T6SS antibacterial activity, it was 
hypothesised that V. vulnificus may employ the T6SS to target eukaryotic cells. T6SS- 
mediated anti-eukaryotic activity has been observed in a variety of microorganisms 
with extremely diverse target ranges. For example, the T6SS of V. cholerae has been 
shown to cross-link actin in phagocytic cells, immobilising the immune cell and 
protecting sister V. cholerae 317. The role of actin cross-linking in V. cholerae infection 
was further established in a recent study showing V. cholerae clearance of Aeromonas 
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veronii from monocolonised Zebrafish intestines through T6SS-driven stimulation of 
intestinal movements, resulting in A. veronii ejection 318. Anti-eukaryotic activity of V. 
vulnificus T6SSs has been previously explored in a Galleria mellonella model of 
infection 172. The authors observed no anti-eukaryotic activity following infection of 
larvae at 37 °C. However, the data presented here has shown that neither T6SS is 
active under these conditions supportive of these previous observations. To test the 
potential anti-eukaryotic capabilities of V. vulnificus T6SSs, attacker strains were co- 
cultured with the social amoeba, D. discoideum, at 21 °C. Predation of V. vulnificus by 
D. discoideum suggested that V. vulnificus was unable to target D. discoideum, further 
supporting the hypothesis that neither T6SS was capable of targeting anti-eukaryotic 
activity under these temperature conditions. Recently, a study demonstrated for the 
first time an anti-fungal T6SS phenotype exhibited by S. marcescens Db10 218. 
Expression of two anti-fungal T6SS effectors, Tfe1 and Tfe2, was shown to induce cell 
death in Candida species through disruption of nutrient uptake, induction of autophagy, 
and loss of plasma membrane potential. Whilst S. marcescens Db10 has shown 
significant virulence against Caenorhabditis elegans, G. mellonella and D. discoideum 
eukaryotic models of infection, this killing showed no reduction when challenged with 
a non-functional T6SS mutant 175. It is therefore possible that V. vulnificus T6SSs may 
demonstrate some form of anti-fungal activity despite the lack of virulence against D. 
discoideum shown in this study. 
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Conclusion 
 
In conclusion, this chapter demonstrates that V. vulnificus 106-2A utilises the T6SS1 
and T6SS2 to kill prey V. vulnificus and S. Enteritidis at 21 °C in vitro. This temperature 
is representative of typical environmental conditions and suggests that the T6SSs may 
play an important role in V. vulnificus ecology. Whilst T6SS1 activity has been 
demonstrated at 23 °C and 30 °C, this is the first study to show activity at 21 °C. 
Furthermore, this is the first time that any role has been identified for the T6SS2. The 
presence of a T6SS2 in every sequenced V. vulnificus strain indicates that the T6SS2 
may be essential for inter-bacterial competition by T6SS1- strains. 
The ability of strain 106-2A to target and kill strain 99-743 in a T6SS2-dependent 
manner suggests that these two strains contain different effector/immunity profiles. In 
this instance, 106-2A appears to encode T6SS2-associated effectors to which 99-743 
lacks cognate immunity proteins, allowing T6SS2-mediated killing of prey 99-743. 
Therefore, distribution of effector/immunity genes between V. vulnificus strains may 
play an important role in the establishment and interactions in in vivo populations. 
V. vulnificus anti-eukaryotic activity was explored through plaque forming assays with 
the phagocytic amoeba, D. discoideum. As antibacterial activity had been 
demonstrated by both T6SSs at 21 °C it was assessed whether V. vulnificus 106-2A 
could also target eukaryotic cells under these conditions. However, plaques indicative 
of predation of V.  vulnificus were observed for 106-2A, T6SS1 and T6SS2, 
confirming no anti-eukaryotic activity at 21 °C against D. discoideum. Future work will 
explore the reproduction of these in vitro killing assays in a representative in vivo 
model. 
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Chapter Four 
 
 
Development of a natural marine snow model for bacterial 
incorporation 
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Introduction and aims 
 
In this study it has been successfully demonstrated that V. vulnificus 106-2A T6SSs 
can kill V. vulnificus and S. Enteritidis in vitro at 21 °C. Thus, it was sought to explore 
whether this in vitro killing was representative of in vivo interactions through the 
development of an oyster model of infection. Being bioaccumulators, oysters facilitate 
uptake and concentration of microorganisms from the surrounding water column within 
their stomachs, presenting the ideal model for studying bacterial interactions in vivo 
319. Furthermore, oyster consumption is a common source of Vibrio infection in 
humans, demonstrating that this model is representative of environmental Vibrio 
interactions 320,321. To undertake competition assays in vivo, sufficient uptake of V. 
vulnificus by oysters for contact-dependent killing between attacker and prey bacteria 
is required. Due to the filter-feeding mechanism of oysters, particles too large are 
rejected as pseudofaeces whereas those too small pass through the gills without being 
retained 247,249,322. Planktonic V. vulnificus fall below the optimal size range for 
ingestion and therefore uptake is sub-optimal 249. 
Previous studies have shown that bacterial cultures can be incorporated into marine 
snow in order to promote ingestion by oysters 249,268,322. Marine snow are microcosms 
composed of aggregated particulate matter into which bacteria can incorporate. Being 
larger structures, marine snow is far more conducive to retention by filter-feeders, 
therefore incorporation of attacker and prey bacteria into marine snow to facilitate 
robust, high-level uptake of bacteria was investigated. 
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Results 
 
4.1. Developing a natural marine snow model 
 
Marine snow consists of a diverse range of matter, including dust, sand, 
microorganisms, diatoms, algae, protists, faecal matter and inorganics 
260,261,267,268,323,324. These components are brought together at random by Brownian 
motion, differential settling and shear forces, resulting in particle collision and 
formation of larger aggregates 260,267,276. There has been a collection of studies that 
have attempted to generate marine snow in a laboratory environment. Froelich et al., 
(2013) describe the optimisation of a method initially put forward by Shanks and 
Edmundson (1989) and adapted by Ward and Kach (2009) 322,324. This technique 
involved supplementing seawater with hyaluronic acid, a ubiquitous carbohydrate 
polymer commonly found in bacterial extracellular matrices, to promote particle 
adhesion and aggregation. The method explored here was rolling of suspensions 
overnight to facilitate aggregation of particles into larger marine snow microcosms as 
described in the methods (section 2.3.1). Marine snow formed using seawater as a 
substrate will be referred to as natural marine snow (NMS) for the remainder of the 
study. Seawater was collected from Dawlish (Devon, UK) to provide the substrate for 
aggregate formation. Care was taken to ensure that seawater was collected from the 
same location at the same point in the tide to ensure consistency. A representative 
micrograph of laboratory-generated NMS is shown in Fig. 4.1. Sizes of formed 
aggregates were typically < 1 cm in diameter; however, this was shown to vary 
between seawater samples collected, with some samples not generating any 
aggregates > 0.1 cm in diameter. 
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Figure 4.1: Natural marine snow generated using seawater as a substrate. Seawater 
from Dawlish was supplemented with hyaluronic acid and rolled overnight to promote 
particle aggregation and NMS formation. (A) Visible NMS microcosms. (B) NMS visualised 
using a light microscope. Magnification × 400. 
 
 
 
 
 
 
4.2. Variation in natural marine snow formation utilising different seawater 
samples 
NMS formation was typically consistent when using the same batch of seawater for 
aggregate generation. However, there was notable variation in size and number of 
aggregates using seawater collected on different days. To quantify this variation, the 
difference in aggregate mass formed using different seawater samples was analysed. 
Seawater samples collected over a period of five days were used to generate NMS. 
NMS was isolated via filtration and the wet weight recorded. Results were recorded as 
milligrams of wet aggregate mass. 
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As can be seen in Fig. 4.2, wet aggregate mass of samples ranged from 50 – 200 mg. 
It was observed that each sample had significantly different mass to at least three other 
samples, with sample 4 significantly different to every other sample tested (p < 0.05). 
This variation in total aggregate mass between samples is likely due to compositional 
differences. External elements such as sea-surface conditions, weather, temperature, 
precipitation and wave volume/frequency all play a role in seawater composition at the 
time and point of collection 325. The use of seawater to generate NMS therefore 
presented a challenge in terms of standardisation and comparison of results obtained 
using different seawater samples. For the remainder of this chapter seawater from 
sample 4 was utilised as this sample resulted in the greatest aggregate mass and 
should therefore facilitate the highest bacterial incorporation. 
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Figure 4.2: Variability in mass of natural marine snow produced using seawater as a 
substrate. NMS was generated from five individually collected seawater samples and 
aggregate mass determined (n = 3). Horizontal bars represent the mean, error bars 
represent the standard deviation. Statistics comparing every strain individually to every 
other strain were performed using a one-way ANOVA with Tukey’s corrections for multiple 
comparisons. The numbers above the bars indicate the samples to which that sample is 
significantly different (p < 0.05). 
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4.3. V. vulnificus enumeration from marine snow on TCBS 
 
As previously discussed in Chapter 3, Vibrio enumeration on TCBS agar is inaccurate 
and results in significantly different CFU/mL values relative to enumeration on LB agar. 
However, a method of isolating V. vulnificus from NMS whilst allowing distinction 
between attacker and prey strains was required. Despite having developed V. 
vulnificus strains with antibiotic resistances in the previous chapter, future oyster 
model work would not allow for plasmid selection throughout the assay, potentially 
promoting plasmid loss prior to attacker and prey strain enumeration. Therefore, a 
replica-plating method was assessed, in which V. vulnificus cultures were plated on 
LB to facilitate accurate growth of bacteria, before being replica-plated onto TCBS for 
 
 
 
 
Figure 4.3: Replica plating V. vulnificus onto TCBS agar from LB agar. V. vulnificus 
106-2A and 99-743 bacterial cultures were combined, spread onto LB agar, and incubated 
overnight (left plate). The following day, colonies were replica-plated onto TCBS agar (right 
plate) to facilitate colour-based enumeration as 106-2A grows green on TCBS, whereas 
99-743 grows yellow. Matching colonies have been marked with arrows to highlight the 
difference between the two V. vulnificus strains on each media. 
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colour-based enumeration of attacker and prey strains. Fig. 4.3 demonstrates an 
example of mixed overnight cultures of V. vulnificus 106-2A (green) and 99-743 
(yellow) plated on LB and then replica-plated onto TCBS. As can be seen, colonies 
that have grown on LB have transferred to TCBS and can now be differentiated from 
one another by colony colour. 
 
 
 
4.4. Incorporation of V. vulnificus into natural marine snow 
 
To test the incorporation efficiency of V. vulnificus into NMS, rolling tubes containing 1 
L seawater supplemented with hyaluronic acid were inoculated with V. vulnificus to 
final concentrations of 103, 105, and 107 CFU/mL. Tubes were rolled for 24 hours at 21 
°C and aggregates isolated by filtration for plate-enumeration the following day. 
Filtration was performed using a Buchner funnel with 3 m pore filter paper 
(Whatman). V. vulnificus measures ~ 2 m and therefore any planktonic V. vulnificus 
cells not associated with NMS should pass through the filter. Conversely, V. vulnificus 
cells incorporated into the larger NMS aggregates would be unable to pass through 
the pores and be retained for enumeration. 
Despite successful incorporation and recovery of V. vulnificus from every sample, the 
total number of bacteria incorporated appeared surprisingly low (Fig. 4.4). NMS 
inoculated to a final V. vulnificus concentration of 103 CFU/mL resulted in 1 – 4 × 103 
CFU/g NMS. As expected, NMS inoculated with higher concentrations of V. vulnificus 
resulted in greater bacterial incorporation, with 105 CFU/mL resulting in 3 × 103 – 2 × 
104 CFU/g NMS and 107 CFU/mL resulting in 5 × 103 – 3 × 104 CFU/g NMS (Figs. 4.4B 
& 4.4C). However, given that there was a 10,000-fold increase in V. vulnificus 
inoculation concentrations between 103 CFU/mL and 107 CFU/mL, a significantly 
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greater difference in incorporation than a 10-fold increase was expected. 
 
 
Interestingly, 99-743 demonstrated significantly greater incorporation into NMS than 
106-2A, despite equal concentrations of each being added under identical conditions. 
It is worthy to note that the two strains were of different genotypes, with 99-743 being 
an E-type (environmental) and 106-2A being a C-type (clinical), according to a 
classification system described by Warner and Oliver, (1999) 42. Studies demonstrate 
that strain genotype impacts integration into NMS, with E-type strains showing 
significantly greater inclusion 249. The results here also show that E-type 99-743 
incorporates into NMS significantly more effectively than C-type 106-2A and that this 
is consistent following inoculation at a range of concentrations. As the aim was to 
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Figure 4.4: Incorporation of V. vulnificus into natural marine snow. V. vulnificus 106- 
2A and 99-743 were incorporated into NMS formed using seawater as a substrate. (A) 103 
CFU/mL (B) 105 CFU/mL (C) 107 CFU/mL. Viable V. vulnificus recovered from aggregates 
was enumerated in triplicate for each sample. Error bars represent the standard deviation 
(n = 3). Statistics comparing the aggregation efficiency of 99-743 and 106-2A were 
performed using an unpaired, two-tailed t-test, ** p < 0.01, *** p < 0.001. 
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assess NMS as a model for Vibrio uptake by oysters, these results present two 
obstacles: low-level V. vulnificus incorporation, and differences in incorporation 
between genotypes. 
 
 
 
4.5. Co-incorporation of E-type and C-type V. vulnificus into natural marine 
snow 
Given the greater individual incorporation of E-type 99-743 into NMS than C-type 106- 
2A, it was investigated whether the presence of an E-type strain would impact 
integration of a C-type strain into NMS during co-incorporation. Significantly greater 
incorporation of E-type V. vulnificus strains into NMS would present a potential 
explanation for the higher presence of E-type V. vulnificus in oysters, compared to C- 
type 33. NMS rolling tubes containing 1 L seawater supplemented with hyaluronic acid 
were inoculated with both V. vulnificus 106-2A and 99-743 to final concentrations of 
107 CFU/mL each and rolled for 24 hours at 21 °C (Fig. 4.5). 
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Figure 4.5: Co-incorporation of V. vulnificus into natural marine snow. V. vulnificus 
106-2A and 99-743 were added to NMS rolling tubes at a 1:1 ratio (107 CFU/mL each). 
Generated NMS was filtered, and incorporated bacteria enumerated (n = 3). Error bars 
represent the standard deviation. Statistics were performed using an unpaired, two-tailed 
t-test, *** p < 0.001. 
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106-2A integration into NMS was dramatically reduced compared to single strain 
incorporation experiments previously performed. When incorporated into NMS 
individually, 106-2A recovery was < 104 CFU/g NMS. However, co-incorporation with 
E-type 99-743, reduced this to < 103 CFU/g NMS. 99-743 still demonstrated 
significantly greater integration than 106-2A, with recovery of ≤ 2 × 104 CFU/g NMS (p 
< 0.001). These findings may explain the discrepancy in numbers between E- and C- 
type V. vulnificus in oysters. 
 
 
 
4.6. Natural microorganisms outcompete V. vulnificus for incorporation into 
natural marine snow 
The ability to generate NMS and show incorporation of two V. vulnificus strains has 
been demonstrated in this study. However, incorporation rates were extremely low 
compared to the inocula. This study theorised that this low-level incorporation may 
have been the result of using seawater as a substrate for aggregate formation. 
Seawater collected from Dawlish was inherently variable in terms of composition, with 
respect to particulate matter and bacterial species present within it. Previous studies 
have shown that seawater has been shown to contain microorganisms at 
concentrations > 105 CFU/mL 326. Consequently, it is very likely that there is competition 
for incorporation from a diverse range of marine microorganisms. To explore the extent 
that natural bacteria were incorporating into NMS, uninoculated NMS was generated 
and enumerated on LB and TCBS agar. 
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Fig. 4.6 shows enumeration of natural bacteria incorporated into NMS generated using 
five separately collected seawater samples. For every sample recovery of natural 
bacteria was ≥ 105 CFU/g NMS, with sample 1 containing > 107 CFU/g NMS, 
significantly greater than every other sample (p < 0.001). Enumeration on TCBS 
showed that whilst samples 2 and 5 contained no detectable Vibrio species, samples 
1, 3 and 4 all contained 102 – 103 CFU/g NMS, although the exact species were 
unknown. This data demonstrates that the presence of incorporated natural Vibrios 
would impact NMS colonisation by exogenous V. vulnificus and confound enumeration 
of bacteria selected for study. Moreover, the data here shows that this approach was 
unable to achieve incorporation of exogenous V. vulnificus into oysters at 
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Figure 4.6: Enumeration of natural bacteria and Vibrio species from natural marine 
snow. Laboratory-generated NMS with no added bacteria was enumerated on LB and 
TCBS agar to assess concentrations of naturally occurring microorganisms per gram of 
NMS. (A) Enumeration on LB agar. (B) Enumeration on TCBS agar. Five individually 
collected seawater samples were assessed (n = 3). Error bars represent the standard 
deviation. Statistics comparing every strain to every other strain were performed using a 
one-way ANOVA with Tukey’s corrections for multiple comparisons, *** p < 0.001. 
 
109  
concentrations significantly higher than the concentrations at which natural Vibrio 
species were already present. 
In conclusion, whilst the generation of NMS using seawater presented numerous 
obstacles to future in vivo assays. These included inconsistent aggregation, variation 
in aggregate formation between seawater samples, competition for incorporation with 
natural bacteria, genotype-dependent variation in V. vulnificus incorporation and 
disparate incorporation of V. vulnificus between seawater samples. 
 
 
 
Discussion 
 
This chapter explores V. vulnificus incorporation into an NMS model for future uptake 
by oysters. Seawater collected from Dawlish was shown to act as a suitable substrate 
for formation of aggregates into which V. vulnificus incorporation was demonstrated. 
However, it was discovered that V. vulnificus incorporation was extremely low-level, 
being largely outnumbered by natural bacteria present in the seawater. Combined with 
the compositional variability of seawater resulting in significantly different aggregate 
formation between seawater samples, NMS was deemed ineffective for the purpose 
of this study. 
Enumeration of natural bacteria from NMS demonstrated significantly greater 
incorporation than exogenous V. vulnificus strains. NMS is a naturally forming 
microenvironment and it is therefore likely that the natural bacteria incorporated into 
NMS were already adhered to the particles within the seawater before NMS 
generation. Kiørbe et al., (2003) examined the dynamics of microbial communities on 
marine aggregates and found that bacteria already attached to NMS demonstrate 
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greatly increased growth and reduced detachment rates compared to exogenous 
bacteria 268. The presence of the detritosphere, a microscopic nutrient sphere 
surrounding aggregates, promotes growth and survival of incorporated 
microorganisms, generating pressure to maintain incorporation 269. The use of 
seawater will have resulted in natural bacteria already having been in contact with the 
substrate matter, resulting in colonisation and inhibiting V. vulnificus incorporation. 
Bochdansky et al., (2017) explored the distribution of prokaryotic and eukaryotic 
microbes on marine snow recovered from the bathyal zone (1,000 – 3,000 m below 
the surface). The study found that, whilst prokaryotes numerically exceeded 
eukaryotes, the biomass of eukaryotic organisms was greater, with fungi and 
labyrinthulomycetes (marine protists) dominating 327. There is therefore a significant 
number of a diverse microorganisms competing with exogenous V. vulnificus for 
incorporation into NMS, resulting in extremely low-level incorporation of attacker and 
prey strains. The variability of seawater is also affected by seasonal changes, with 
different bacteria demonstrating prevalence throughout the year. This fluctuation is 
particularly apparent with Vibrio species, who have demonstrated observable 
association with SST through spiking CFU counts in summer and falling to often 
undetectable levels in winter 4,48,57. Consequently, an NMS model employing seawater 
as a substrate would suffer further inconsistency over time as a result of changing 
bacterial populations within collected seawater. 
These findings help explain the results put forth by Warner and Oliver, (2008) 
highlighting the elevated presence of E-type V. vulnificus compared to C-type strains 
in oysters 33. Despite being present at similar concentrations in the surrounding water 
(E-type – 46.9 %, C-type – 53.1 %), E-type V. vulnificus outnumbered their C-type 
counterparts 84.4 % to 15.6 % when isolated from oyster tissues. The significant 
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incorporation advantage for E-type V. vulnificus into NMS suggests that E-type V. 
vulnificus are successfully outcompeting C-type V. vulnificus strains in situ and are 
consequently present in much higher concentrations in oysters. This offers a potential 
explanation for the disparity between E-type and C-type presence in oysters, and the 
low clinical occurrence observed despite the organism’s ubiquity. Reduced C-type 
presence in oysters as a result of E-type competition would serve to result in reduced 
human exposure to pathogenic strains. 
 
 
 
Conclusions 
 
This study has explored the use of seawater to generate an NMS model for the high- 
level uptake of bacteria by oysters. Incorporation studies showed that despite 
inoculation concentration to a final concentration of 107 CFU/mL, incorporation was < 
105 CFU/g NMS. NMS presents a starting point for the development of a marine snow 
model to facilitate the high-level uptake of bacteria by oysters. However, the model 
presents too many challenges to be considered a viable model as it stands. Future 
work will look at developing a more defined model which address the issues of 
aggregate consistency, low incorporation levels, and presence of natural bacteria. 
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Chapter Five 
 
 
Development of an artificial marine snow model for 
bacterial incorporation 
113  
Introduction and aims 
 
The previous chapter confirmed that whilst V. vulnificus incorporation into NMS is 
possible, due to presence of natural microorganisms and variation in seawater 
composition the method is ineffective. Therefore, it was decided to explore the 
possibility of generating a defined ‘artificial’ marine snow (AMS) using diatom 
monocultures as a substrate. Diatoms are common components of natural marine 
aggregates and a common oyster food. Two diatom species, Thalassiosira 
pseudonana CCMP 1335 and Phaeodactylum tricornutum UTEX 646, were 
investigated to determine whether they were a suitable substrate for AMS generation. 
It was hypothesised that using defined diatoms would facilitate precise control over the 
volume of substrate (diatoms/mL) as diatom cultures could be enumerated prior to 
aggregation to ensure concentration consistency. The use of laboratory-grown diatom 
cultures would also enable greater control over the sterility of the substrate, removing 
the issue of contaminating natural microorganisms. Thus, the aim was to generate a 
reproducible AMS model into which V. vulnificus and S. Enteritidis could be reliably 
incorporated for future uptake by oysters. 
 
 
 
Results 
 
5.1. V. vulnificus incorporation into diatom-based artificial marine snow 
 
AMS was generated using the same methodology as previously described for NMS, 
with the exception of using 1 L artificial seawater supplemented with diatoms to a final 
concentration of 106 cells/mL in place of seawater (methods, section 2.3.1). Diatom 
suspensions formed visible aggregates after overnight incubation, a representative 
micrograph of which can be seen in Fig. 5.1. 
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Figure 5.1: Light micrograph of T. pseudonana artificial marine snow. Diatom AMS 
was generated by incubating 1 L suspensions consisting of artificial seawater, 106 cells/mL 
diatom culture, and hyaluronic acid at 16 rpm for 24 hours. Magnification × 100. 
 
 
 
Bacteria-free negative controls were established for T. pseudonana and P. tricornutum 
and plated on LB agar. A lack of colonies recovered from either negative control 
confirmed the sterility of the AMS model. Once aggregation of T. pseudonana and P. 
tricornutum had been assessed, diatom AMS suspensions were supplemented with 
bacterial cultures to a final concentration of 105 CFU/mL. Remarkably, V. vulnificus 
incorporation into AMS was extremely successful (Fig. 5.2). 99-743 demonstrated > 
108 CFU/g AMS, 10,000-fold greater than 99-743 incorporation into NMS (Fig. 4.4). 
Similarly, 106-2A demonstrated consistently > 107 CFU/g AMS, 1,000-fold greater than 
incorporation into NMS. As observed with NMS, there was a significant difference 
between incorporation of 99-743 and 106-2A into AMS. This difference was observed 
with both T. pseudonana and P. tricornutum aggregates, and in each instance 99-743 
demonstrated a 10-fold greater integration than 106-2A (P. tricornutum p < 0.05, T. 
pseudonana p < 0.01). 
 
250 m 
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Despite the success of this diatom based AMS model, diatom growth rate was a major 
limitation. Due to the high concentrations of diatom cells required, laboratory-grown 
cultures typically took 14 days to reach a suitable density in sufficient volume for 
extensive AMS generation and testing. It was therefore decided to continue using 
diatoms as an AMS substrate but in a more time-effective and easily manageable 
manner. 
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Figure 5.2: Incorporation of V. vulnificus into diatom-based artificial marine snow. 
V. vulnificus 106-2A and 99-743 were incorporated into AMS generated using cultures of 
two separate diatom species, T. pseudonana CCMP 1135 and P. tricornutum UTEX 646 
for 24 hours at 21 °C. Bacteria-free negative controls were established and enumerated in 
parallel on LB agar. Error bars represent the standard deviation (n = 3). Statistics were 
performed using t-tests, * p < 0.05, ** p < 0.01. 
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5.2. V. vulnificus incorporation into Reef Phytoplankton-based artificial 
marine snow 
To replace laboratory-grown diatom cultures, a highly concentrated commercial 
phytoplankton stock was procured. Reef Phytoplankton (RP) is a concentrated (5 × 
108 cells/mL) blend of five phytoplankton genera, Isochrysis, Pavlova, Tetraselmis, 
Thalassiosira and Nannochloropsis. RP was added to marine snow tubes in place of 
laboratory-grown diatom cultures and AMS generated as previously described. 
Curiously, no visible AMS formation was recorded following overnight aggregation of 
RP. A possible explanation for this was the non-viability of the phytoplankton cells 
contained within the phytoplankton blend (as stated by the manufacturer). Being non- 
viable, these phytoplankton retain their structure and nutritional content, but no longer 
grow and replicate. It was theorised that, being non-viable, these cells may lack some 
component for promoting aggregation. However, this study hypothesised that 
formation of large aggregates may not be entirely essential for facilitating uptake by 
oysters. As long as exogenous bacteria can adhere to phytoplankton cells, they will be 
within the optimal size range for ingestion by oysters. AMS was therefore generated as 
previously described, with the use of RP in place of a live diatom culture. 
Fig. 5.3 shows incorporation of V. vulnificus 106-2A and 99-743 into RP-based AMS. 
Bacteria-free controls demonstrated incorporation of natural bacteria at ~ 104 CFU/g 
AMS, however absence of bacterial colonies on TCBS confirmed that no natural 
bacteria were Vibrio species. 106-2A was consistently recovered from AMS at 
concentrations > 107 CFU/g AMS, and 99-743 at concentrations > 108 CFU/g AMS. 
99-743 demonstrated significantly greater integration than 106-2A, with bacterial loads 
consistently 10-fold higher (p < 0.01). Reassuringly, RP was equally successful as 
laboratory-cultured diatoms for bacterial incorporation. It is necessary to note that 
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negative controls plated on LB agar indicated presence of natural bacteria at 103 – 104 
CFU/g AMS. However, the extremely high-level uptake of 106-2A and 99-743 into 
AMS demonstrated that, despite the presence of natural microorganisms, exogenous 
V. vulnificus could be incorporated into RP-based AMS in extremely high 
concentrations. 
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Figure 5.3: Incorporation of V. vulnificus into Reef Phytoplankton-based artificial 
marine snow. V. vulnificus 106-2A and 99-743 were incorporated into AMS generated 
using RP as a substrate for 24 hours at 21 °C. Suspensions were supplemented with 105 
CFU/mL of either 106-2A or 99-743. Bacteria-free controls were established and plated on 
LB and TCBS agar. Error bars represent the standard deviation (n = 3). Statistics were 
performed using an ordinary one-way ANOVA with Tukey’s corrections for multiple 
comparisons, ** p < 0.01. 
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5.3. Scanning-electron microscopy visualisation of V. vulnificus incorporated 
into Reef Phytoplankton-based artificial marine snow 
To visually confirm incorporation of V. vulnificus into AMS, inoculated aggregates were 
subjected to scanning electron microscopy (SEM). Processed samples consisted of 
106-2A in AMS, 99-743 in AMS, a bacteria-free AMS control and an adhesion control. 
The purpose of the adhesion control was to confirm that bacteria visually observed 
incorporated into AMS were not simply unincorporated cells that had settled on AMS 
aggregates during sample processing for SEM, giving the appearance of integration. 
Adhesion control AMS was supplemented with V. vulnificus immediately prior to 
sampling, preventing sufficient time for incorporation into AMS to occur. Observation 
of bacteria in the adhesion control would therefore indicate planktonic bacteria that 
had been retained during sample processing and that this would have to be taken into 
account for all other samples. 
AMS samples were processed according to the methods, section 2.9, and visualised 
using a JEOL JSM 6390 LV scanning electron microscope operated at 5 kV. Figs. 5.4 
and 5.5 show SEM micrographs of V. vulnificus 99-743 and 106-2A incorporation into 
AMS, respectively. V. vulnificus cells have been false-coloured in Photoshop for ease 
of identification; 99-743 – blue, 106-2A – pink (unprocessed images can be observed 
in Appendix 10 and 11). Figs. 5.4A and 5.5A show examples of some of the 
phytoplankton species contained within RP, including Tetraselmis, Nannochloropsis 
and Thalassiosira. Figs. 5.4B and 5.5B show representative micrographs of 99-743 
and 106-2A adhesion controls. The absence of bacteria present in these samples 
confirmed that planktonic bacteria were not settling on AMS during sample processing 
and therefore all bacteria observed in other samples were legitimately incorporated 
into phytoplankton aggregates. 
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Figure 5.4: Scanning electron microscopy visualisation of V. vulnificus 99-743 
incorporated into Reef Phytoplankton-based artificial marine snow. V. vulnificus 99- 
743 was incorporated into RP-based AMS and processed for SEM visualisation. (A) RP- 
only negative control, magnification × 9,000. (B) Adhesion control, magnification × 7,000. 
(C) 99-743 only control, magnification × 7,000. (D & E) 99-743 incorporated into AMS, 
magnification × 9,000 and × 3,000 respectively. (I) Nannochloropsis, (II) Thalassiosira, (III) 
T. weissfloggi, (IV) Isochrysis (flagella), (V) unknown. 
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Figs. 5.4D/E and 5.5D/E illustrate successful incorporation of 99-743 and 106-2A into 
AMS. Initially, there were no AMS aggregates visible with the naked eye following 
overnight aggregation of RP, which was theorised to be due to phytoplankton non- 
viability. However, these images confirm that aggregation is occurring, but merely on 
a far smaller scale than was observed with viable diatom cultures. Whilst AMS 
aggregates using laboratory-grown diatom cultures were up to 250 m in diameter, 
RP-based AMS resulted in the formation of far smaller aggregates, ~ 10 – 30 m in 
diameter. 
These SEM images confirm successful V. vulnificus incorporation into AMS. However, 
there were numerous unidentified constituents within samples alongside the expected 
phytoplankton species (all indicated with arrows). I – IV are Nannochloropsis, 
Thalassiosira, Tetraselmis, and Isochrysis, respectively, all of which were expected to 
be identified as they are listed amongst the five phytoplankton species contained within 
RP. However, V is unidentified and does not appear to be any of the listed 
phytoplankton species. 
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Figure 5.5: Scanning electron microscopy visualisation of V. vulnificus 106-2A 
incorporated into Reef Phytoplankton-based artificial marine snow. (A) RP-only 
control, magnification × 11,000. (B) Adhesion control, magnification × 7,000. (C) 106-2A 
only control, magnification × 15,000. (D & E) 106-2A Incorporated into AMS, magnification 
× 7,000 and × 6,500, respectively. (I) Nannochloropsis, (II) Thalassiosira, (III) Tetraselmis. 
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5.4. Inconsistent bacterial incorporation into artificial marine snow due to 
variable Reef Phytoplankton composition 
The previous section demonstrates that phytoplankton provide a highly effective 
substrate for generating AMS, facilitating significant V. vulnificus incorporation. 
However, microscopic analysis of different RP stocks revealed disparities in the ratios 
of phytoplankton within. Fig. 5.6 shows incorporation of V. vulnificus 106-2A and 99- 
743 into AMS using three separate RP stocks. Results showed consistent 
incorporation into AMS between replicates from the same stock solution, however 
incorporation was far more varied between stock solutions. Integration of 106-2A into 
RP sample 1 resulted in > 107 CFU/g AMS, however the same bacterial inocula added 
to RP sample 2 resulted in < 106 CFU/g AMS. 
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Figure 5.6: V. vulnificus incorporation into artificial marine snow using separate Reef 
Phytoplankton samples. V. vulnificus 106-2A and 99-743 were incorporated into AMS 
formed using three individual RP samples at 21 °C for 24 hours. Negative controls were 
plated on LB and TCBS agar. Error bars represent the standard deviation (n = 3). Statistics 
comparing every strain to every other strain were performed using a two-way ANOVA with 
Tukey’s corrections for multiple comparisons, **** p < 0.0001. 
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Whilst not statistically significant, this difference could have a major impact on ensuring 
uptake and co-culture of consistent ratios of attacker and prey bacteria in oysters. 
Similarly, 99-743 incorporation into RP sample 1 resulted in > 108 CFU/g AMS, 
whereas in RP sample 3 99-743 was < 107 CFU/g AMS (p < 0.0001). These results 
confirm that RP composition variability had a direct effect on bacterial incorporation. 
This is potentially due to particular phytoplankton species within the blend binding V. 
vulnificus with greater affinity than others. Observation of the SEM images (Figs. 5.4 
and 5.5) appeared to suggest that V. vulnificus commonly bound to Nannochloropsis 
in greater volumes than other species, however this could not be confirmed without 
further testing. 
This variability introduced a question of consistency around AMS generated with 
different RP stocks and the complication of comparisons between assays using 
different stocks. One possible solution was to perform incorporation assays for every 
new batch of RP to determine the incorporation efficiency, however this is time 
consuming. It was therefore decided to further optimise the model by switching to a 
phytoplankton concentrate consisting of only T. pseudonana. Controlling one diatom 
species would prevent discrepancies caused by varying ratios of different species and 
help ensure consistent V. vulnificus incorporation. 
 
 
 
5.5. V. vulnificus incorporation into T. pseudonana artificial marine snow 
 
Commercially cultured T. pseudonana (TP1800, Reed Mariculture) was obtained in a 
highly concentrated suspension (109 cells/mL). T. pseudonana was primarily chosen 
as it has previously been demonstrated to be a highly effective substrate for marine 
snow formation and bacterial incorporation (Fig. 5.2). Similarly to RP, T. pseudonana 
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cells from TP1800 were non-viable, and as such would maintain their structure but no 
longer grow or replicate. AMS was generated as previously described but with the 
addition of 1 mL TP1800 in place of RP to a final concentration of 106 cells/mL. A 
bacteria-free negative control was also established in parallel for enumeration of 
bacteria present in TP1800 naturally. 
As observed with RP, no visible aggregates formed following overnight agglomeration 
of T. pseudonana. Given that both RP and TP1800 consist of non-viable phytoplankton 
cells this was not unexpected. Remarkably, enumeration of bacteria-free negative 
controls resulted in no recovery of contaminating bacteria, either on LB or TCBS (Fig. 
5.7). This lack of natural microorganisms was surprising as some level of 
contamination was expected as observed with the RP stock. V. vulnificus 106-2A 
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Figure 5.7: Incorporation of V. vulnificus into artificial marine snow using TP1800 as 
a substrate. V. vulnificus 106-2A, and 99-743 were incorporated into TP1800 AMS over 
24 hours at 21 °C. Bacteria-free controls were established and enumerated on LB and 
TCBS agar. Error bars represent the standard deviation (n = 3). Statistics were performed 
using an ordinary one-way ANOVA with Tukey’s corrections for multiple comparisons, * p 
< 0.05. 
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incorporated at > 107 CFU/g AMS, again 99-743 incorporation was significantly higher 
than 106-2A as seen previously, demonstrating > 108 CFU/g AMS (p < 0.05). 
Comparison of different TP1800 batches confirmed that bacterial incorporation was 
consistent between batches (Appendix 12). 
These data confirmed development of a defined and reproducible AMS model for 
incorporation of V. vulnificus at concentrations 10,000-fold greater than NMS. From 
here on all AMS referenced consists of this T. pseudonana TP1800 model. 
 
 
5.6. Dose-dependent incorporation of V. vulnificus into artificial marine snow 
 
Whilst this chapter has described the development of a robust AMS model for high- 
level bacterial incorporation, significantly greater 99-743 incorporation into aggregates 
than 106-2A is always observed with both NMS and AMS models. Future in vivo killing 
assays will require oyster exposure to defined ratios of attacker and prey bacteria. 
Given this, V. vulnificus 106-2A and 99-743 incorporation into AMS was tested at final 
concentration of 105, 106 and 107 CFU/mL to determine whether increased inocula 
results in increased incorporation. Fig. 5.8 shows a consistent increase in V. vulnificus 
recovered from AMS relative to the increase in inoculation concentration. When 
supplemented at 105 CFU/mL, 106-2A was recovered at > 107 CFU/g AMS, when 
inoculation was increased 100-fold to 107 CFU/mL, 106-2A recovery from AMS also 
increased 100-fold to > 109 CFU/mL. 99-743 demonstrated similar activity, with 
inoculation at 105 CFU/g AMS resulting in > 108 CFU/g AMS, and 107 CFU/mL resulting 
in > 1010 CFU/g AMS. At every inoculation concentration tested, 99-743 demonstrated 
significantly greater incorporation than 106-2A (p < 0.05). 
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5.7. Equal incorporation of V. vulnificus strains into artificial marine snow 
 
Having demonstrated dose-dependent incorporation of V. vulnificus 106-2A and 99- 
743 into AMS, bacterial inoculation concentrations were selected to facilitate equal 
incorporation of attacker and prey strains. Fig. 5.9A demonstrates incorporation of V. 
vulnificus 106-2A, T6SS1, T6SS2, T6SS1/2, and 99-743 into AMS at a final 
concentration of 108 CFU/ml. Bacteria-free controls plated on LB and TCBS agar 
recovered no contaminating microorganisms. 
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Figure 5.8: Incorporation of V. vulnificus into artificial marine snow at increasing 
concentrations. V. vulnificus 106-2A and 99-743 were incorporated into AMS at 105, 106, 
and 107 CFU/ml. AMS was enumerated and CFU counts taken following 24 hours rolling 
at 21 °C. Error bars represent the standard deviation (n = 3). Statistics were performed 
using unpaired t-tests, * p < 0.05. 
 
127  
 
 
 
 
ns 
LB
 C
on
tr
ol
TC
B
S
 C
on
tr
ol
99
-7
43
10
6-
2A
T
6S
S
1
T
6S
S
2
T
6S
S
1/
2
C
C
01
2
100
101
102
103
104
105
106
107
108
109
1010
C
F
U
/g
 M
a
ri
n
e
 S
n
o
w
LB
 C
on
tr
ol
TC
B
S
 C
on
tr
ol
99
-7
43
10
6-
2A
T
6S
S
1
T
6S
S
2
T
6S
S
1/
2
C
C
01
2
100
101
102
103
104
105
106
107
108
109
1010
C
F
U
/g
 M
a
ri
n
e
 S
n
o
w
******* A. 
B. 
Figure 5.9: Incorporation of adjusted V. vulnificus concentrations into artificial 
marine snow. (A) 105 CFU/mL V. vulnificus 99-743, 106-2A, T6SS1, T6SS2 and 
T6SS1/2 were incorporated into AMS for 24 hours at 21 °C. (B) V. vulnificus 99-743 (105 
CFU/ml), 106-2A, T6SS1, T6SS2 and T6SS1/2 (106 CFU/ml) were incorporated into 
AMS for 24 hours at 21 °C. Bacteria-free negative controls were plated on LB and TCBS 
agar. Error bars represent the standard deviation (n = 3). Statistics comparing every strain 
to every other strain were performed using a one-way ANOVA with Tukey’s corrections for 
multiple comparisons, *** p < 0.001, ns – not significant. 
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As expected, 99-743 demonstrated significantly greater incorporation than the 
respective attacker strains with > 108 CFU/g AMS (p < 0.001). Interestingly, 
enumeration of wild type V. vulnificus 106-2A and the isogenic T6SS mutants from 
AMS demonstrated no significant difference in incorporation efficacy. This data 
suggests that the T6SS is not involved in V. vulnificus integration into AMS. Fig. 5.9B 
shows that increasing inoculation concentrations for attacker V. vulnificus results in 
equal incorporation of attacker and prey strains into AMS at 108 CFU/g AMS. 
 
 
5.8. S. Enteritidis incorporation into artificial marine snow 
 
Having demonstrated the effectiveness of AMS for V. vulnificus incorporation, it was 
investigated whether S. Enteritidis CC012 would show similar incorporation for future 
in vivo inter-species killing assays. AMS was inoculated with S. Enteritidis to a final 
concentration of 105 CFU/mL and rolled at 21 °C for 24 hours. Bacteria-free negative 
controls were plated on LB and Salmonella-selective ChromoSelect agar. Fig. 5.10 
shows recovery of S. Enteritidis from AMS relative to V. vulnificus 106-2A and the 
T6SSs mutants. CC012 was consistently recovered from AMS at ~ 109 CFU/g AMS, 
demonstrating significantly greater incorporation than 99-743 (p < 0.05), 106-2A, and 
the T6SSs mutants (p < 0.0001). 
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S. Enteritidis incorporation into AMS was tested at a range of concentrations to 
determine the required concentrations for downstream in vivo assays (Fig. 5.11). As 
previously observed with V. vulnificus, dose-dependent inoculation of AMS resulted in 
a relative increase in bacterial incorporation into aggregates. Inoculation of AMS to a 
final S. Enteritidis concentration of 105 CFU/mL resulted in 108 – 109 CFU/g AMS. 100-
fold increase in inocula to a final concentration of 105 CFU/mL resulted in a similar 100-
fold increase in incorporated S. Enteritidis at 1010 – 1011 CFU/g AMS.
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Figure 5.10: Incorporation of V. vulnificus and S. Enteritidis into artificial marine 
snow. 105 CFU/mL S. Enteritidis CC012 was incorporated into AMS for 24 hours at 21 °C 
before enumeration on TCBS or ChromoSelect agar. Bacteria-free negative controls were 
plated on LB and ChromoSelect agar. This graph compares incorporation data for S. 
Enteritidis CC012 to previously obtained incorporation data for V. vulnificus (Fig.5.9A). 
Error bars represent the standard deviation (n = 3). Statistics comparing every strain to 
every other strain were performed using a one- way ANOVA with Tukey’s corrections for 
multiple comparisons, * p < 0.05, *** p < 0.001, 
**** p < 0.0001. 
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Figure 5.11: Dose-dependent incorporation of S. Enteritidis CC012 into artificial 
marine snow. S. Enteritidis CC012 was incorporated in AMS at final concentrations of 105, 
106 and 107 CFU/mL. A bacteria-free negative control was also established and plated on 
LB and Salmonella-selective ChromoSelect agar. Error bars represent the standard 
deviation (n = 3). 
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Figure 5.12: Comparison of dose adjusted S. Enteritidis CC012 incorporation into 
artificial marine snow versus V. vulnificus attacker and prey strains. Error bars 
represent the standard deviation (n = 3). Statistics were performed using a one-way ANOVA 
with Tukey’s corrections for multiple comparisons, ns – not significant. 
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Given this, S. Enteritidis inocula was reduced from a final concentration of 105 CFU/mL 
to 104 CFU/mL to facilitate equal incorporation into AMS as V. vulnificus. Fig. 5.12 
shows the standardised incorporation of V. vulnificus and S. Enteritidis into AMS in 
which no significant difference was observed between any of the strains tested. 
 
 
 
5.9. Scanning-electron microscopy visualisation of V. vulnificus and S. 
 
Enteritidis in artificial marine snow 
 
Following confirmation of V. vulnificus and S. Enteritidis incorporation into AMS, 
samples were processed for SEM visualisation (Fig. 5.13). Fig. 5.13A shows a 
representative micrograph of the adhesion control in which no bacteria were observed. 
As previously described in this study, this confirms that all the bacteria observed in 
experimental samples are genuinely associated with AMS, and not present as an 
artefact of the sample preparation process. Figs. 5.13B-D show individual 
incorporation of V. vulnificus and S. Enteritidis into AMS. Bacterial cells have been 
false-coloured in Photoshop for ease of identification (106-2A – pink, 99-743 – blue, 
CC012 – green). In all images V. vulnificus and S. Enteritidis incorporation into AMS 
aggregates is clearly observable, confirming quantitative data. Unprocessed SEM 
images can be seen in Appendix 13. 
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Figure 5.13: SEM visualisation of V. vulnificus and S. Enteritidis incorporation into 
artificial marine snow. V. vulnificus 106-2A, 99-743 and S. Enteritidis CC012 were 
incorporated into AMS generated using T. pseudonana as a substrate at 21 °C for 24 
hours. (A) Adhesion control, magnification × 5,000. (B) V. vulnificus 106-2A (pink) 
incorporated into AMS, magnification × 4,000. (C) V. vulnificus 99-743 (blue) incorporated 
into AMS, magnification × 4,000. (D) S. Enteritidis CC012 (green) incorporated into AMS, 
magnification × 4,000. 
 
 
The data presented so far in this study demonstrates the development of a highly 
reproducible model for bacterial incorporation into diatom AMS. Controlling the 
substrate ensures consistent aggregate formation and equally consistent incorporation 
of attacker and prey bacteria. Furthermore, removal of seawater as a component has 
ensured complete reduction of natural bacteria and the impact they may have posed 
in future killing assays. 
A. B. 
5 m 5 m 
C. D. 
5 m 5 m 
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5.10. Co-incorporation of attacker and prey bacteria into artificial marine snow 
 
Having observed in vitro killing activity of the T6SS1 and T6SS2 of V. vulnificus, it was 
hypothesised that these systems may be active when incorporated into AMS. This 
would present an opportunity for attacker strains to kill prey strains before oyster 
uptake. To control for this possibility, attacker V. vulnificus 106-2A, T6SS1, T6SS2 
and T6SS1/2 were co-incorporated into AMS with either V. vulnificus 99-743 or S. 
Enteritidis CC012 prey strains (Fig. 5.14). All strains demonstrated incorporation of ~ 
108 CFU/g AMS, with no strain outcompeting the other. No significant reduction of 
either prey strain was observed following co-incorporation with WT 106-2A when 
compared to individual uptake observed previously in this chapter. This data 
suggested that no T6SS-dependent killing was taking place. 
Previously in this study, E-type V. vulnificus 99-743 was shown to outcompete C-type 
106-2A for integration into NMS during co-incorporation (Fig. 4.4). Furthermore, 106- 
2A competition with 99-743 was shown to result in reduced incorporation of 106-2A 
relative to previous single-strain incorporation studies (Fig. 4.5). A similar interaction 
was not observed using this AMS model. Instead, co-incorporation of E- and C-type 
V. vulnificus was shown to have no significant impact on C-type incorporation, with 
total integration comparable to single-strain controls. 
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Figure 5.1: Co-incorporation of attacker and prey bacteria into artificial marine snow. 
Attacker V. vulnificus 106-2A, T6SS1 and T6SS2 were co-incorporated into AMS with 
either (A) V. vulnificus 99-743 or (B) S. Enteritidis CC012 for 24 hours at 21 °C. Vertical 
dotted lines separate co-cultures. Each dot represents a replicate performed in triplicate. 
Attacker strains are marked with empty circles, prey strains with black diamonds. Error 
bars represent the standard deviation (n = 3). Statistics comparing recovered attacker 
versus prey for each co-culture were performed using a nested one-way ANOVA with 
Tukey’s corrections for multiple comparisons. No samples were significantly different to 
one another.  
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Discussion 
 
This chapter describes the development of a defined and highly controllable AMS 
model through aggregation of the cosmopolitan diatom, T. pseudonana. This diatom- 
based model facilitated the incorporation of V. vulnificus and S. Enteritidis into 
aggregates at significantly greater concentrations than previously observed with NMS 
in this study. 
Diatoms are unicellular eukaryotes found ubiquitously in wet and moist environments, 
with an estimated 100,000 species across 200 genera 328. Diatoms and other 
phytoplankton are common constituents of marine snow, with phytoplankton blooms 
and diatom mats directly influencing marine snow formation 329–331. Furthermore, this 
chapter shows that successful aggregate formation only requires a singular diatom 
species, allowing for strict control over the volume of substrate utilised to generate 
diatom-based AMS 
332
. Bacterial incorporation into AMS using diatoms as a substrate 
was highly successful, demonstrating 10,000-fold greater incorporation into AMS than 
NMS as previously explored in this study. Use of a diatom model also facilitated 
straightforward dose-dependent incorporation of different bacterial species and strains 
into aggregates. As a result, concentrations of attacker and prey bacteria with different 
incorporation efficiencies can be easily adjusted to achieve required incorporation 
concentrations. 
AMS addresses all the issues presented by NMS. Artificial seawater supplemented 
with diatoms circumvented both seawater variability and natural bacteria presence, as 
observed for NMS. AMS generation using diatom species, T. pseudonana and P. 
tricornutum, showed > 107 CFU/g incorporation of V. vulnificus, 10,000-fold greater 
than incorporation into NMS. Most importantly, bacterial incorporation was extremely 
consistent, demonstrating that utilising equal volumes of diatom substrate facilitated 
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highly reproducible bacterial incorporation between replicates. However, the downside 
to this method was the slow rate of growth of both diatom species, limiting the rate at 
which diatom based AMS studies could progress. 
Therefore, this study explored the use of commercial phytoplankton concentrates to 
provide the substrate for AMS generation. Initial tests utilised RP, a blend of 
Thalassiosira, Nannochloropsis, Tetraselmis, Pavlova and Isochrysis species. Despite 
initial success incorporating high concentrations of V. vulnificus into RP-based AMS, 
further replicates demonstrated significant variation between V. vulnificus 
incorporation into separate RP stocks. Microscopic analysis of RP samples 
demonstrated that the ratios of the contained phytoplankton species were typically 
unequal, with one species often more frequent. Previous studies have demonstrated 
that particular bacterial colonisers demonstrate distinct affinities for specific 
phytoplankton. For example, Behringer et al., (2018) utilised 16S metabarcoding to 
assess four Asterionellopsis glacialis and three Nitzschia longissima phytoplankton 
strains over a year to observe changes in their bacterial composition 333. They recorded 
only very minimal changes in bacterial populations despite strong pressures from 
culturing conditions, indicating significant associations between diatom hosts and 
bacterial communities. These findings were supported by subsequent data 
demonstrating similar short and long-term associations between bacterial 
communities and Thalassiosira species 334. The preferential association of bacteria 
with certain phytoplankton would likely result in significant differences in the number 
of incorporated bacteria between RP stocks in accordance with which species of 
diatom was most prevalent within the suspension. To circumvent this, a concentrated 
T. pseudonana monoculture was investigated as a suitable substrate for AMS. 
Bacterial incorporation into T. pseudonana aggregates using laboratory-grown T. 
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pseudonana cultures had been explored previously in this chapter, and the use of a 
diatom monoculture would prevent phytoplankton species variation from impacting 
incorporation. AMS studies using T. pseudonana in place of RP were extremely 
successful, demonstrating significant and reproducible incorporation of both V. 
vulnificus and S. Enteritidis into diatom aggregates. 
Every marine snow model investigated in this study demonstrated significantly greater 
incorporation of E-type V. vulnificus 99-743 than C-type 106-2A. One theory highlights 
the enhanced chitin-binding ability of E-type strains promoting adhesion to chitin-rich 
aggregates 276. Chitin is the second most abundant polysaccharide on earth behind 
cellulose and is present in marine snow due to being an important structural 
component of marine zooplankton and phytoplankton 335. Bacteria such as Vibrio 
harveyi have recently been shown to be critical for chitin recycling, utilising a 
‘chitoporin’ membrane protein, ChiP, for uptake of chito-oligosaccharides 336. Many 
Vibrionaceae utilise only chitin as a source of energy, whilst other Vibrio species such 
as V. cholerae have been demonstrated to regulate particular cellular process such as 
natural competence when in association with chitinous surfaces 337. Activity of 
chitinolytic bacteria (particularly from the Vibrionaceae family), is so extensive that, 
despite the high prevalence of chitin within vertically falling marine snow, chitin 
accumulation on the ocean floor is extremely minimal 336,338. Williams et al., (2014) 
explored the role of surface proteins in chitin attachment, notably the type 4 pilus 276. 
Two V. vulnificus type 4 pilus mutants, pilA and pilD, displayed significantly reduced 
attachment to chitin-coated beads versus wild type V. vulnificus. To determine whether 
this was genotype-specific, E- and C-type strains were incubated with chitin fragments 
and relative gene expression monitored. Their results demonstrated that E-type 
strains expressed 23-fold more PilA and 9-fold more PilD than C-type strains, 
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supporting the hypothesis of enhanced chitin binding resulting in greater E-type 
incorporation into marine snow. Furthermore, chitin attachment assays performed at 
both 30 °C and 37 °C showed increased C-type binding at 37 °C, in conjunction with 
decreased E-type attachment 278. This suggests that C-type chitin binding activity may 
be predominantly geared towards human infection, as opposed to environmental 
interactions. This hypothesis is further supported by the elevated expression of gpbA 
in C-type strains. GbpA is a chitin binding protein expressed 46- fold greater in C-type 
strains which has been associated with host colonisation in host colonisation by V. 
cholerae 279. Combined with the data presented by this study, these results suggest 
that greater incorporation of E-type V. vulnificus into AMS may be facilitated by an 
increased affinity of E-type strains to chitin compared to C-type V. vulnificus. 
The overall aim of this thesis is to explore the role of the T6SS of V. vulnificus on both 
intra and inter-species killing activity in an in vivo oyster model. As such, this chapter 
also demonstrates S. Enteritidis incorporation into AMS. Assessment of S. Enteritidis 
CC012 incorporation demonstrated significantly greater levels than V. vulnificus, even 
E-type V. vulnificus 99-743. As the mechanics behind bacterial incorporation into 
marine snow are not well understood it is unclear why this is the case. As previously 
discussed, chitin binding ability has been identified as a possible factor in determining 
aggregation into marine snow. Salmonella species chitin binding has been primarily 
explored in S. enterica serovar Typhimurium 339–341. Brandl et al., (2011) demonstrated 
that pre-incubation of S. Typhimurium with chitin reduced binding to chitin beads by 
727-fold 339. However further assays comparing the chitin binding abilities of attacker 
and prey strains would be required to understand the significance of chitin-binding 
ability on the data presented in this chapter. 
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Finally, co-incorporation of T6SS1+ attacker V. vulnificus (106-2A, T6SS1, T6SS2, 
 
T6SS1/2) and T6SS1- prey V. vulnificus (99-743) and prey S. Enteritidis CC012 into 
AMS resulted in no observable T6SS-dependent killing of V. vulnificus and S. 
Enteritidis prey strains. Whilst initially believed to be due to the conditions not being 
conducive to T6SS activity, analysis of SEM images (Fig. 5.13) suggested that the lack 
of killing may be insufficient contact between attacker and prey bacteria. T6SS killing 
requires cell-cell contact to facilitate the translocation of cytotoxic effectors from the 
host cell into the periplasm of the prey cell 169,232,299. However, SEM micrographs 
indicate that bacteria are not incorporated into AMS in high enough densities to 
facilitate ample cell-cell contact, but rather are typically spread out over the 
aggregates. It therefore appears likely that any T6SS activity in AMS would be of too 
low a level to accurately record. This is perhaps unsurprising as 109 T. pseudonana 
cells were exposed to only 108 CFU bacterial cells. Future work would look at either 
increasing the bacterial inoculation or reducing the number of diatom cells used. Either 
of these solutions would ensure increased colonisation of aggregates by attacker and 
prey strains, facilitating interaction between attacker and prey bacteria. 
 
 
 
Conclusions 
 
This chapter has developed a defined model for incorporating bacterial cultures into 
phytoplankton based AMS for future uptake by oysters. Use of T. pseudonana 
monocultures has eliminated the compositional variability issues presented by NMS, 
resulting in a highly reproducible and controllable AMS model into which both V. 
vulnificus and S. Enteritidis are effectively incorporated. Bacterial concentrations in 
AMS significantly outweigh loads incorporated into NMS as explored by this study. 
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Moving forwards, AMS uptake by oysters will be assessed to determine the 
applicability of this model for facilitating bacterial uptake by oysters and exploring in 
vivo interactions. 
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Chapter Six 
 
 
V. vulnificus T6SS1 and T6SS2 have antibacterial activity 
in an in vivo oyster model 
142  
Introduction and aims 
 
This chapter focuses on the uptake and retention of bacteria from AMS by the Pacific 
oyster, C. gigas. Previous chapters have demonstrated that V. vulnificus employs both 
the T6SS1 and the T6SS2 to kill prey V. vulnificus and S. Enteritidis strains in vitro and 
as such this chapter will also explore whether these in vitro results are reproducible in 
vivo. This will be conducted by co-culture of attacker and prey strains within oysters 
and subsequent in vivo killing assays. This chapter also describes the development of 
a series of qPCR assays designed to enumerate V. vulnificus and S. Enteritidis from 
oyster homogenates. qPCRs will be used to confirm data obtained from V. vulnificus 
and S. Enteritidis plate-counts following in vivo co-culture. 
 
 
 
Results 
 
6.1. Oyster uptake of V. vulnificus and S. Enteritidis from artificial marine 
snow 
Having demonstrated that V. vulnificus and S. Enteritidis could be successfully 
incorporated into AMS at high concentrations, the subsequent step was to confirm this 
facilitated high-level uptake of bacteria by oysters. V. vulnificus and S. Enteritidis were 
incorporated into AMS at 108 CFU/g AMS for uptake by oysters according to the 
workflow shown in Fig. 6.1 (methods, section 2.6). It should be noted that AMS was 
individually generated for each bacterial strain to prevent any potential bacterial 
competition in the aggregates prior to oyster uptake. Six oysters were exposed to AMS 
containing bacteria for each strain to account for variance in bacterial populations 
found within oysters. Each assay was performed in triplicate, resulting in a total of 18 
oysters per sample. Control oysters were exposed to bacteria-free AMS. After  
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A. 
 
 
   
 
 
 
 
Figure 6.1: Oyster in vivo co-culture killing assay workflow. (A) Oysters were cleaned 
upon arrival to remove any fouling organisms and placed into individual aquaria to 
acclimatise to 21 °C, 20 ppt salinity conditions. (B) Once oysters had acclimatised for five 
days, AMS was generated as required. (C) Oysters were exposed to AMS for 24 hours at 
21 °C. Circulation was maintained with the presence of an air stone and regular manual 
stirring. (D) After 24 hours oysters were removed and washed with 70 % ethanol to remove 
non-ingested bacteria. (E) Oysters were shucked with a sterile shucking knife and the 
stomach isolated. Stomachs were weighed and homogenised in PBS. (F) Homogenates 
were serially diluted and plated on LB agar. Once colonies had grown, LB plates were 
replica-plated onto TCBS to select for Vibrio species. Assays requiring Salmonella 
selection were plated on ChromoSelect agar. 
A. B. C. 
D. E. F. 
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exposure for 24 hours, oyster stomachs were excised, homogenised and plated on the 
relevant selective media for enumeration. 
Numbers of bacterial strains taken up by oysters from AMS are shown in Fig. 6.2. 
Despite professional depuration of oysters prior to delivery, natural bacteria were 
isolated from control oysters at 102 – 104 CFU/g tissue. Enumeration of bacteria-free 
AMS oyster controls on TCBS and ChromoSelect agar demonstrated < 103 CFU/g  
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Figure 6.1: Oyster uptake of V. vulnificus and S. Enteritidis from artificial marine 
snow. V. vulnificus 99-743, 106-2A, T6SS1, T6SS2, T6SS1/2 and S. Enteritidis 
CC012 were incorporated into AMS and added to oyster tanks for uptake over 24 hours. 
Control oysters were exposed to bacteria-free AMS and plated on LB, TCBS and 
ChromoSelect agar. Each circle represents the mean of six oysters (n = 3). Horizontal bars 
represent the mean, error bars represent the standard deviation. Downward arrows 
indicate that one or more samples were below the limit of detection (100 CFU/g tissue). 
Statistics comparing every strain to every other strain were performed using a nested one-
way ANOVA with Tukey’s corrections for multiple comparisons, no samples were 
significantly different to one another. 
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tissue and < 102 CFU/g tissue for Vibrio and Salmonella species, respectively. 
However, not all oysters contained contaminating Vibrio or Salmonella species, as 
indicated by downward arrows on the graph (Fig. 6.2). Excitingly, uptake of V. 
 
vulnificus and S. Enteritidis from AMS was extremely successful. Bacterial uptake 
ranged from 106 – 108 CFU/g tissue and was highly consistent between replicates. 
Importantly, there was no significant difference in uptake observed between any 
strains or species. Therefore, no AMS inocula adjustment was required to compensate 
for dissimilar ingestion of different strains. This demonstrated the development of an 
extremely robust and reproducible AMS model for facilitating high volume ingestion of 
bacterial cultures by oysters. 
 
 
 
6.1.1. Uptake of V. vulnificus and S. Enteritidis over 48 hours 
 
Having demonstrated that AMS facilitates effective bacterial uptake by oysters, rate of 
bacterial ingestion was explored over 48 hours to determine whether there were 
significant differences in uptake between different strains as this would impact 
downstream co-culture assays. Bacterial loads in oysters exposed to AMS were 
enumerated at T0, T4, T8, T24 and T48 hours to establish the rates at which different 
strains were ingested from AMS. Fig. 6.3 shows rapid initial uptake of bacteria from 
AMS, with bacterial concentrations rising from 102 CFU/g tissue at T0 to 105 – 107 
CFU/g tissue at T4. This rapid uptake was expected as depuration had reduced native 
oyster microflora, enabling colonisation by exogenous bacteria. Ingested bacterial 
concentrations peaked at T8, ranging from 5 × 106 – 5 × 108 CFU/g tissue. T24 shows 
V. vulnificus and S. Enteritidis concentrations plateauing at 106 – 108 CFU/g tissue. 
 
Enumeration at T48 demonstrated a decrease in total number of V. vulnificus and S. 
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Enteritidis present within the oysters, concentrations observed ranged from 5 × 104 – 
5 × 107 CFU/g tissue. Reassuringly, no significant difference was observed between 
the rates at which V. vulnifcus and S. Enteritidis strains are taken up by oysters. 
 
 
 
 
 
 
6.1.2. V. vulnificus and S. Enteritidis depuration from oysters 
 
An aim of this study was to develop an in vivo model that would enable study of 
bacterial interactions in oysters, specifically to reproduce in vitro data that showed 
T6SS1 and T6SS2 antibacterial activity at 21 °C. Two key problems typically 
encountered by previous studies in this field are extremely low uptake of planktonic 
bacteria by oysters and very rapid depuration of ingested bacteria following uptake 249. 
Having demonstrated successful uptake of V. vulnificus and S. Enteritidis from AMS, 
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Figure 6.2: Oyster uptake of V. vulnificus and S. Enteritidis from artificial marine 
snow over 48 hours. Oyster uptake of V. vulnificus 99-743, 106-2A, T6SS1, T6SS2, 
T6SS1/2 and S. Enteritidis CC012 from AMS over 48 hours. Each point on the graph 
represents the mean of six oysters (n = 3), error bars represent the standard deviation. 
Bacterial loads were enumerated at T0, T4, T8, T24 and T48 hours post exposure to AMS. 
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this study sought to compare the uptake and depuration of bacteria from AMS with the 
uptake and depuration of planktonic bacteria by oysters. This would elucidate whether 
incorporation into AMS is advantageous for bacterial retention in oysters during 
depuration. 
Oysters were exposed to inoculated AMS for 24 hours to facilitate uptake of 
incorporated bacteria as previously described. Planktonic control oysters had their 
tank water supplemented with equal concentrations of V. vulnificus to those 
incorporated into AMS. Following exposure (T24), tanks were cleaned and replaced 
with fresh artificial seawater to promote depuration of ingested bacteria. This process 
was repeated at 8 hours, then again after 24 hours, and then finally again after 48 
hours. Six oysters per strain were removed and homogenised at T0, T24 (0 hours post- 
depuration), T32 (8 hours post-depuration), T56 (24 hours post-depuration), and T80 (48 
hours post-depuration) to enumerate the bacterial load (Fig. 6.4). As previously 
described for uptake experiments in section 6.1.1, all assays were performed in 
triplicate, resulting in a total of 18 oysters per strain, per timepoint. 
As previously observed, bacterial concentrations in oysters following exposure to 
inoculated AMS for 24 hours was 106 – 108 CFU/g tissue. The planktonic control was 
far less effective, demonstrating < 105 CFU/g tissue uptake of V. vulnificus and S. 
Enteritidis, up to 1,000-fold less than AMS-exposed animals. Enumeration of V. 
vulnificus and S. Enteritidis from oysters at T24, T32, T56 and T80 hours showed a steady 
reduction in bacterial load within oyster stomachs. Final enumeration at T80, after 48 
hours of depuration, showed a 10,000-fold reduction in bacteria compared to oyster 
samples enumerated at T24. No strains incorporated into AMS demonstrated 
significantly faster or increased depuration from oysters than any other. The planktonic 
control achieved background levels of bacteria far more rapidly as was expected due 
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to the low initial levels of uptake. Bacterial loads after 24-hour depuration (T56) showed 
< 103 CFU/g tissue, similar to natural bacteria levels observed at T0. Depuration rates 
were similar between the planktonic control and the AMS-exposed oysters. The 
planktonic control dropped from 5 × 104 CFU/g tissue at T24 to 5 × 102 CFU/g tissue at 
T56 (24-hour depuration). This 100-fold reduction was also observed in all oysters 
exposed to inoculated AMS whose recorded bacterial loads dropped from 5 × 107 
CFU/g tissue at T24 to 5 × 105 CFU/g tissue at T56. This suggests that AMS does not 
provide a significant advantage in bacterial retention during depuration and that oyster 
expulsion of microflora is not concentration dependent. 
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Figure 6.3: Depuration of V. vulnificus and S. Enteritidis from oysters over 48 hours. 
Oysters were exposed to AMS containing V. vulnificus 99-743, 106-2A, T6SS1, T6SS2, 
T6SS1/2 and S. Enteritidis CC012 for 24 hours at 21 °C to facilitate uptake of incorporated 
bacteria. A subset of oysters were also exposed to planktonic V. vulnificus to act as a 
control for typical oyster inoculation protocols (planktonic control; V. vulnificus 106-2A). At 
24 hours, tanks were cleaned and filled with sterile artificial seawater to stimulate 
depuration. This process was repeated at T32, T56 and T80 hours. Six oysters were 
assessed per strain at each timepoint (n = 3). Timepoints consisted of T0, T24 (0 hours post-
depuration), T32 (8 hours post-depuration), T56 (24 hours post-depuration) and T80 (48 
hours post-depuration). 
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6.2. In vivo intra-species V. vulnificus co-culture assays 
 
6.2.1. Attacker to prey ratio of 1:1 
 
This chapter has demonstrated that incorporation of bacteria into AMS facilitates 
uptake by oysters to concentrations ranging from 106 – 108 CFU/g tissue. Furthermore, 
there has been no observed difference in uptake rate between different bacterial 
strains and species. Given these data, this study proceeded to perform bacterial co- 
culture assays in oysters to explore the activity of the T6SSs in vivo. Initially, oysters 
were exposed to AMS containing attacker and prey V. vulnificus at a 1:1 ratio for 24 
hours to facilitate uptake and competition between competing V. vulnificus strains. 
Whilst previous in vitro co-culture assays had been performed at an attacker to prey 
ratio of 3:1, it was decided to initially test a 1:1 ratio to be more representative of a 
natural situation. Negative control oysters were exposed to bacteria-free AMS and 
plated on LB and TCBS agar to enumerate natural microorganisms. Simultaneously, 
individual strain uptake controls were performed to ensure that each batch of oysters 
demonstrated consistent uptake and that there were no extraneous factors impacting 
the assay. 
Fig. 6.5 shows enumeration of attacker and prey V. vulnificus from oyster stomach 
tissue following co-culture at 21 °C for 24 hours. Bacteria-free AMS control oyster 
enumeration identified natural microorganisms at 103 – 104 CFU/g tissue. Again, this 
was expected as depuration of established bacteria from oysters is difficult. Of these 
bacteria, plating on TCBS agar confirmed < 103 CFU/g tissue to be Vibrio species. 
Several oysters returned no colonies on TCBS at all. 
All single strain control oysters demonstrated previously observed levels of V. 
vulnificus uptake (Fig. 6.2), with concentrations between 106 – 108 CFU/g tissue. 
Comparison of prey 99-743 recovered from co-culture oysters demonstrated no  
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Figure 6.4: In vivo intra-species V. vulnificus co-culture at an attacker to prey ratio 
of 1:1. In vivo co-culture assays were performed between attacker V. vulnificus strains, 
106-2A, T6SS1, T6SS2 or T6SS1/2, and prey V. vulnificus 99-743 for 24 hours at 21 
°C at an attacker to prey ratio of 1:1. Control oysters were exposed to either bacteria-free 
AMS or AMS containing a single bacterial strain. Each mark represents a biological 
replicate consisting of six technical oyster replicates processed per strain/co-culture (n = 
3). Clear triangles mark bacteria-free controls, clear circles mark attacker strains, black 
diamonds mark prey strains. Downward arrows indicate some replicates are below the 102 
CFU/g tissue limit of detection. Vertical dotted lines separate the co-culture assays and 
controls. Horizontal lines represent the mean of the three replicates, error bars represent 
the standard deviation. Statistics comparing all prey strain data from the co-cultures with 
the prey data from the prey control and all co-culture attacker strain data with their 
respective attacker strain control data were performed using a nested one-way ANOVA 
with Dunnett’s corrections for multiple comparisons. 
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significant reduction when compared to the single strain 99-743 oyster control subset, 
with consistently 106 – 108 CFU/g AMS recovered. This contrasted with the in vitro data 
where prey 99-743 showed a 1,000-fold reduction following co-culture with attacker V. 
vulnificus (Fig. 3.9). Enumeration of V. vulnificus attacker strains from co- culture 
oysters showed no significant difference in concentration of 106-2A, T6SS1 and 
T6SS2 compared to single strain controls also. It was hypothesised that killing of prey 
99-743 may have simply been occurring on too small a scale to be significant. The 
ratio of attacker to prey cells was therefore increased from 1:1 to both 5:1 and 10:1 to 
determine whether dose-dependent killing could be observed with higher attacker 
concentrations. 
 
6.2.2. Attacker to prey ratios of 5:1 and 10:1 
 
To achieve an attacker to prey ratio of 5:1, inocula of attacker strains was increased 
from 108 CFU/g AMS (initial inocula: 108 CFU/mL) to 5 × 108 CFU/g AMS (initial inocula: 
5 × 108 CFU/mL)  and co-culture assays performed as previously described (methods, 
section 2.6). Oysters exposed to bacteria-free AMS were plated on LB and TCBS agar 
(Fig. 6.6). 
Background bacteria were recovered at 104 CFU/g tissue, of which 102 – 103 CFU/g 
tissue were confirmed to be Vibrio species by plating on TCBS. These results were 
similar to those previously obtained (section 6.2.1), demonstrating relative consistency 
between oysters utilised in these assays. Single strain controls consistently 
demonstrated > 107 CFU/g tissue uptake into oysters, with no strains showing 
significantly increased or reduced uptake relative to each other and previous uptake 
experiments. However, 99-743 co-culture with V. vulnificus 106-2A, T6SS1, and 
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T6SS2 at an attacker to prey ratio of 5:1 resulted in 99-743 recovery at 105 – 106 
CFU/g tissue, significantly lower than the 99-743 single strain control (p < 0.0001). 
This reduction was T6SS-dependent, as co-culture assays performed between 99-743 
and the double mutant, T6SS1/2, resulted in no significant killing of prey 99-743, with 
recovery of 106 – 108 CFU/g tissue, equal to the single strain control. 
It was considered that the observed 99-743 reduction may be a result of increasing 
attacker to prey ratios to 5:1, simply increasing the levels of attacker strain available 
for uptake. However, if this was the case a reduction of 99-743 would also be expected 
following co-culture with T6SS1/2. Isolation of 99-743 from co-culture with T6SS1/2 
at concentrations equal to the single strain control confirmed that increased attacker 
to prey ratios did not impact co-culture results in ways other than T6SS-dependent 
killing. 
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Figure 6.5: In vivo intra-species V. vulnificus co-culture at an attacker to prey ratio 
of 5:1. In vivo co-culture assays were performed between attacker V. vulnificus strains, 
106-2A, T6SS1, T6SS2 or T6SS1/2, and prey V. vulnificus 99-743 for 24 hours at 21 
°C at an attacker to prey ratio of 5:1. Control oysters were exposed to either bacteria-free 
AMS or AMS containing a single bacterial strain. Each mark represents a biological 
replicate consisting of six technical oyster replicates processed per strain/co-culture (n = 
3). Clear triangles mark bacteria-free controls, clear circles mark attacker strains, black 
diamonds mark prey strains. Downward arrows indicate some replicates are below the 102 
CFU/g tissue limit of detection. Vertical dotted lines separate the co-culture assays and 
controls. Horizontal lines represent the mean of the three replicates, error bars represent 
the standard deviation. Statistics comparing all prey strain data from the co-cultures with 
the prey data from the prey control and all co-culture attacker strain data with their 
respective attacker strain control data were performed using a nested one-way ANOVA 
with Dunnett’s corrections for multiple comparisons, **** p < 0.0001. 
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These results therefore confirm that the reduction in prey 99-743 observed following 
co-culture with 106-2A, T6SS1, and T6SS2 was as a result of T6SS dependent 
killing, mediated by both the T6SS1 and the T6SS2. This is the first time that V. 
vulnificus T6SSs have been demonstrated to have intra-species killing activity in vivo. 
Having demonstrated T6SS-dependent killing of prey 99-743 at attacker to prey ratios 
of 5:1, co-culture assays were repeated at 10:1 (Fig. 6.7). 99-743 co-culture with 106- 
2A, T6SS1, and T6SS2 resulted in a significant decrease to 102 – 104 CFU/g tissue 
(p < 0.0001). This reduction in 99-743 was 1,000-fold greater than the reduction 
observed at 5:1, and 10,000-fold greater than the single strain controls. Due to the 
enumeration method, the limit of detection for plate-enumeration was 102 CFU/g 
tissue. Downward arrows in Fig. 6.7 indicate that there were one or more samples in 
which concentrations were < 102 CFU/g tissue, resulting in no recovery of prey 
colonies. 
Interestingly, 99-743 co-culture with T6SS1/2, resulted in a semi-log reduction of 99- 
743 to 5 × 106 CFU/g tissue (p < 0.01). This reduction was not observed at 5:1, 
suggesting that exposure of oysters to increased attacker V. vulnificus concentrations 
was resulting in significantly greater uptake of attacker strains and impacting uptake 
of 99-743. However, this study still observed significantly greater reduction of 99-743 
when co-cultured with 106-2A, T6SS1, and T6SS2 compared to T6SS1/2, 
confirming that these strains are killing 99-743 in vivo in a T6SS-dependent manner. 
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Figure 6. 6: In vivo intra-species V. vulnificus co-culture at an attacker to prey ratio 
of 10:1. In vivo co-culture assays were performed between attacker V. vulnificus strains, 
106-2A, T6SS1, T6SS2 or T6SS1/2, and prey V. vulnificus 99-743 for 24 hours at 21 
°C at an attacker to prey ratio of 10:1. Control oysters were exposed to either bacteria-free 
AMS or AMS containing a single bacterial strain. Each mark represents a biological 
replicate consisting of six technical oyster replicates processed per strain/co-culture (n = 
3). Clear triangles mark bacteria-free controls, clear circles mark attacker strains, black 
diamonds mark prey strains. Downward arrows indicate some replicates are below the 102 
CFU/g tissue limit of detection. Vertical dotted lines separate the co-culture assays and 
controls. Horizontal lines represent the mean of the three replicates, error bars represent 
the standard deviation. Statistics comparing all prey strain data from the co-cultures with 
the prey data from the prey control and all co-culture attacker strain data with their 
respective attacker strain control data were performed using a nested one-way ANOVA 
with Dunnett’s corrections for multiple comparisons, ** p < 0.01, **** p < 0.0001. 
156  
6.3. V. vulnificus inter-species competition assays in vivo 
 
6.3.1. Attacker to prey ratios of 5:1 and 10:1 
 
Having demonstrated V. vulnificus 106-2A and the isogenic single T6SS deletion 
mutants were able to kill prey V. vulnificus in vivo, co-culture assays were performed 
investigating inter-species competition with prey S. Enteritidis CC012. As no significant 
killing was observed at an attacker to prey ratio of 1:1 for intra-species killing it was 
decided to only test 5:1 and 10:1 attacker to prey ratios for inter-species assays. 
Fig. 6.8 shows enumeration of V. vulnificus and S. Enteritidis from oysters following 
co-culture at an attacker to prey ratio of 5:1 for 24 hours at 21 °C. Control oysters 
exposed to bacteria-free AMS were enumerated and numbers of natural 
microorganisms enumerated on LB agar and ChromoSelect agar. Whilst oysters 
tended to contain natural microorganisms at around the same 102 – 104 CFU/g tissue 
concentrations observed in other assays, S. Enteritidis concentrations were generally 
lower than was observed for Vibrio species. Typically, Vibrios were enumerated at < 5 
× 103 CFU/g tissue with 7 oysters out of the 36 control oysters utilised in the 5:1 and 
10:1 assays containing no Vibrios at all. However, S. Enteritidis was always present 
at < 4 × 102 CFU/g tissue, and only identified in 15 out of 36 control oysters assessed 
over the two co-culture assays. 
Single strain control oysters demonstrated uptake of V. vulnificus and S. Enteritidis at 
 
106 – 108 CFU/g tissue. S. Enteritidis enumeration from co-culture with106-2A, 
 
T6SS1, and T6SS2 demonstrated significant reduction of prey S. Enteritidis. 
Bacterial loads showed a reduction from 106 – 108 CFU/g tissue in the single strain 
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Figure 6.7: In vivo inter-species V. vulnificus co-culture with S. Enteritidis at an 
attacker to prey ratio of 5:1. In vivo co-culture assays were performed between attacker 
V. vulnificus strains, 106-2A, T6SS1, T6SS2 or T6SS1/2, and prey S. Enteritidis 
CC012 for 24 hours at 21 °C at an attacker to prey ratio of 5:1. Control oysters were 
exposed to either bacteria-free AMS or AMS containing a single bacterial strain. Each mark 
represents a biological replicate consisting of six technical oyster replicates processed per 
strain/co-culture (n = 3). Clear triangles mark bacteria-free controls, clear circles mark 
attacker strains, black diamonds mark prey strains. Downward arrows indicate some 
replicates are below the 102 CFU/g tissue limit of detection. Vertical dotted lines separate 
the co-culture assays and controls. Horizontal lines represent the mean of the three 
replicates, error bars represent the standard deviation. Statistics comparing all prey strain 
data from the co-cultures with the prey data from the prey control and all co-culture attacker 
strain data with their respective attacker strain control data were performed using a nested 
one-way ANOVA with Dunnett’s corrections for multiple comparisons, ** p < 0.01. 
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control to 104 – 106 CFU/g tissue when co-cultured with 106-2A, T6SS1, or T6SS2 
(p < 0.01). This 100-fold reduction demonstrated V. vulnificus T6SS1 and T6SS2 have 
inter-species killing activity in vivo, complementing previous in vitro data from this 
study. Furthermore, no reduction in S. Enteritidis recovery when cultured with the 
T6SS1/2 double mutant confirmed that killing observed by wild type 106-2A and the 
two single T6SS mutants was T6SS-dependent. 
In vivo inter-species assays were repeated at an attacker to prey ratio of 10:1 to 
determine whether reduction of prey S. Enteritidis was dose-dependent, as previously 
shown for intra-species competition. Negative control oysters exposed to bacteria-free 
AMS were enumerated on LB and ChromoSelect agar. LB agar returned natural 
microorganisms at 102 – 104 CFU/g tissue. Of these, ChromoSelect agar confirmed 
Salmonella species to be < 103 CFU/g tissue. Single strain uptake of V. vulnificus and 
S. Enteritidis from AMS was consistently > 107 CFU/g tissue and demonstrated no 
significant difference between samples or replicates. In vivo co-culture of S. Enteritidis 
with V. vulnificus 106-2A, T6SS1, or T6SS2 resulted in a significant reduction in 
recovered S. Enteritidis from > 107 CFU/g tissue in the single strain control to 102 – 104 
CFU/g tissue (p < 0.001). In no oysters were S. Enteritidis completely removed from 
the oyster as was observed with intra-species competition. 
To confirm that this reduction was T6SS-dependent S. Enteritidis was co-cultured with 
the T6SS1/2 double mutant. Interestingly, this resulted in a significant S. Enteritidis 
reduction, with a reduction from > 107 CFU/g tissue in the single strain control to 5 × 
106 CFU/g tissue in the co-culture (p < 0.05). Although statistically significant, the 
change in concentration is minimal respective to the reduction observed following co- 
culture with wild-type V. vulnificus or either single T6SSs deletion mutant. Given that 
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Figure 6.8: In vivo inter-species V. vulnificus co-culture with S. Enteritidis at an 
attacker to prey ratio of 10:1. In vivo co-culture assays were performed between attacker 
V. vulnificus strains, 106-2A, T6SS1, T6SS2 or T6SS1/2, and prey S. Enteritidis 
CC012 for 24 hours at 21 °C at an attacker to prey ratio of 10:1. Control oysters were 
exposed to either bacteria-free AMS or AMS containing a single bacterial strain. Each mark 
represents a biological replicate consisting of six technical oyster replicates processed per 
strain/co-culture (n = 3). Clear triangles mark bacteria-free controls, clear circles mark 
attacker strains, black diamonds mark prey strains. Downward arrows indicate some 
replicates are below the 102 CFU/g tissue limit of detection. Vertical dotted lines separate 
the co-culture assays and controls. Horizontal lines represent the mean of the three 
replicates, error bars represent the standard deviation. Statistics comparing all prey strain 
data from the co-cultures with the prey data from the prey control and all co-culture attacker 
strain data with their respective attacker strain control data were performed using a nested 
one-way ANOVA with Dunnett’s corrections for multiple comparisons, * p < 0.05, *** p < 
0.001. 
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similar significance was observed following V. vulnificus 99-743 co-culture with 
 
T6SS1/2, this difference was suggested to be a result of the greater concentration of 
attacker strain to which oysters were exposed. The extent of prey killing by 106-2A, 
T6SS1, and 
T6SS2 clearly demonstrated that T6SS-depedent killing was the cause of the 
reduction in prey numbers. 
 
 
 
6.4. qPCR quantification of V. vulnificus and S. Enteritidis from in vivo oyster 
matrices 
Probe-based TaqMan qPCR is a highly sensitive and accurate technique for 
microorganism enumeration from a range of environments where plate-culture may 
not always be possible 342. Whilst dye-based SYBR qPCR is popular, this study 
employed a TaqMan probe-based qPCR due to the increased sensitivity of the 
sequence-specific fluorescent probe. The aim of the TaqMan qPCR was to utilise a 
molecular enumeration method to confirm plate-count data demonstrating antibacterial 
T6SS activity in vivo. A schematic of qPCR primer and probe binding sites can be seen 
in Appendix 15. 
 
 
 
6.4.1. Generation of standard curve material 
 
TaqMan qPCR primers and probes were designed as described in the methods 
(section 2.7.1) against vvhA, vgrG1, vcgE and sefA. These genes were each carefully 
selected to identify both 106-2A and the T6SS mutants (vgrG1), 99-743 (vcgE), V. 
vulnificus species (vvhA), or S. Enteritidis species (sefA). VvhA is an extracellular V. 
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vulnificus haemolysin pore-forming toxin commonly used as a marker for the species 
 
343–345. This probe was employed as a V. vulnificus species control to identify natural 
 
V. vulnificus in negative controls. VgrG1 forms part of the tip complex of the T6SS1 
and is therefore only present in T6SS1+ attacker V. vulnificus strains, 106-2A, T6SS1, 
T6SS2, and T6SS1/2 346. Whilst vcgE does not encode a protein, it is only identified 
in E-type V. vulnificus, such as 99-743 43. SefA is a S. Enteritidis fimbrin protein 
involved in actin-cross-linking and was therefore utilised as a Salmonella-specific 
probe 347. 
To enable absolute quantification of V. vulnificus and S. Enteritidis from oyster 
matrices, standard curves were generated against which experimental samples could 
be plotted to determine copy number/L and total CFU/oyster. Standards were 
generated by cloning the fragments of vvhA, vgrG1, vcgE and sefA amplified by the 
qPCR primers designed for the assay into holding vector, pGEM-T Easy. Plasmid 
maps for pGEM-T Easy–vvhA, pGEM-T Easy–vgrG1, pGEM-T Easy–vcgE and 
pGEM-T Easy–sefA are shown in Appendix 14. Once constructed, purified plasmid 
DNA was adjusted to a series of standard concentrations, ranging from 108 – 103 
copies/L for vgrG1 and 108 – 101 copies/L for vcgE, sefA and vvhA as these samples 
required greater sensitivity due to lower concentrations observed using plate-counts. 
 
 
 
6.4.2. qPCR optimisation and standard curve generation 
 
To ensure accurate absolute quantification of V. vulnificus and S. Enteritidis from 
oyster matrices TaqMan qPCR primer and probe concentrations were optimised to 
ensure the consistent generation of a standard curve with an r2 value ≥ 0.99. Any curve 
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< 0.99 was not determined accurate enough for enumeration purposes. Primers and 
probes were designed according to the methods (section 2.7.1) (Appendix 15). 
Primer concentration was first optimised through combination of forward and reverse 
primers at 50, 100, 200, 400, 600 and 800 nM so that every concentration of the 
forward primer was tested with every concentration of the reverse primer. Fig. 6.10A/B 
shows the optimisation of vgrG1 as a representative example for all qPCRs. The 
optimal combination of forward and reverse primer concentrations was determined by 
which combination resulted in a sigmoidal curve at the earliest cycle number. The 
results varied between qPCRs and can be seen in Table 2.5. Once established, probe 
concentration was optimised by testing at 50, 100, 200, 400, 600 and 800 nM (Fig. 
6.10C). The probe concentration resulting in a sigmoidal curve at the earliest cycle 
number was deemed optimal. Finalised probe concentrations for vvhA, vcgE, vgrG1, 
and sefA are also listed in Table 2.5. 
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Figure 6.10: vgrG1 qPCR primer and probe optimisation. (A) Primer optimisation 
amplification plots. The horizontal blue line represents the cycle threshold (Ct). (B) 
Optimised vgrG1 primer concentrations and the resulting sigmoidal curve. FWD primer – 
200nM, REV primer – 800 nM. (C) Probe optimisation plots utilising the optimised primer 
concentration. Probe concentration was assessed at 50, 100, 200, 400, 600, and 800 nM. 
A no-template control (NTC) using H2O in place of template DNA was included. 
600 nM 
800 nM 
 
400 nM 
200 nM 
 
100 nM 50 nM & NTC 
B. 
 
200 nM/800 nM 
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Having optimised primer and probe concentrations, standard curves for quantification 
were generated. A representative standard curve can be seen in Fig. 6.11 for vgrG1 
following optimisation. Each standard was loaded in triplicate to account for pipetting 
error. As can be seen, amplification of 108 – 103 copies/L standards generates a 
robust standard curve with an r2 value of 0.994, meeting the > 0.99 value required for 
absolute quantification. To ensure standard curve generation was consistent, each 
curve was generated in triplicate on separate days and using different reagents and 
template DNA stocks. 
Unfortunately, this study was unable to effectively generate standard curves for vcgE, 
sefA and vvhA which included 102 and 101 copies/L standards. Despite optimisation 
there appeared to be too much variability at these low concentrations to generate a 
consistent curve with an acceptable r2 value of > 0.99. The lowest standard for these 
curves was therefore 103 copies/L. An example of these ineffective standard curves 
including the 102 and 101 standards can be seen in Appendix 16. This presented a 
problem in that the limit of detection for these qPCRs was limited to 103 copies/L of 
extracted DNA. However, oyster homogenates had been diluted 10-fold, and the 
extracted DNA dissolved in 100 L ddH2O (of which 5 L was used as template). 
Therefore, qPCR quantification data had to be multiplied by 200 to calculate the 
concentration of bacteria in the original samples. This resulted in 105 CFU/g tissue 
being the lowest bacterial concentration possible to enumerate. It was decided to 
perform the qPCR assays regardless and simply denote samples where amplification 
was < 105 CFU/g tissue with a downwards arrow. 
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Figure 6.11: Optimised vgrG1 standard curve. (A) Amplification of qPCR standards from 
108 – 103 copies/L. Each standard was run in triplicate to account for pipetting error. (B) A 
representative vgrG1 standard curve generated using the amplification from the top image. 
Higher copy number standards result in lower Ct values due to increased amplification 
resulting in greater fluorescence. As lower concentration standards have less template 
material it take a greater number of cycles for fluorescence to cross the Ct and for 
amplification to be detected. An r2 value of 0.994 indicates that this curve would be suitable 
for quantification. 
108 copies/L 
Ct value 103 copies/L 
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6.4.3. qPCR quantification of V. vulnificus and S. Enteritidis from single strain 
uptake experiments 
Once vvhA, vgrG1, vcgE and sefA qPCRs had been successfully optimised, DNA 
extracted from oyster homogenates was utilised as template for qPCR enumeration of 
V. vulnificus and S. Enteritidis CC012. Firstly, V. vulnificus and S. Enteritidis were 
enumerated from the single strain uptake controls shown previously in Fig. 6.2. 
Comparison of qPCR quantification data and plate count enumeration can be seen in 
Fig. 6.12. As observed, qPCR quantification resulted in highly similar CFU/g tissue 
results compared to plate enumeration with none of the assessed strains 
demonstrating significantly different results following comparison.  
 
99
-7
43
99
-7
43
10
6-
2A
10
6-
2A
T
6S
S
1
T
6S
S
1
T
6S
S
2
T
6S
S
2
T
6S
S
1/
2
T
6S
S
1/
2
C
C
01
2
C
C
01
2
100
101
102
103
104
105
106
107
108
109
C
F
U
/g
 O
y
s
te
r 
T
is
s
u
e
qPCR
Plate-counts
Figure 6.9: Comparison of qPCR and plate count enumeration of V. vulnificus  and 
S. Enteritidis from oysters matrices. Optimised qPCR assays were utilised to quantify 
V. vulnificus 99-743, 106-2A, T6SS1, T6SS2, T6SS1/2, and S. Enteritidis CC012 from 
oyster homogenates previously enumerated using plate-counts (Fig. 6.2). Plate counts are 
represented by clear circles, qPCR counts by black diamonds. Each mark represents the 
mean of six technical oyster replicates (n = 3). Horizontal lines represent the mean, error 
bars represent the standard deviation, vertical lines separate comparisons between 
strains. Statistics comapring plate count data versus qPCR data for each strain were 
performed using individual unpaird t-tests, no data showed significant differences. 
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6.4.4. qPCR quantification of V. vulnificus from in vivo intra-species co-culture 
assays 
DNA extracted from oyster homogenates from 5:1 and 10:1 bacterial co-culture assays 
was utilised as template DNA in qPCR assays to quantify V. vulnificus loads in oyster 
tissue. qPCR data was compared to plate-count data to confirm that observed results 
were consistent across different methods of enumeration. Quantification of intra- 
species killing between V. vulnificus attacker and prey strains can be seen in Fig. 6.13. 
As previously discussed, qPCR reactions had a 103 copies/L accuracy limit, and 
therefore could not enumerate bacteria present at < 105 CFU/g tissue. For this reason, 
qPCR was unable to quantify the levels of natural V. vulnificus in the oyster samples 
using the vvhA probe and this has been indicated with a downwards arrow. 
Quantification of single strain controls confirmed uptake of attacker and prey V. 
vulnificus strains by oysters at concentrations > 107 CFU/g tissue (Fig. 6.13). Attacker 
strain concentrations remained > 107 CFU/g tissue following co-culture with prey V. 
vulnificus 99-743 for 24 hours at 21 °C. However, prey 99-743 demonstrated a 
significant reduction from > 107 CFU/g tissue to 105 – 107 CFU/g tissue following co- 
culture with 106-2A, T6SS1, and T6SS2 (p < 0.05, p < 0.01). No significant 
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Figure 6.10: qPCR quantification of V. vulnificus from in vivo intra-species co-
culture. In vivo co-culture assays were performed between attacker V. vulnificus strains, 
106-2A, T6SS1, T6SS2 or T6SS1/2, and prey V. vulnificus 99-743 for 24 hours at 21 
°C at an attacker to prey ratio of 5:1. Control oysters were exposed to either bacteria-free 
AMS or AMS containing a single bacterial strain. Each mark represents a biological 
replicate consisting of six technical oyster replicates processed per strain/co-culture (n = 
3). Clear circles mark attacker strains, black diamonds mark prey strains. Downward 
arrows indicate some replicates are below the 105 CFU/g tissue limit of detection. Vertical 
dotted lines separate the co-culture assays and controls. Horizontal lines represent the 
mean of the three replicates, error bars represent the standard deviation. Statistics 
comparing all prey strain data from the co-cultures with the prey data from the prey control 
and all co-culture attacker strain data with their respective attacker strain control data were 
performed using a nested one-way ANOVA with Dunnett’s corrections for multiple 
comparisons, * p < 0.05, ** p < 0.01. 
Limit of detection 
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reduction in prey 99-743 was observed when co-cultured with the double mutant, 
 
T6SS1/2, confirming that this killing was T6SS-dependent. This data confirms plate 
count enumeration results and supports the finding that V. vulnificus T6SS1 and 
T6SS2 are active and employed in intra-species competition in an environmentally 
representative model. 
Quantification of 99-743 from 10:1 co-culture assays by qPCR confirmed consistent 
uptake of attacker and prey strains at > 107 CFU/g tissue (Fig. 6.14). As demonstrated 
by plate enumeration, 99-743 showed significantly greater reduction at an attacker to 
prey ratio of 10:1 compared to 5:1. Due to the limitations of the qPCR assay at these 
low bacterial concentrations no data was recovered for these samples. However, the 
absence of qPCR data confirms that these samples were below the 103 copies/L 
threshold, indicating that 99-743 was not present in oysters at > 105 CFU/g tissue. 
Interestingly, whilst plate-count enumeration of 10:1 intra-species competition showed 
a small but significant reduction of 99-743 when co-cultured with T6SS1/2 (p < 0.01) 
(Fig. 6.7), qPCR quantification shows no significant difference between 99-743 from 
co-culture vs 99-743 from single strain controls. 
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Figure 6.11: qPCR quantification of V. vulnificus from in vivo intra-species co-
culture. In vivo co-culture assays were performed between attacker V. vulnificus strains, 
106-2A, T6SS1, T6SS2 or T6SS1/2, and prey V. vulnificus 99-743 for 24 hours at 21 
°C at an attacker to prey ratio of 10:1. Control oysters were exposed to either bacteria-free 
AMS or AMS containing a single bacterial strain. Each mark represents a biological 
replicate consisting of six technical oyster replicates processed per strain/co-culture (n = 
3). Clear circles mark attacker strains, black diamonds mark prey strains. Downward 
arrows indicate some replicates are below the 105 CFU/g tissue limit of detection. Vertical 
dotted lines separate the co-culture assays and controls. Horizontal lines represent the 
mean of the three replicates, error bars represent the standard deviation. Statistics 
comparing all prey strain data from the co-cultures with the prey data from the prey control 
and all co-culture attacker strain data with their respective attacker strain control data were 
performed using a nested one-way ANOVA with Dunnett’s corrections for multiple 
comparisons. 
Limit of detection 
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6.4.5. qPCR quantification of V. vulnificus and S. Enteritidis from in vivo inter- 
species co-culture assays 
Inter-species in vivo killing assays between V. vulnificus attacker strains and prey S. 
Enteritidis CC012 were similarly assessed via qPCR using the sefA probe to quantify 
CC012. Fig. 6.15 shows qPCR quantification of attacker and prey strains following co- 
culture at an attacker to prey ratio of 5:1. As previously discussed, the developed 
qPCRs lacked the sensitivity to detect bacterial loads < 105 CFU/g tissue and therefore 
this study was unable to accurately enumerate CC012 from negative control oysters. 
Whilst this confirms bacterial loads are < 105 CFU/g tissue, it is unable to accurately 
identify an exact concentration. 
Single strain uptake controls demonstrated consistent uptake of attacker and prey 
strains at > 107 CFU/g tissue, as observed previously in intra-species co-culture 
assays. Attacker bacterial loads remain > 107 CFU/g tissue in all co-culture oysters 
also, demonstrating no reduction from co-culture with CC012. However, quantification 
of prey CC012 showed a significant reduction from > 107 CFU/g tissue to as low as 
105 CFU/g tissue when co-cultured with 106-2A, T6SS1 and T6SS2 (p < 0.05, p < 
0.01). Co-culture of CC012 with T6SS1/2 shows no significant CC012 reduction 
compared to the CC012 single strain control, confirming that CC012 reduction with 
other attacker strains, T6SS1 and T6SS2, was T6SS-dependent. 
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Figure 6.12: qPCR quantification of V. vulnificus and S. Enteritidis from in vivo inter-
species co-culture. In vivo co-culture assays were performed between attacker V. 
vulnificus strains, 106-2A, T6SS1, T6SS2 or T6SS1/2, and prey S. Enteritidis CC012 
for 24 hours at 21 °C at an attacker to prey ratio of 5:1. Control oysters were exposed to 
either bacteria-free AMS or AMS containing a single bacterial strain. Each mark represents 
a biological replicate consisting of six technical oyster replicates processed per strain/co-
culture (n = 3). Clear circles mark attacker strains, black diamonds mark prey strains. 
Downward arrows indicate some replicates are below the 105 CFU/g tissue limit of 
detection. Vertical dotted lines separate the co-culture assays and controls. Horizontal 
lines represent the mean of the three replicates, error bars represent the standard 
deviation. Statistics comparing all prey strain data from the co-cultures with the prey data 
from the prey control and all co-culture attacker strain data with their respective attacker 
strain control data were performed using a nested one-way ANOVA with Dunnett’s 
corrections for multiple comparisons, * p < 0.05, ** p < 0.01. 
Limit of detection 
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Fig. 6.16 shows V. vulnificus and S. Enteritidis enumeration from oysters following co- 
culture at an attacker to prey ratio of 10:1. Single strain controls showed uptake of 
attacker and prey strains at 106 – 108 CFU/g tissue. However, quantification of CC012 
following co-culture with 106-2A, T6SS1, and T6SS2 resulted in no detection of 
CC012 by qPCR, indicating that bacterial concentrations within oysters were < 105 
CFU/g tissue. Whilst qPCR was unable to accurately determine the exact 
concentrations of CC012 within oyster matrices, this data did confirm that CC012 
reduction was greater at an attacker to prey ratio of 10:1 than 5:1, as expected and 
demonstrated previously by plate count enumeration. Interestingly, no significant 
CC012 reduction was observed following co-culture with the double T6SS mutant as 
was previously seen for the 10:1 assay plate count data (Fig. 6.9). 
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Figure 6.13: qPCR quantification of V. vulnificus and S. Enteritidis from in vivo 
inter-species co-culture. In vivo co-culture assays were performed between attacker V. 
vulnificus strains, 106-2A, T6SS1, T6SS2 or T6SS1/2, and prey S. Enteritidis CC012 
for 24 hours at 21 °C at an attacker to prey ratio of 10:1. Control oysters were exposed to 
either bacteria-free AMS or AMS containing a single bacterial strain. Each mark 
represents a biological replicate consisting of six technical oyster replicates processed 
per strain/co-culture (n = 3). Clear circles mark attacker strains, black diamonds mark 
prey strains. Downward arrows indicate some replicates are below the 105 CFU/g tissue 
limit of detection. Vertical dotted lines separate the co-culture assays and controls 
Horizontal lines represent the mean of the three replicates, error bars represent the 
standard deviation. Statistics comparing all prey strain data from the co-cultures with the 
prey data from the prey control and all co-culture attacker strain data with their respective 
attacker strain control data were performed using a nested one-way ANOVA with 
Dunnett’s corrections for multiple comparisons 
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This chapter confirms that the T6SS1 and T6SS2 of V. vulnificus 106-2A are active in 
an oyster in vivo model, where the systems demonstrate antibacterial activity against 
both V. vulnificus and S. Enteritidis strains. These results support in vitro findings 
previously described in this study (Chapter 3) which show that both the T6SS1 and the 
T6SS2 have antibacterial activity at 21 °C. This is first study to describe the activity of 
the T6SS2 of V. vulnificus and the first to characterise the activity of both V. vulnificus 
T6SSs in vivo. 
 
 
 
Discussion 
 
This chapter describes the application of AMS for facilitating oyster uptake of bacteria. 
Animals exposed to AMS inoculated with V. vulnificus and S. Enteritidis demonstrated 
significantly higher bacterial uptake than previous studies in which oysters’ tanks were 
simply inoculated with planktonic bacteria. Using this in vivo oyster model, a role for 
the T6SS1 and the T6SS2 of V. vulnificus in intra-species killing in vivo has been 
identified. Furthermore, similar killing activity was demonstrated against S. Enteritidis, 
showing that V. vulnificus T6SSs are antibacterial and are involved in both intra and 
inter-species competition in vivo. 
Vibrios are ubiquitous aquatic microorganisms that have the potential to cause fatal 
human disease, thus it is essential to understand their ecology and apply this 
knowledge to manage disease spread and prevention. Investigating Vibrio ecology is 
important for food security concerns due to the threat pathogenic Vibrios present to 
the aquaculture industry. The State of the World Fisheries and Aquaculture (SOFIA) 
report (2018) describes 80 million tonnes of aquaculture produced in 2016, of which 
molluscs totalled 17.1 million tonnes (47 % of global production) 348. However, 
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intensive farming practices are resulting in large-scale seasonal losses due to 
pathogenic Vibrio species 349,350. Vibrio splendidus is an oyster pathogen that has been 
responsible for consistent seasonal oyster losses of up to 80 % over a 10-year period 
in the bay of Morlaix, France 351. 
For this reason, it is important that studies can effectively explore bacteria-host 
interactions using an oyster model. However, many of these studies rely on the uptake 
of planktonic bacteria by oysters, which is inefficient and results in low-level bacterial 
uptake 246,253,255,257. This is due to filter-feeding shellfish preferentially retaining 
particles above a certain size threshold, which planktonic bacteria do not attain 249. 
Marine snow was first characterised in 1930s, and its role in nutrient transport in the 
ocean is well understood 258,331,352. Froelich and Oliver, (2013) were the first to explore 
incorporation of bacteria, specifically V. vulnificus, into NMS for uptake by oysters 249. 
However, incorporation into NMS and subsequent uptake by oysters was low-level, at 
~ 105 CFU/mL in NMS and 102 – 103 CFU/g tissue, respectively. The data presented 
in this study demonstrates that aggregation of T. pseudonana results in a significantly 
more effective and reproducible AMS model for bacterial incorporation. Subsequent 
exposure of inoculated AMS to oysters for uptake of incorporated bacteria resulted in 
highly successful uptake and retention, with all strains ingested at > 107 CFU/g tissue 
on average. Bacterial loads in oysters > 107 CFU/g tissue uptake is significantly higher 
than any other study published to date and demonstrates the superiority of AMS to all 
current oyster inoculation techniques. Furthermore, as levels of naturally occurring 
bacteria in oysters were ~ 104 CFU/g tissue, this model ensures that exogenous 
bacteria greatly outnumber native microorganisms, reducing the impact potentially 
presented by any interactions between native and exogenous bacteria. No significant 
difference in uptake between different bacterial strains and species over 48 hours 
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indicates that this model facilitates even uptake of whichever strain or species has 
been incorporated, allowing for easy co-culture of various strains and species. 
Interestingly, despite oysters being exposed to 10-fold higher bacterial concentrations 
in the 10:1 assays versus the 1:1 assays, no significant difference was observed in 
bacterial uptake between the groups. This suggests that there may be a physical limit 
to the volumes of bacteria which oysters can accommodate. 
The success of the AMS model reported in this thesis suggests potential use in a wider 
range of applications outside of research. Global awareness regarding the reduction 
of antibiotic use in agriculture and aquaculture has led to a directed effort to identify 
novel methods of pathogen control. One such application is the use of ‘probiotic’ 
bacteria that either kill or directly compete with dangerous pathogens, reducing their 
impact and viability. A recent study by Stevick et al., (2019) showed that the addition 
of probiotic Bacillus pumilus to oyster rearing tanks aided in larval survival following 
challenge with the oyster pathogen, Vibrio coralliilyticus 353. Similarly, Kang et al., 
(2018) identified novel applicable probiotic activity of Enterococcus faecium 354. Co- 
culture of E. faecium and V. parahaemolyticus in oysters at 105 CFU/mL resulted in a 
10-fold decrease in recovered V. parahaemolyticus. However, E. faecium 
incorporation into AMS would result in greater uptake by oysters, potentially facilitating 
more effective reduction of V. parahaemolyticus numbers and increasing food safety. 
As expected, natural bacteria were always isolated from control oysters exposed to 
bacteria-free AMS, despite professional depuration. Bivalve depuration involves 
placing shellfish in continuously circulating, UV-treated water to eliminate any 
expunged microorganisms 355. Whilst effective for reducing natural bacteria to safe 
concentrations for human consumption, microflora are never entirely cleared 233. It was 
initially theorised that this endogenous natural population may have some impact on 
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in vivo killing assays, whether through killing of either attacker or prey strains, or 
competing with exogenous bacteria for oyster colonisation. However, comparison of 
natural bacteria levels to levels of exogenous bacteria showed that the uptake of 
exogenous bacteria from AMS was so significantly greater that it was not considered 
to be a conflicting factor. Uptake of AMS containing exogenous bacteria resulted in 
attacker and prey strain concentrations in oysters at 10,000-fold greater levels than 
the natural population. No significant difference was observed between levels of 
attacker and prey bacteria individually introduced into oysters using AMS. This 
indicates that no exogenous strain or species was negatively impacted by any naturally 
occurring microorganisms within the oysters. Uptake of exogenous bacteria from AMS 
was so effective that a small population of native microorganisms would be unlikely to 
noticeably impact the viability of exogenous populations. 
Significant T6SS-dependent killing of prey V. vulnificus 99-743 was observed following 
co-culture with 106-2A, T6SS1 or T6SS2 within oysters. A lack of prey reduction 
when co-cultured with the double mutant, T6SS1/2, confirmed that this killing was 
due to activity of the T6SS1 and T6SS2 of V. vulnificus. Having demonstrated in vivo 
intra-species competition, further studies were performed to confirm that V. vulnificus 
was also capable of utilising its T6SSs for inter-species competition. Oysters were 
exposed to AMS inoculated with S. Enteritidis CC012 and attacker V. vulnificus strains. 
As observed for intra-species co-culture, a significant reduction of prey S. Enteritidis 
was recorded following co-culture with 106-2A, T6SS1, and T6SS2 but not 
T6SS1/2, confirming inter-species in vivo killing activity of the V. vulnificus T6SS1 
and T6SS2. 
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All plate count enumeration data in this study was confirmed using qPCR. Four qPCR 
assays were designed and optimised for absolute quantification of all V. vulnificus 
species, all Salmonella species, and V. vulnificus 106-2A, V. vulnificus T6SS1, V. 
vulnificus T6SS2, V. vulnificus T6SS1/2, and V. vulnificus 99- 743. Initially, it was 
expected that qPCRs would identify significantly greater bacterial concentrations than 
plate count enumeration. This was because qPCR would also quantify free DNA from 
dead bacteria and DNA from VBNC bacteria not detected by plate culture. However, 
whilst qPCR quantification was typically higher than respective plate counts, the 
increase was marginal, confirming the reliability of the plate count data described by 
this study. It was expected that there would be a greater difference between the plate 
count data and the qPCR data when enumerating bacteria from oysters due to the 
ability of qPCR to also enumerate free DNA released from dead cells. Jana et al., 
(2019) describes the discovery of a widespread DNase toxin domain in a range of 
Gram-negative and Gram-positive bacteria, termed PoNe (Polymorphic Nuclease 
effector) 224. PoNe domains are commonly fused to delivery domains of T6SS proteins 
and suggest that V. vulnificus may employ nuclease effectors to kill target bacteria. 
The degradation of bacterial DNA upon death would limit the volume of free DNA 
released from dead cells, therefore reducing the final counts provided by the qPCR 
assay. Further genomic investigation would be required to identify whether PoNe 
domains are found in V. vulnificus. Their identification in close V. vulnificus relative, V. 
parahaemolyticus, suggests it is a possibility, however more research is required. 
Significantly greater killing of prey bacteria was observed in vivo compared to in vitro 
assays. The most obvious explanation for which was the increased volumes of 
attacker to prey bacteria utilised. In vitro assays were performed at an attacker to prey 
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ratio of 3:1, whereas in vivo assays were performed at both 5:1 and 10:1. As T6SS 
activity is contact dependent it is expected that increasing the concentrations of the 
attacking strain would increase contact between attacker and prey strains, facilitating 
increased prey strain killing. However, it is also possible that the oyster stomach 
environment plays a role in promoting T6SS activity. More specifically, that the less 
nutrient-rich oyster stomach may promote up-regulation of V. vulnificus T6SSs to 
facilitate more effective competition with neighbouring microorganisms. Recently, the 
T6SSs of B. thailandensis, P. aeruginosa and Yersinia pseudotuberculosis have all 
been shown to secrete effectors involved in the acquisition of essential nutrients such 
as iron, zinc and manganese 228,305,356. In P. aeruginosa, iron down-regulates H2-T6SS 
expression by binding to two ferric uptake repressor (Fur) sequences, known as Fur 
boxes, overlapping predicted 70 promoters 356. High iron concentration results in 
increased binding of Fur proteins to the Fur boxes, reducing HS-T6SS expression. Y. 
pseudotuberculosis RelA, a stress-response protein also found in V. vulnificus, directly 
upregulates expression of the T6SS4 in response to nutrient starvation conditions 
305,357. Whilst a simple model, the conditions within the oyster stomach are not well 
characterised and therefore it is hard to say to exactly which conditions ingested 
bacteria are exposed. It is possible that the T6SS1 and T6SS2 of V. vulnificus are 
upregulated under in vivo conditions, resulting in the observed increase in T6SS- 
dependent killing, although further work would be required to test this hypothesis. 
Whilst this is the first study to date to demonstrate V. vulnificus intra and inter-species 
competition in an oyster model, this is not the first study to demonstrate the role of a 
Vibrio T6SS in in vivo competition. Speare et al., (2018) demonstrate that V. fischeri 
employs a T6SS2 to target and kill competing strains in the light-organ crypts of a 
Euprymna scolopes squid model 173. Interestingly, that study showed that whilst ‘lethal’ 
181  
and ‘nonlethal’ strains were unable to coexist due to killing of the nonlethal strain, two 
lethal strains were able to coexist with one another due to continued killing of the other 
strain 173. This further supports a possible role for the T6SS in V. vulnificus ecology, 
where even though two ‘attacker’ strains may possess lethal T6SS machinery to which 
the other strain does not express the requisite immunity proteins, reciprocal killing of 
each strain by the other ensures that both strains are equally capable of surviving 
within that niche. 
 
 
 
Conclusions 
 
This chapter successfully demonstrates that the defined AMS model developed by this 
study facilitates efficient and reproducible uptake of incorporated bacteria by oysters. 
This model was shown to function for both V. vulnificus and S. Enteritidis strains and 
presents a novel methodology for promoting bacterial uptake by oysters for both 
research and aquaculture purposes. AMS was utilised to ensure uptake of attacker 
and prey V. vulnificus and S. Enteritidis for in vivo co-culture assays. The results of 
these assays confirm previous in vitro data that the T6SSs of V. vulnificus 106-2A have 
antibacterial activity in vivo. This data suggests that the T6SS may play a significant 
role in the establishment of V. vulnificus, and other T6SS+ bacteria, in vivo. 
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Chapter Seven 
Concluding remarks and future work 
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V. vulnificus is an opportunistic human pathogen, capable of causing severe 
fulminating infection and death if not treated rapidly. Previous studies attempting to 
characterise the virulence potential of environmental and clinical V. vulnificus isolates 
identified two T6SSs, named the T6SS1 and the T6SS2 172. The T6SS has been 
identified across a wide range of Gram-negative bacteria and has been shown to have 
roles in bacterial competition, nutrient acquisition, natural competence and immune 
cell killing. The aim of this PhD was to characterise the roles of the T6SS1 and T6SS2 
of V. vulnificus under environmental conditions to assess the roles of these T6SSs in 
the ecology of this bacterium. 
In vitro bacterial co-culture killing assays demonstrated that attacker V. vulnificus 106- 
2A (T6SS1+/T6SS2+) was able to target and kill prey V. vulnificus 99-743 (T6SS1- 
/T6SS2+), and prey S. Enteritidis CC012 using both the T6SS1 and T6SS2. 
Interestingly, the two systems were differentially thermoregulated. The T6SS1 being 
active at both 21 °C and 30 °C, whereas the T6SS2 was active only at a more 
environmentally representative 21 °C. This is the first described role for the T6SS2 of 
V. vulnificus, suggesting that it may play an important role in bacterial competition in 
vivo. Despite significant anti-prokaryotic killing activity, no anti-eukaryotic killing was 
observed following co-culture with the phagocytic amoeba, D. discoideum, suggesting 
that the role of these T6SSs is primarily antibacterial. This data supports previous 
studies that have explored V. vulnificus T6SS anti-eukaryotic activity using alternative 
models of infection, such as the larvae of the greater wax moth, G. mellonella 172. 
Of interest, this study observed T6SS2-dependent killing of T6SS2+ prey V. vulnificus. 
One possible explanation for this is that V. vulnificus 106-2A may possess different 
T6SS2 effector/immunity modules to prey 99-743. Future work would look at 
undertaking genomic comparisons between T6SS1+/T6SS2+ and T6SS1-/T6SS2+ V. 
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vulnificus to identify differences in effector/immunity modules and the impact this may 
have on bacterial co-culture killing assays. To facilitate this, WGS has been performed 
on V. vulnificus strains for future analysis, however no further research into this area 
was performed during this study. Furthermore, it would be interesting to support 
bioinformatic data with a proteomics-based approach in which V. vulnificus 
secretomes are investigated using mass-spectrometry to identify potential secreted 
effectors of interest. 
Having demonstrated that V. vulnificus employs both the T6SS1 and the T6SS2 to 
target and kill neighbouring bacteria in an intra and inter-species manner, it was 
hypothesised that the T6SSs may play a key role in determining V. vulnificus 
population structure within shellfish hosts. To test this hypothesis, this study aimed to 
characterise V. vulnificus T6SS activity using an in vivo oyster model for replication of 
the natural environment. A marine snow model using seawater as a substrate was 
tested to facilitate sufficient uptake of attacker and prey bacterial strains for in vivo co- 
culture. However, low-level bacterial incorporation into aggregates, contaminating 
natural bacteria, and inconsistent aggregate formation resulted in this being an 
ineffective and unsuitable model. Therefore, a more defined and highly controllable 
artificial marine snow (AMS) model was developed using phytoplankton cultures as a 
substrate for aggregate formation. AMS enabled significant incorporation of attacker 
and prey bacteria into aggregates with none of the drawbacks previously described 
with the NMS model. 
This study identified significant differences in the effectiveness of different bacterial 
strains when incorporating into both NMS and AMS. Previous studies have shown that 
V. vulnificus genotype is an indicator of incorporation efficiency, with E-type V. 
vulnificus demonstrating significantly greater incorporation than their C-type V.
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vulnificus counterparts. There has been surprisingly little research into the mechanics 
by which V. vulnificus incorporates into marine snow aggregates. Currently, the only 
avenue of exploration has identified the role of the T4SS pilus in binding chitin to 
mediate attachment. Future work should investigate the mechanisms behind bacterial 
incorporation into marine snow to understand how this may shape microbial 
communities within shellfish hosts. As S. Enteritidis was shown to incorporate into 
AMS significantly more effectively than even E-type 99-743, chitin adhesion assays 
could be performed using V. vulnificus 106-2A, 99-743 and S. Enteritidis CC012. If 
chitin adhesion is the driving factor behind incorporation into aggregates, then results 
would demonstrate significantly greater S. Enteritidis adhesion to chitin. However, a 
non-significant or even significantly reduced binding to chitin by S. Enteritidis would 
indicate that there are other factors mediating bacterial incorporation to marine snow 
aggregates to be considered. 
AMS was demonstrated to act a suitable substrate for both V. vulnificus and S. 
Enteritidis incorporation and uptake by oysters. Uptake experiments demonstrated 
that incorporation of bacteria into AMS facilitated bacterial uptake into oysters at 
significantly greater concentrations than has been achieved by any other study to date. 
This demonstrates that this study has developed a highly efficient and robust model 
for the inoculation of oysters with bacteria for in vivo study. Due to the versatile nature 
of this model, future work would explore incorporation of different bacterial species into 
these aggregates and how this may be used in downstream research or aquaculture 
applications. 
Having developed an optimised AMS model for the high-level uptake of V. vulnificus 
and S. Enteritidis, this study demonstrated that V. vulnificus 106-2A T6SS1 and T6SS2 
have intra and inter-species killing activity in an oyster model. Significant killing of prey 
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V. vulnificus and S. Enteritidis was observed following co-culture with wild type 106- 
2A and the two single T6SS mutants, T6SS1 and T6SS2. This was confirmed as 
T6SS-dependent through the inclusion of the double mutant, T6SS1/2, with which no 
reduction in prey bacteria was observed. This study therefore demonstrates that V. 
vulnificus utilises both the T6SS1 and the T6SS2 to mediate antibacterial activity in 
vivo, resulting in significant killing of competing bacterial strains. The T6SS is regulated 
by a range of conditions, such as temperature and salinity. Future work would be 
required to characterise the modulation of T6SS activity in vivo under a wider range of 
environmental conditions. There is also a potential question here about how well this 
model may represent genuine in vivo interactions between attacker and prey strains 
in oysters in a natural, non-depurated state. It may therefore be interesting to repeat 
these in vivo studies in a non-depurated oyster model to elucidate further the impact 
of the natural microflora on these interactions. 
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Appendix 1: Schematic demonstrating generation of pVv3-tmp by overlap-extension 
PCR. (A) Overlap-extension primers were designed to amplify pVv3-kan-tmp whilst 
removing the kanamycin resistance cassette from the plasmid. Primers are highlighted in 
yellow, capitalised bases represent those that bind to the plasmid DNA template, lowercase 
letters indicate the 5’ primer tails. Primers were designed so that each 5’ tail is 
complementary to the DNA-binding region (capitalised letters) of the opposing primer. 
These complementary regions are highlighted in boxes of matching colours.  
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Appendix 2: S. Enteritidis CC012 growth on LB agar compared to ChromoSelect 
agar. S. Enteritidis overnight cultures were adjusted to an OD590nm of 0.03 and incubated 
at 37 °C, 200 rpm, until the OD590nm reached 1.0. Cultures were adjusted to an OD590nm of 
0.8 and plated for Miles and Misra enumeration on LB and ChromoSelect agar. Plates were 
incubated overnight at 37 °C and CFU/mL counts determined the following day. Statistics 
performed using an ordinary t-test, ns – not significant. 
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Appendix 1: Growth curves of antibiotic resistant V. vulnificus at 21, 30 and 37 °C. 
Growth curves were performed for V. vulnificus 106-2A pVv3-kan, T6SS1 pVv3-kan, 
T6SS2 pVv3-kan, and 99-743 pVv3-tmp, according to the Materials and Methods (section 
2.4.1). OD590nm readings were taken at T0, T2, T4, T6, T8 and T24 hours before samples were 
serially diluted and plated on LB agar supplemented with the required antibiotic for 
enumeration. Growth curves were performed in triplicate at three individual temperature 
conditions. (A & B) 21 °C. (C & D) 30 °C. (E & F) 37 °C. 
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Appendix 2: Plasmid retention assay of pVv3-Kan and pVv3-Tmp in V. vulnificus 
over 5 hours at 30 °C and 24 hours at 21 °C. Overnight V. vulnificus 106-2A pVv3-kan, 
T6SS1 pVv3-kan, T6SS2 pVv3-kan, T6SS1/2 pVv3-kan, and 99-743 pVv3-tmp 
cultures were adjusted to an OD590nm of 0.03 and grown to an OD590nm of 1.0. Cultures were 
adjusted to an OD590nm of 0.8 and spotted onto selective LB and LB agar with no antibiotics 
for incubation at the required temperature for 5 hours at 30 °C (A) and 24 hours at 21 °C 
(B). T0 cultures were enumerated to quantify the initial concentration of V. vulnificus 
present. Bacterial growths were resuspended and plated onto selective media to determine 
whether there had been a loss in plasmid retention compared to bacteria cultured on 
selective LB. No significant loss of plasmid was noted for either plasmid under either 
temperature/time condition. Statistics were performed using a nested one-way ANOVA, no 
results were significant different to one another. 
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Appendix 4: Total data from in vitro inter-species co-cultures between V. vulnificus 
and S. Enteritidis at 30 and 37 °C. Attacker V. vulnificus 106-2A, T6SS1, and T6SS2 
were co-cultured for 5 hours at 30 °C and 37 °C with prey S. Enteritidis CC012. (A) Co-
culture performed at 30 °C. (B) Co-culture performed at 37 °C. Vertical dotted lines group 
strains that were co-cultured together. Error bars represent the mean (n = 3). Statistics 
were performed using an unpaired, two-tailed student’s t-test, ** p < 0.01. 
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Appendix 4: Total data from in vitro intra-species V. vulnificus co-cultures at 30 
and 37 °C. Attacker V. vulnificus 106-2A, T6SS1, and T6SS2 were co-cultured for 5 
hours at 30 °C and 37 °C with prey V. vulnificus 99-743. (A) Co-culture performed at 30 
°C. (B) Co-culture performed at 37 °C. Vertical dotted lines group strains that were co-
cultured together. Error bars represent the mean (n = 3). Statistics were performed using 
an unpaired, two-tailed student’s t-test, ** p < 0.01. 
 
193 
 
 
 
 
 
A. B. 
99
-7
43
 T
0
99
-7
43
 T
24
99
-7
43
 T
0
99
-7
43
 T
24
10
6-
2A
 T
0
10
6-
2A
 T
24
99
-7
43
 T
0
99
-7
43
 T
24
T
6S
S
1 
T0
T
6S
S
1 
T2
4
99
-7
43
 T
0
99
-7
43
 T
24
T
6S
S
2 
T0
T
6S
S
2 
T2
4
100
101
102
103
104
105
106
107
108
109
1010
1011
1012
C
F
U
/m
l
**
C
C
01
2 
T0
 
C
C
01
2 
T2
4
C
C
01
2 
T0
C
C
01
2 
T2
4
10
6-
2A
 T
0
10
6-
2A
 T
24
C
C
01
2 
T0
C
C
01
2 
T2
4
T
6S
S
1 
T0
T
6S
S
1 
T2
4
C
C
01
2 
T0
C
C
01
2 
T2
4
T
6S
S
2 
T0
T
6S
S
2 
T2
4
100
101
102
103
104
105
106
107
108
109
1010
1011
1012
C
F
U
/m
l
**
Appendix 8: Sequence confirmation of in-frame hcp2 deletion in V. vulnificus 
T6SS1 to generate T6SS1/2. The hcp2 region was PCR amplified and sequenced to 
confirm no mutations had been introduced during allelic exchange. Truncated hcp2 is 
marked with both start and stop codons boxed in red. Ligation of the left and right flanks 
has reduced the gene from 466 bp to 42 bp. The sequence data for the region is 
displayed above. 
 
Appendix 7: Total data from in vitro intra and inter-species co-culture killing 
assays at 21 °C. Attacker V. vulnificus 106-2A, T6SS1, and T6SS2 were co-cultured 
for 24 hours at 21 °C with either (A) V. vulnificus 99-743 or (B) S. Enteritidis CC012 prey 
strains. Vertical dotted lines group strains that were co-cultured together. Error bars 
represent the mean (n = 3). Statistics were performed using an unpaired, two-tailed 
student’s t-test,** p < 0.01. 
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Appendix 5: Growth curves of T6SS1/2 and T6SS1/2 pVv3-kan at 21, 30 and 37 °C. 
Growth curves were performed for V. vulnificus T6SS1/2 pVv3-kan and T6SS1/2 pVv3-
kan according to the Materials and Methods (section 2.4.1). OD590nm readings were taken 
at T0, T2, T4, T6, T8 and T24 hours before samples were serially diluted and plated on LB 
agar supplemented with kanamycin for enumeration. Growth curves were performed at (A 
& B) 21 °C. (C & D) 30 °C. (E & F) 37 °C. 
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Appendix 10: SEM visualisation of V. vulnificus 99-743 incorporation into RP-based 
artificial marine snow. V. vulnificus 99-743 was incorporated into RP-based AMS and 
processed for SEM visualisation. (A) RP-only negative control, magnification × 9,000. (B) 
Adhesion control, magnification × 7,000. (C) 99-743 only control, magnification × 7,000. (D 
& E) 99-743 incorporated into AMS, magnification × 9,000 and × 3,000 respectively. 
A. B. 
C. D. 
E. 
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Appendix 11: SEM visualisation of V. vulnificus 106-2A incorporation into RP-based 
artificial marine snow. V. vulnificus 106-2A was incorporated into RP-based AMS and 
processed for SEM visualisation. (A) RP-only control, magnification × 11,000. (B) Adhesion 
control, magnification × 7,000. (C) 106-2A only control, magnification × 15,000. (D & E) 
106-2A Incorporated into AMS, magnification × 7,000. 
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Appendix 6: V. vulnificus incorporation into T. pseudonana artificial marine snow 
using separate TP1800 batches. V. vulnificus 106-2A and 99-743 were incorporated into 
AMS formed using three individual TP1800 samples at 21 °C for 24 hours. Negative 
controls were plated on LB and TCBS agar. Error bars represent the standard deviation (n 
= 3).  
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Appendix 13: SEM visualisation of V. vulnificus and S. Enteritidis incorporation into 
T. pseudonana artificial marine snow. V. vulnificus 106-2A, 99-743, and S. Enteritidis 
CC012 were incorporated into AMS using T. pseudonana as a substrate for 24 hours at 21 
°C. (A) Adhesion control, magnification × 5,000. (B) V. vulnificus 106-2A incorporated into 
AMS, magnification × 4,000. (C) V. vulnificus 99-743 incorporated into AMS, magnification 
× 4,000. (D) S. Enteritidis CC012 incorporated into AMS, magnification × 4,000. 
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Appendix 14: Plasmid maps for qPCR standard curve material. vvhA, vgrG1, vcgE and 
sefA gene regions were cloned into pGEM-T Easy to generate constructs for qPCR 
standard curves. Primer binding sites for qPCR primers have been labelled. 
 
 
 
 
 
 
 
pGEM-T Easy-vgrG1 
 
 
 
 
 
 
pGEM-T Easy-vvhA 
 
 
 
 
 
 
pGEM-T Easy-vcgE 
 
 
 
 
 
 
 
pGEM-T Easy-sefA 
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Appendix 15: qPCR primer and probe binding sites. Gene regions for vvhA, vgrG1, 
vcgE, and sefA regions are shown with the qPCR forward/reverse primers and probes 
binding sites marked. 
D. 
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Appendix 16: vcgE qPCR standard curve showing ineffective amplification of 102 and 
101 copies/L standards. (A) Amplification of qPCR standards from 108 – 101 copies/L. 
Each standard was run in triplicate to account for pipetting error. (B) A representative vcgE 
standard curve generated using the amplification from the top image. An r2 value of 0.956 
indicates that this curve would be unsuitable for quantification as it does not reach the 
required 0.99 value. 
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